0001495584 Firsthand Technology Value Fund, Inc. false --12-31 FY 2023 true 2,629 3,235 1,260,371 30,609,591 0.001 0.001 100,000,000 100,000,000 1,260,371 30,609,591 8.8 June 10, 2016 June 10, 2016 November 07, 2016 333.2 10 December 29, 2022 10 December 29, 2022 September 18, 2015 August 7, 2017 February 1, 2019 August 7, 2019 February 12, 2020 July 9, 2018 September 4, 2018 February 01, 2019 August 07, 2017 September 28, 2017 7.0 15 October 11, 2019 15 October 22, 2021 15 October 29, 2019 15 October 6, 2021 500,000 500,000 1,577 15 November 12, 2021 500,000 15 November 29, 2021 500,000 15 December 31, 2018 10,961,129 15 February 27, 2020 1,000,000 15 February 28, 2022 200,000 15 March 25, 2020 500,000 15 March 30, 2022 150,000 150,000 15 April 20, 2021 1,000,000 15 April 6, 2022 350,000 15 May 8, 2020 400,000 15 June 10, 2021 500,000 15 June 10, 2022 700,000 15 July 12, 2019 1,300,000 15 July 16, 2021 500,000 500,000 15 July 31, 2020 15 August 28, 2020 15 September 22, 2021 July 12, 2013 8 February 10, 2017 8 February 28, 2014 7.9 10 March 11, 2019 0.0 July 3, 2018 306.5 November 14, 2016 October 3, 2022 23.8 April 18, 2011 0.0 June 7, 2019 12 January 10, 2023 12 October 13, 2020 12 October 20, 2021 12 October 21, 2022 12 October 5, 2021 12 November 11, 2020 12 November 14, 2022 12 November 23, 2021 12 November 24, 2020 12 December 11, 2020 12 December 23, 2020 12 December 28, 2021 12 December 9, 2021 12 December 23, 2021 12 December 9, 2022 12 March 11, 2022 12 April 12, 2022 12 April 14, 2022 12 May 10, 2022 12 May 18, 2021 12 May 26, 2022 12 June 10, 2022 12 June 22, 2021 12 June 28, 2022 12 June 7, 2019 12 July 13, 2022 12 July 26, 2021 12 July 28, 2022 12 August 12, 2020 12 August 12, 2022 12 August 19, 2021 12 September 10, 2022 12 September 22, 2021 18 August 25, 2023 June 7, 2019 July 20, 2020 5.8 133,967,669 693.0 593.0 100.0 2.9 June 10, 2016 June 10, 2016 November 07, 2016 25.8 5 December 29, 2022 1,200,000 10 December 29, 2022 5,359,791 September 18, 2015 August 7, 2017 February 01, 2019 August 7, 2019 February 12, 2020 July 9, 2018 September 04, 2018 February 01, 2019 August 07, 2017 September 28, 2017 55.9 15 December 31, 2018 10,961,129 15 July 12, 2019 1,300,000 15 October 11, 2019 500,000 15 October 29, 2019 500,000 15 February 27, 2020 1,000,000 15 March 25, 2020 500,000 15 May 08, 2020 400,000 15 July 31, 2020 500,000 15 August 08, 2020 750,000 15 April 20, 2021 1,000,000 15 June 10, 2021 500,000 15 July 16, 2021 500,000 15 September 22, 2021 500,000 15 October 06, 2021 500,000 15 October 22, 2021 1,000,000 15 November 12, 2021 500,000 15 November 29, 2021 500,000 15 February 28, 2022 200,000 15 March 30, 2022 150,000 15 April 6, 2022 350,000 15 June 06, 2022 700,000 July 12, 2013 26,856,187 8 February 28, 2014 3,000,000 8 February 10, 2017 2,000,000 0.3 10 March 11, 2019 100,000 0.0 July 03, 2018 869,792 11.5 November 14, 2016 October 02, 2022 39,774,889 2.4 April 18, 2011 5,704,480 April 18, 2011 82,914 April 18, 2011 850,830 April 18, 2011 921,892 April 18, 2011 37,982 April 18, 2011 912,453 March 10, 2016 48,370,793 March 10, 2016 837,942 1.1 April 18, 2011 1,500,000 29.0 April 11, 2013 May 06, 2019 69,102 12 June 07, 2019 4,929,015 12 August 12, 2020 750,000 12 September 10, 2020 900,000 12 October 13, 2020 1,050,000 12 November 11, 2020 400,000 12 November 24, 2020 375,000 12 December 11, 2020 400,000 12 December 23, 2020 2,000,000 12 February 23, 2021 1,400,000 12 April 12, 2021 1,200,000 12 May 18, 2021 1,000,000 12 June 22, 2021 1,000,000 12 July 26, 2021 1,000,000 12 August 19, 2021 1,000,000 12 September 22, 2021 300,000 12 October 5, 2021 700,000 12 October 20, 2021 1,000,000 12 November 23, 2021 1,000,000 12 December 28, 2021 1,000,000 12 February 23, 2022 200,000 12 March 11, 2022 185,000 12 April 14, 2022 65,000 12 May 10, 2022 250,000 12 May 26, 2022 250,000 12 June 10, 2022 250,000 12 June 28, 2022 250,000 12 July 13, 2022 250,000 12 July 28, 2022 250,000 250,000 12 August 12, 2022 250,000 250,000 12 October 21, 2022 135,000 135,000 12 November 14, 2022 165,000 165,000 12 December 09, 2022 125,000 125,000 July 20, 2020 60,733,693 17,355,887 June 07, 2019 609,756 0 2.2 142,790,010 131.1 31.1 100.0 30,609,591 7.21 4.11 3.12 3.10 2.84 — — — 8.02 9.91 7.21 4.11 3.12 11.12 12.75 7.21 4.11 3.12 3.10 2.80 8.13 20.96 2.94 0.64 3.93 — — — — 0.33 8.13 20.96 2.94 0.64 3.60 1 15 16 13 18 April 18, 2011 3 3 3 2.5 613,650 0.4 4.2 0.0 0.1 0.1 0.2 7.9 8.9 0.9 0.2 17.1 0 0 December 31, 2024 December 31, 2025 December 31, 2027 December 31, 2028 0 April 26, 2016 September 30, 2016 November 10, 2017 October 24, 2018 23.2702 4,467 20 false false false false Per share results are calculated based on weighted average shares outstanding for each period. Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only. Controlled investments. Primary exposure is equity risk. As of December 31, 2022, the Fund used various methods to develop fair market estimates. Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses). Includes warrants whose primary risk exposure is equity contracts. Security whose interest accrues over the life of the Note and is not payable until maturity. An interest adjustment was made in 2022. See Note 2 to the financial statements. Fair Value Level 3 security. (117% of net assets). Non-income producing security. CDI:CHESS Depositary Interests Calculated using average shares outstanding. The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of December 31, 2022 was $(30,670,079). The Fidelity Investments Money Market Portfolio invests primarily in U.S. Treasury securities. Includes Fidelity Investment Money Market Treasury Portfolio - Class I, which invests primarily in U.S. Treasury securities. The yields as of 12/31/22 and 12/31/21 were 4.13% and 0.01%, respectively. Please see  for additional information. An increase in the input would result in an increase in the security's valuation; a decrease in the input would result in a decrease in the security's valuation. Restricted security. Fair Value is determined by or under the direction of the Company's Board of Directors (see Note 3). At December 31, 2023, we held $4,797,872 (or 380.7% of net assets) in restricted securities (see Note 2). Affiliated issuer. The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities. Asset derivatives include warrants. Fair Value Level 3 security. (380.7% of net assets). Restricted security. Fair Value is determined by or under the direction of the Company's Board of Directors (See note 3). At December 31, 2022, we held $35,929,005 (or 117.4% of net assets) in restricted securities (see Note 2). Amount includes the incentive fee. For the year ended December 31, 2019, the ratio of the incentive fee to average net assets was (5.64)% The deferred tax expense and tax benefit are based on average net assets. Controlled Investments. As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense. Security whose interest accrues until maturity however, based on December 31, 2023 valuation no such interest accrued during year ended December 31, 2023. 5.23 4.13 5.23 4.13 8 1.0 0.9 5 5 50 50 3.84 3.84 22.7 22.7 2.1 2.1 0 0 5 5 50 50 3.84 3.84 4.01 4.01 1.2 1.5 1.4 5.7 7.6 6.7 0.7 1.0 0.9 5 5 50 50 3.99 3.99 22.7 22.7 5.2 5.2 5 5 60 60 3.99 3.99 5 5 50 50 3.99 3.99 0.0 22.7 0.0 10 10 2.6 3.5 3.2 5 5 50 50 3.99 3.99 12.5 12.5 5 5 55 55 3.99 3.99 0.0 24.3 0.0 2.2 2.5 2.32

 0001495584 2023-01-01 2023-12-31
 0001495584 2023-12-31
 0001495584 2024-03-01
 thunderdome:item
 0001495584 us-gaap: InvestmentUnaffiliatedIssuerMember 2023-12-31
 0001495584 us-gaap: InvestmentUnaffiliatedIssuerMember 2022-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerMember 2023-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerMember 2022-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 2022-12-31
 0001495584 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember srt: MinimumMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember srt: MaximumMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember srt: MinimumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember srt: MaximumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember srt: MinimumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember srt: MaximumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember srt: MinimumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember srt: MaximumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNote2Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNote2Member 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: KymaIncMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: KymaIncMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: KymaIncMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: LynceanTechnologiesIncMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: LynceanTechnologiesIncMember us-gaap: SeriesBPreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: LynceanTechnologiesIncMember us-gaap: SeriesBPreferredStockMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember srt: MinimumMember 2023-01-01 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember srt: MaximumMember 2023-01-01 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: UCTCoatingsIncMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt33Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt33Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt34Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt34Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember srt: MinimumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember srt: MaximumMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2023-12-31
 0001495584 svvc: InvestmentSectorMember svvc: FidelityInvestmentsCompanyMember 2023-12-31
 0001495584 svvc: RestrictedSecuritiesMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member svvc: RestrictedSecuritiesMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember srt: MinimumMember 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember srt: MaximumMember 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember srt: MinimumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember srt: MaximumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember srt: MinimumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember srt: MaximumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember srt: MinimumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember srt: MaximumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNote2Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: IntraOpMedicalCorpIMember svvc: TermNote2Member 2022-01-01 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: KymaIncMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: KymaIncMember us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: KymaIncMember us-gaap: ConvertibleDebtMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: LynceanTechnologiesIncMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: LynceanTechnologiesIncMember us-gaap: SeriesBPreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: LynceanTechnologiesIncMember us-gaap: SeriesBPreferredStockMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember srt: MinimumMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember srt: MaximumMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: UCTCoatingsIncMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember us-gaap: CommonStockMember srt: MinimumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember us-gaap: CommonStockMember srt: MaximumMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2022-12-31
 0001495584 svvc: InvestmentSectorMember svvc: FidelityInvestmentsCompanyMember 2022-12-31
 0001495584 svvc: InvestmentSectorMember us-gaap: InvestmentUnaffiliatedIssuerMember 2022-12-31
 0001495584 svvc: InvestmentSectorMember 2022-12-31
 0001495584 svvc: RestrictedSecuritiesMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member svvc: RestrictedSecuritiesMember 2022-12-31
 0001495584 2021-01-01 2021-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlledMember 2023-01-01 2023-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlledMember 2022-01-01 2022-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlledMember 2021-01-01 2021-12-31
 0001495584 2021-12-31
 0001495584 2020-12-31
 0001495584 2019-12-31
 0001495584 2018-12-31
 0001495584 2020-01-01 2020-12-31
 0001495584 2019-01-01 2019-12-31
 0001495584 2011-04-18 2011-04-18
 0001495584 us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: TechnologyCompaniesMember srt: MinimumMember 2023-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SmallcapStocksCompaniesMember srt: MinimumMember 2023-12-31
 0001495584 us-gaap: TechnologySectorMember srt: MinimumMember 2023-12-31
 0001495584 us-gaap: TechnologySectorMember srt: MaximumMember 2023-12-31
 0001495584 svvc: CaymanSubsidiariesMember 2018-12-17 2018-12-17
 0001495584 us-gaap: VentureCapitalFundsMember 2023-12-31
 0001495584 svvc: RestrictedSecuritiesMember 2023-12-31
 0001495584 svvc: RestrictedSecuritiesMember 2022-12-31
 0001495584 2023-09-30
 0001495584 svvc: PurchasedOptionsMember 2023-12-31
 0001495584 us-gaap: WarrantMember 2023-12-31
 0001495584 svvc: WrittenOptionsMember 2023-12-31
 0001495584 srt: ManagementMember 2023-09-30
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel1Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel2Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: MutualFundMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: MutualFundMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: MutualFundMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel1Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel2Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member us-gaap: MutualFundMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member us-gaap: MutualFundMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: MutualFundMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel1Member 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel2Member 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2023-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: CommonStockMember 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: PreferredStockMember 2021-12-31
 0001495584 us-gaap: EquityContractMember us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2021-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: EquitySecuritiesMember 2021-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2021-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2022-01-01 2022-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member us-gaap: ConvertibleDebtMember 2021-12-31
 0001495584 us-gaap: FairValueInputsLevel3Member 2021-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member 2022-12-31
 0001495584 svvc: DifferenceInTaxRateDueToChangesInDeferredTaxAssetsMember 2023-01-01 2023-12-31
 0001495584 svvc: DifferenceInTaxRateDueToChangesInDeferredTaxAssetsMember 2022-01-01 2022-12-31
 utr: Y
 0001495584 svvc: CarryforwardExpirationDate1Member 2023-01-01 2023-12-31
 0001495584 us-gaap: CapitalLossCarryforwardMember svvc: CarryforwardExpirationDate1Member 2023-12-31
 0001495584 svvc: CarryforwardExpirationDate2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: CapitalLossCarryforwardMember svvc: CarryforwardExpirationDate2Member 2023-12-31
 0001495584 svvc: CarryforwardExpirationDate3Member 2023-01-01 2023-12-31
 0001495584 us-gaap: CapitalLossCarryforwardMember svvc: CarryforwardExpirationDate3Member 2023-12-31
 0001495584 svvc: CarryforwardExpirationDate4Member 2023-01-01 2023-12-31
 0001495584 us-gaap: CapitalLossCarryforwardMember svvc: CarryforwardExpirationDate4Member 2023-12-31
 0001495584 us-gaap: CapitalLossCarryforwardMember 2023-12-31
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2016-04-26 2016-04-26
 0001495584 srt: MaximumMember svvc: InvestmentCompanyShareRepurchasePlanMember 2016-04-26
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2016-09-01 2016-09-30
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2017-11-10 2017-11-10
 0001495584 srt: MaximumMember svvc: InvestmentCompanyShareRepurchasePlanMember 2017-11-10
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2017-11-10 2017-12-31
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2017-12-31
 0001495584 srt: MaximumMember svvc: InvestmentCompanyShareRepurchasePlanMember 2018-08-31
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2018-10-24 2018-10-24
 0001495584 svvc: InvestmentCompanyShareRepurchasePlanMember 2018-12-31
 0001495584 srt: MaximumMember svvc: InvestmentCompanyTenderOfferMember 2014-12-22
 0001495584 svvc: InvestmentCompanyTenderOfferMember 2014-12-22 2014-12-22
 0001495584 svvc: InvestmentCompanyTenderOfferMember 2014-12-31
 0001495584 svvc: InvestmentCompanyTenderOfferMember 2014-12-22
 0001495584 svvc: InvestmentCompanyModifiedDutchAuctionTenderOfferMember 2019-12-16
 0001495584 srt: MinimumMember svvc: InvestmentCompanyModifiedDutchAuctionTenderOfferMember 2019-12-16 2019-12-16
 0001495584 srt: MaximumMember svvc: InvestmentCompanyModifiedDutchAuctionTenderOfferMember 2019-12-16 2019-12-16
 0001495584 svvc: InvestmentCompanyModifiedDutchAuctionTenderOfferMember 2019-12-16 2019-12-16
 0001495584 svvc: InvestmentCompanyModifiedDutchAuctionTenderOfferMember 2020-02-14 2020-02-14
 0001495584 svvc: InvestmentCompanyModifiedDutchAuctionTenderOfferMember 2020-03-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-01-01 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt22Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt22Member 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt22Member 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-01-01 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2023-01-01 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-01-01 2023-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-01-01 2023-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-01-01 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt33Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt33Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt33Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: ConvertibleDebt34Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt34Member 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt34Member 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2023-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlledMember 2022-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlledMember 2023-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerControlled1Member 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: EQXCapitalIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-01-01 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt3Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt3Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt4Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt4Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt5Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt5Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt6Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt6Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt7Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt7Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt8Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt8Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt9Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt9Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt10Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt10Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt11Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt11Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt12Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt12Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt13Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt13Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt14Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt14Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt15Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt15Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt16Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt16Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt17Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt17Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt18Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt18Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt19Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt19Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt20Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt20Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt21Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt21Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt22Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt22Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt22Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt23Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt23Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt23Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt24Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt24Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt24Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt25Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt25Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt25Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt26Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt26Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt26Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt27Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt27Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt27Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt28Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt28Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt28Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt29Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt29Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt29Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt30Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt30Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt30Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt31Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt31Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt31Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt32Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt32Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt32Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt33Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt33Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt33Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt34Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt34Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt34Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt35Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt35Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt35Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt36Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt36Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: ConvertibleDebt36Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesBPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrantsMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants2Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants3Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember svvc: SeriesBPreferredStockWarrants4Member 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember us-gaap: SeriesCPreferredStockMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt22Member 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt22Member 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: ConvertibleDebt22Member 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember us-gaap: SeriesCPreferredStockMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: IntraOpMedicalCorpIMember svvc: TermNoteMember 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-01-01 2022-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: PivotalSystemsCorpMember svvc: ChessDepositaryInterestsCDIsMember 2021-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: PivotalSystemsCorpMember svvc: ChessDepositaryInterestsCDIsMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: PivotalSystemsCorpMember svvc: ChessDepositaryInterestsCDIsMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SVXRIncMember us-gaap: SeriesAPreferredStockMember 2021-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SVXRIncMember us-gaap: SeriesAPreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SVXRIncMember us-gaap: SeriesAPreferredStockMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2021-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: RevasumIncMember svvc: ChessDepositaryInterestsCDIsMember 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-01-01 2022-12-31
 0001495584 svvc: SemiconductorEquipmentSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: CommonStockWarrantMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesC1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesD1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesE1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesF1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesG1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: SiliconGenesisCorpMember svvc: SeriesH1PreferredStockMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-01-01 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2021-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: UCTCoatingsIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-01-01 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember us-gaap: CommonStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt1Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt2Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt3Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt4Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt5Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt6Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt7Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt8Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt9Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt10Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt11Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt12Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt13Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt14Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt15Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt16Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt17Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt18Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt19Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt20Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt21Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt22Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt23Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt24Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt25Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt26Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt27Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt28Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt29Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt30Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt31Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: ConvertibleDebt32Member 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: WrightspeedIncMember svvc: SeriesAAPreferredStockWarrantsMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember 2022-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlled1Member 2021-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlled1Member 2022-01-01 2022-12-31
 0001495584 svvc: InvestmentAffiliatedIssuerAndControlled1Member 2022-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerMember 2021-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerControlledMember 2021-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerMember svvc: HeraSystemsIncMember srt: MinimumMember 2023-12-31
 0001495584 us-gaap: InvestmentAffiliatedIssuerMember svvc: RevasumIncMember srt: MinimumMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember 2023-01-01 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember 2022-01-01 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: InvestmentAffiliatedIssuerControlledMember svvc: HeraSystemsIncMember 2021-01-01 2021-12-31

 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: MinimumMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: MaximumMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember svvc: ValuationTechniqueMarketValueOfInvestedCapitalMember 2023-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember svvc: ValuationTechniqueMarketValueOfInvestedCapitalMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember svvc: ValuationTechniqueLiquidationValueMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember svvc: ValuationTechniqueLiquidationValueMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: MinimumMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: MaximumMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: MedicalDevicesSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2023-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: MinimumMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: MaximumMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: MinimumMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: MaximumMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: AdvancedMaterialsSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AerospaceSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember svvc: ValuationTechniquePriorTransactionAnalysisMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember svvc: ValuationTechniquePriorTransactionAnalysisMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: MinimumMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: MaximumMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: WeightedAverageMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member svvc: MeasurementInputGoingConcernProbabilityMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 us-gaap: AutomotiveSectorMember us-gaap: FairValueInputsLevel3Member svvc: MeasurementInputGoingConcernProbabilityMember srt: WeightedAverageMember svvc: ValuationTechniqueProbabilityweightedExpectedReturnMethodMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: MinimumMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: MaximumMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputEbitdaMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember svvc: ValuationTechniqueLiquidationValueMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember svvc: ValuationTechniqueLiquidationValueMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: EquipmentLeasingSectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member svvc: MeasurementInputWeightedAverageCostOfCapitalMember us-gaap: ValuationTechniqueDiscountedCashFlowMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member svvc: MeasurementInputWeightedAverageCostOfCapitalMember srt: WeightedAverageMember us-gaap: ValuationTechniqueDiscountedCashFlowMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputMaturityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputPriceVolatilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRiskFreeInterestRateMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: MinimumMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: MaximumMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputDiscountForLackOfMarketabilityMember srt: WeightedAverageMember us-gaap: ValuationTechniqueOptionPricingModelMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: MinimumMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: MaximumMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31
 0001495584 svvc: IntellectualPropertySectorMember us-gaap: FairValueInputsLevel3Member us-gaap: MeasurementInputRevenueMultipleMember srt: WeightedAverageMember us-gaap: MarketApproachValuationTechniqueMember 2022-12-31

 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

 Form 10-K

 (Mark One)

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal year ended December 31, 2023
 or

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from to

 Commission file number: 814-00830

 (Exact name of registrant as specified in its charter)

 Maryland (State or other jurisdiction of incorporation or organization)

 27-3008946 (I.R.S. Employer Identification No.)

 150 Almaden Boulevard, Suite 1250 San Jose, California 95113 (Address and zip code of principal executive offices)

 ( 408) 886-7096 (Registrant ' s telephone number, including area code)

 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class

 Name of each exchange on which registered

 Common Stock, $0.001 par value

 The NASDAQ Global Market

 Securities registered pursuant to Section 12(g) of the Act: None

 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

 Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes No

 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in the definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 Emerging growth company

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No

 The aggregate market value of the Common Stock held by non-affiliates of the registrant as of December 31, 2023 was approximately $ 1 million (computed using the closing price of $0.30 per share of Common Stock on December 31, 2023, as reported by OTC Markets Group.

 As of March 1, 2024, Firsthand Technology Value Fund had 6,893,056 shares of common stock, par value $0.001 per share, outstanding.

 DOCUMENTS INCORPORATED BY REFERENCE

 Portions of the registrant's definitive proxy statement prepared in connection with the Annual Meeting of Stockholders to be held in 2023 are incorporated by reference in Part III of this Form 10-K.

 Item 1. Business

 Item 1A. Risk Factors

 Item 1B. Unresolved Staff Comments

 Item 1C. C ybersecurity

 Item 2. Properties

 Item 3. Legal Proceedings

 Item 4. Mine Safety Disclosures

 Item 5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

 Item 6. Selected Financial Data

 Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A. Quantitative And Qualitative Disclosures About Market Risk

 Item 8. Financial Statements and Supplementary Data

 Item 9. Changes In And Disagreements With Accountants On Accounting And Financial Disclosure

 Item 9A. Controls and Procedures

 Item 9B. Other Information

 Item 10. Directors, Executives Officers And Corporate Governance

 Item 11. Executive Compensation

 Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 Item 13. Certain Relationships and Related Transactions, and Director Independence

 Item 14. Principal Accountant Fees and Services

 Item 15. Exhibits, Financial Statements Schedules

 Item 1.

 Business

 FORWARD LOOKING STATEMENTS

 This report, and other statements that we may make, may contain forward-looking statements, which relate to future events or our future performance or financial condition. We use words such as "anticipates," "believes," "expects," "plans," "will," "may," "continues," "seeks," "likely," "intends," and similar expressions to identify forward-looking statements. The forward-looking statements contained in this Annual Report on Form 10-K involve risks and uncertainties, including forward-looking statements as to:

 our future operating results,

 our business prospects and the prospects of our prospective portfolio companies,

 the impact of investments that we expect to make,

 our contractual arrangements and relationships with third parties,

 the dependence of our future success on the general economy and its impact on the industries in which we invest,

 the ability of our prospective portfolio companies to achieve their objectives,

 our expected financings and investments,

 the adequacy of our cash resources and working capital, and

 the timing of cash flows, if any, from the operations of our prospective portfolio companies.

 Our actual results could differ materially from those projected in the forward-looking statements for any reason, including the factors set forth in "Risk Factors" and elsewhere in this Annual Report on Form 10-K. In addition, several factors that could materially affect our actual results are the ability of the portfolio companies in which we invest to achieve their objectives; our ability to source favorable private investments; changes in the securities markets, especially the markets for technology companies including those that may be early stage or micro-cap companies; the dependence of our future success of the general economy and its impact on the industries in which we invest and other factors discussed in our periodic filings with the Securities and Exchange Commission (the "SEC").

 Unpredictable or unknown factors could also have material adverse effects on us. Since our actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements, we cannot give any assurance that any of the events anticipated by the forward-looking statements will occur, or, if any of them do, what impact they will have on our results of operations and financial condition. All forward-looking statements included in this Annual Report on Form 10-K are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the risk factors contained in this Annual Report on Form 10-K, whether as a result of new information, future events or otherwise, except as may be required under the federal securities laws. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC.

 GENERAL

 Firsthand Technology Value Fund, Inc. ("we," "us," "our," the "Company", the "Fund," or "SVVC") is an externally managed, closed-end, non-diversified management investment company organized as a Maryland corporation that has elected to be treated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). As such, we are required to comply with certain regulatory requirements. For instance, we generally have to invest at least 70 percent of our total assets in "qualifying assets," including securities of private or micro-cap public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments a RIC and will be taxed as a C corporation for tax purposes. Firsthand Capital Management, Inc. (the "Investment Adviser", the "Adviser", or "FCM") serves as our investment adviser and manages the investment process on a daily basis.

 We were incorporated under the Maryland General Corporation Law in April 2010 and acquired our initial portfolio of securities through the reorganization (the "Reorganization") into us of Firsthand Technology Value Fund ("TVF"), an open-end mutual fund and a series of Firsthand Funds, which is a Delaware statutory trust. The reorganization was completed on April 15, 2011 and we commenced operations on April 18, 2011.

 Our investment objective is to seek long-term growth of capital, principally by seeking capital gains on our equity and equity-related investments. There can be no assurance that we will achieve our investment objective. Under normal circumstances, we invest at least 80 percent of our total assets for investment purposes in technology companies. We consider technology companies to be those companies that derive at least 50 percent of their revenues from products and/or services within the information technology sector and in the "cleantech" sector. Information technology companies include, but are not limited to, those focused on computer hardware, software, telecommunications, networking, Internet, and consumer electronics. While there is no standard definition of cleantech, it is generally regarded as including goods and services designed to harness renewable energy and materials, eliminate emissions and waste, and reduce the use of natural resources. In addition, under normal circumstances we invest at least 70 percent of our assets in privately held companies and public companies with market capitalizations less than $250 million. Our portfolio is primarily composed of equity and equity derivative securities of technology and cleantech companies (as defined above). These investments generally range between $1 million and $10 million each, although the investment size will vary proportionately with the size of our capital base. We acquire our investments through direct investments in private companies, negotiations with selling shareholders, and in organized secondary marketplaces for private securities.

 While our primary focus is to invest in illiquid private technology and cleantech companies, we may also invest in micro-cap publicly traded companies. In addition, we may invest up to 30% of the portfolio in opportunistic investments that do not constitute the private companies and micro-cap public companies described above. These other investments may include investments in securities of public companies that are actively traded. These other investments may also include investments in high-yield bonds, distressed debt, or securities of public companies that are actively traded; and securities of companies located outside of the United States. Our investment activities are managed by FCM.

 Neither our investments nor an investment in us are intended to constitute a balanced investment program. We expect to be risk-seeking rather than risk-averse in our investment approach. There is no assurance that our investment objective will be achieved.

 We invest a substantial portion of our assets in securities that we consider to be private venture capital equity investments. These private venture capital equity investments usually do not pay interest or dividends and usually are subject to legal or contractual restrictions on resale that may adversely affect the liquidity and marketability of such securities. We expect to make speculative venture capital investments with limited marketability and a greater risk of investment loss than less-speculative investments. We are not limited by the diversification requirements applicable to a regulated investment company ("RIC"), which means that we may commit all of our assets to only a few investments.

 Subject to continuing to meet the compliance tests applicable to BDCs, there are no limitations on the types of securities or other assets in which we may invest. Investments may include the following:

 Venture capital investments, whether in corporate, partnership, or other form, including development-stage or start-up entities;

 Equity, equity-related securities (including options and warrants), and debt with equity features from either private or public issuers;

 Debt obligations of all types having varying terms with respect to security or credit support, subordination, purchase price, interest payments, and maturity;

 Foreign securities;

 Intellectual property or patents or research and development in technology or product development that may lead to patents or other marketable technology; and

 Miscellaneous investments.

 The table below provides a summary of our investments as of December 31, 2023.

 INVESTMENT

 BUSINESS DESCRIPTION

 FAIR VALUE 1

 EQX Capital, Inc.

 $

 110,227

 Fidelity Investments Money Market Treasury Portfolio - Class I 2

 Investment Company

 Hera Systems, Inc.

 IntraOp Medical Corp.

 Kyma, Inc.

 Lyncean Technologies, Inc.

 Revasum, Inc. 2

 UCT Coatings, Inc.

 Wrightspeed, Inc.

 Fair value for our private company holdings was determined in good faith by our Board of Directors (the " Board " or " Board of Directors ") on December 31, 2023. For public companies, the figure represents the market value of our securities on December 31, 2023, less any discount due to resale restriction on the security.

 Public company.

 INVESTMENTS AND STRATEGIES

 The following is a summary description of the types of assets in which we may invest, the investment strategies we may use, and the attendant risks associated with our investments and strategies.

 VENTURE CAPITAL INVESTMENTS

 We define venture capital as the money and resources made available to privately held start-up firms and privately held and publicly traded small businesses with exceptional growth potential. These businesses can range in stage from pre-revenue to generating positive cash flow. Most of our long-term venture capital investments are in thinly capitalized, unproven, small companies focused on commercializing risky technologies. These businesses also tend to lack management depth, have limited or no history of operations, and have not attained profitability. Because of the speculative nature of these investments, these securities have a significantly greater risk of loss than traditional investment securities. Some of our venture capital investments will never realize their potential, and some will be unprofitable or result in the complete loss of our investment.

 We acquire our investments through direct investments in private companies, negotiations with selling shareholders, and in organized secondary marketplaces for private securities. Our current focus is on investing in late-stage private companies, particularly those with potential for near-term realizations by way of initial public offering ("IPO") or acquisition.

 In connection with our venture capital investments, we may participate in providing a variety of services to our portfolio companies, including the following:

 Recruiting management,

 Formulating operating strategies,

 Formulating intellectual property strategies,

 Assisting in financial planning,

 Providing management in the initial start-up stages, and

 Establishing corporate goals.

 We may assist in raising additional capital for these companies from other potential investors and may subordinate our own investment to that of other investors. We typically find it necessary or appropriate to provide additional capital of our own. We may introduce these companies to potential joint venture partners, suppliers, and customers. In addition, we may assist in establishing relationships with investment bankers and other professionals. We may also assist with mergers and acquisitions ("M&As"). We do not currently derive income from these companies for the performance of any of the above services.

 We may control, be represented on, or have observer rights on the board of directors of a portfolio company through one or more of our officers or directors, who may also serve as officers of the portfolio company. We indemnify our officers and directors for serving on the board of directors or as officers of portfolio companies, which exposes us to additional risks. Particularly during the early stages of an investment, we may, in rare instances, in effect be conducting the operations of the portfolio company. Our goal is to assist each company in establishing its own independent capitalization, management, and board of directors. As a venture capital-backed company emerges from the developmental stage with greater management depth and experience, we expect that our role in the portfolio company's operations will diminish.

 EQUITY, EQUITY-RELATED SECURITIES AND DEBT WITH EQUITY FEATURES

 We may invest in equity, equity-related securities, and debt with equity features. These securities include common stock, preferred stock, debt instruments convertible into common or preferred stock, limited partnership interests, other beneficial ownership interests and warrants, options, or other rights to acquire any of the foregoing.

 We may make investments in companies with operating histories that are unprofitable or marginally profitable, that have negative net worth, or that are involved in bankruptcy or reorganization proceedings. These investments would involve businesses that management believes have potential through the infusion of additional capital and management assistance. In addition, we may make investments in connection with the acquisition or divestiture of companies or divisions of companies. There is a significantly greater risk of loss with these types of securities than is the case with traditional investment securities.

 Warrants, options, and convertible or exchangeable securities generally give the investor the right to acquire specified equity securities of an issuer at a specified price during a specified period or on a specified date. Warrants and options fluctuate in value in relation to the value of the underlying security and the remaining life of the warrant or option, while convertible or exchangeable securities fluctuate in value both in relation to the intrinsic value of the security without the conversion or exchange feature and in relation to the value of the conversion or exchange feature, which is like a warrant or an option. When we invest in these securities, we incur the risk that the option feature will expire worthless, thereby either eliminating or diminishing the value of our investment.

 Most of our current portfolio company investments are in the equity securities of private companies. Investments in equity securities of private companies often involve securities that are restricted as to sale and cannot be sold in the open market without registration under the Securities Act of 1933, as amended or pursuant to a specific exemption from these registrations. Opportunities for sale are more limited than in the case of marketable securities, although these investments may be purchased at more advantageous prices and may offer attractive investment opportunities. Even if one of our portfolio companies completes an IPO, we are typically subject to a lock-up agreement for 180 days, and the stock price may decline substantially before we are free to sell.

 We may also invest in publicly traded securities of whatever nature, including relatively small, emerging growth companies that management believes have long-term growth potential. These investments may be through open-market transactions or through private investments in public equity ("PIPE transactions"). Securities purchased in PIPE transactions are typically subject to a lock-up agreement for 180 days, or are issued as unregistered securities that are not freely available for six months.

 Even if we have registration rights to make our investments in privately held and publicly traded companies more marketable, a considerable amount of time may elapse between a decision to sell or register the securities for sale and the time when we are able to sell the securities. The prices obtainable upon sale may be adversely affected by market conditions or negative conditions affecting the issuer during the intervening time. We may elect to hold formerly restricted securities after they have become freely marketable, either because they remain relatively illiquid or because we believe that they may appreciate in value, during which holding period they may decline in value and be especially volatile as unseasoned securities. If we need funds for investment or working capital purposes, we might need to sell marketable securities at disadvantageous times or prices.

 DEBT OBLIGATIONS

 We may hold debt securities, including in privately held and thinly traded public companies, for income and as a reserve pending more speculative investments. Debt obligations may include U.S. government and agency securities, commercial paper, bankers' acceptances, receivables or other asset-based financing, notes, bonds, debentures, or other debt obligations of any nature and repurchase agreements related to these securities. These obligations may have varying terms with respect to security or credit support; subordination; purchase price; interest payments; and maturity from private, public, or governmental issuers of any type located anywhere in the world. We may invest in debt obligations of companies with operating histories that are unprofitable or marginally profitable, that have negative net worth or are involved in bankruptcy or reorganization proceedings, or that are start-up or development-stage entities. In addition, we may participate in the acquisition or divestiture of companies or divisions of companies through issuance or receipt of debt obligations. As of December 31, 2023, the debt obligations held in our portfolio consisted of convertible bridge notes and term notes. The convertible bridge notes generally do not generate cash payments to us, nor are they held for that purpose. Our convertible bridge notes and the interest accrued thereon are held for the purpose of potential conversion into equity at a future date. The term notes we hold are income generating.

 Our investments in debt obligations may be of varying quality, including non-rated, unsecured, highly speculative debt investments with limited marketability. Investments in lower-rated and non-rated securities, commonly referred to as "junk bonds," including our venture debt investments, are subject to special risks, including a greater risk of loss of principal and non-payment of interest. Generally, lower-rated securities offer a higher return potential than higher-rated securities, but involve greater volatility of price and greater risk of loss of income and principal, including the possibility of default or bankruptcy of the issuers of these securities. Lower-rated securities and comparable non-rated securities will likely have large uncertainties or major risk exposure to adverse conditions and are predominantly speculative with respect to the issuer's capacity to pay interest and repay principal in accordance with the terms of the obligation. The occurrence of adverse conditions and uncertainties to issuers of lower-rated securities would likely reduce the value of lower-rated securities held by us, with a commensurate effect on the value of our shares.

 The markets in which lower-rated securities or comparable non-rated securities are traded generally are more limited than those in which higher-rated securities are traded. The existence of limited markets for these securities may restrict our ability to obtain accurate market quotations for the purposes of valuing lower-rated or non-rated securities and calculating net asset value or to sell securities at their fair value. Any economic downturn could adversely affect the ability of issuers' lower-rated securities to repay principal and pay interest thereon. The market values of lower-rated and non-rated securities also tend to be more sensitive to individual corporate developments and changes in economic conditions than higher-rated securities. In addition, lower-rated securities and comparable non- rated securities generally present a higher degree of credit risk. Issuers of lower-rated securities and comparable non-rated securities are often highly leveraged and may not have more traditional methods of financing available to them, so that their ability to service their debt obligations during an economic downturn or during sustained periods of rising interest rates may be impaired. The risk of loss owing to default by these issuers is significantly greater because lower-rated securities and comparable non-rated securities generally are unsecured and frequently are subordinated to the prior payment of senior indebtedness. We may incur additional expenses to the extent that we are required to seek recovery upon a default in the payment of principal or interest on our portfolio holdings.

 The market value of investments in debt securities that carry no equity participation usually reflects yields generally available on securities of similar quality and type at the time purchased. When interest rates decline, the market value of a debt portfolio already invested at higher yields can be expected to rise if the securities are protected against early call. Similarly, when interest rates increase, the market value of a debt portfolio already invested at lower yields can be expected to decline. Deterioration in credit quality also generally causes a decline in market value of the security, while an improvement in credit quality generally leads to increased value.

 FOREIGN SECURITIES

 We may make investments in securities of issuers whose principal operations are conducted outside the United States, and whose earnings and securities are stated in foreign currency. In order to maintain our status as a BDC, our investments in non-qualifying assets, including the securities of companies organized outside the U.S., would be limited to 30 percent of our assets.

 Compared to otherwise comparable investments in securities of U.S. issuers, currency exchange risk of securities of foreign issuers is a significant variable. The value of these investments to us will vary with the relation of the currency in which they are denominated to the U.S. dollar, as well as with intrinsic elements of value such as credit risk, interest rates, and performance of the issuer. Investments in foreign securities also involve risks relating to economic and political developments, including nationalization, expropriation of assets, currency exchange freezes, and local recession. Securities of many foreign issuers are less liquid and more volatile than those of comparable U.S. issuers. Interest and dividend income and capital gains on our foreign securities may be subject to withholding and other taxes that may not be recoverable by us. We may seek to hedge all or part of the currency risk of our investments in foreign securities through the use of futures, options, and forward currency purchases or sales.

 INTELLECTUAL PROPERTY

 We believe there is a role for organizations that can assist in technology transfer. Scientists and institutions that develop and patent intellectual property perceive the need for and rewards of entrepreneurial commercialization of their inventions. Our form of investment may be:

 Funding research and development in the development of a technology,

 Obtaining licensing rights to intellectual property or patents,

 Acquiring intellectual property or patents, or

 Forming and funding companies or joint ventures to commercialize further intellectual property.

 Income from our investments in intellectual property or its development may take the form of participation in licensing or royalty income, fee income, or some other form of remuneration. Investment in developmental intellectual property rights involves a high degree of risk that can result in the loss of our entire investment as well as additional risks, including uncertainties as to the valuation of an investment and potential difficulty in liquidating an investment. Further, investments in intellectual property generally require investor patience, as investment return may be realized only after or over a long period. At some point during the commercialization of a technology, our investment may be transformed into ownership of securities of a development-stage or start-up company, as discussed under "Venture Capital Investments" above.

 REPURCHASE OF SHARES

 Our shareholders do not have the right to compel us to redeem our shares. We may, however, purchase outstanding shares of our common stock from time to time, subject to approval of our Board of Directors and in compliance with applicable corporate and securities laws. The Board of Directors may authorize public open-market purchases or privately negotiated transactions from time to time when deemed to be in the best interest of our shareholders. Public purchases would be conducted only after notification to shareholders through a press release or other means. The Board of Directors may or may not decide to undertake any purchases of our common stock.

 Our repurchases of our common shares would decrease our total assets and would therefore likely have the effect of increasing our expense ratio. Subject to our investment restrictions, we may borrow money to finance the repurchase of our common stock in the open market pursuant to any tender offer. Interest on any borrowings to finance share repurchase transactions would reduce our net assets. If, because of market fluctuations or other reasons, the value of our assets falls below the required 1940 Act coverage requirements, we may have to reduce our borrowed debt to the extent necessary to comply with the requirement. To achieve a reduction, it is possible that we may be required to sell portfolio securities at inopportune times when it may be disadvantageous to do so.

 PORTFOLIO COMPANY TURNOVER

 Changes with respect to portfolio companies will be made as our management considers necessary in seeking to achieve our investment objective. The rate of portfolio turnover will not be treated as a limiting or relevant factor when circumstances exist that are considered by management to make portfolio changes advisable.

 Although we expect that many of our investments will be relatively long term in nature, we may make changes in particular portfolio holdings whenever it is considered that an investment no longer has substantial growth potential or has reached its anticipated level of performance, or (especially when cash is not otherwise available) that another investment appears to have a relatively greater opportunity for capital appreciation. We may also make general portfolio changes to increase our cash to position us in a defensive posture. We may make portfolio changes without regard to the length of time we have held an investment, or whether a sale results in profit or loss, or whether a purchase results in the reacquisition of an investment that we may have only recently sold. Our investments in privately held companies are illiquid, which limits portfolio turnover. The portfolio turnover rate may vary greatly during a year as well as from year to year and may also be affected by cash requirements.

 COMPETITION

 We compete for investments with a number of BDCs and other investment funds (including private equity funds and venture capital funds), reverse merger and special purpose acquisition company ("SPACs") sponsors, investment bankers that underwrite initial public offerings, hedge funds that invest in PIPEs, traditional financial services companies such as commercial banks, and other sources of financing. Many of these entities have greater financial and managerial resources than we do. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act will impose on us as a BDC. We believe we compete with these entities primarily on the basis of our willingness to make smaller, non-controlling investments, the experience and contacts of our investment professionals within our targeted industries, our responsive and efficient investment analysis and decision-making processes, and the investment terms that we offer. We do not seek to compete primarily on the deal terms we offer to potential portfolio companies. We use the industry information available to FCM to assess investment risks and determine appropriate pricing for our investments in portfolio companies. In addition, we believe that the relationships of Kevin Landis (FCM's President and Chief Investment Officer), and the other senior investment professionals FCM retains, enable us to learn about, and compete effectively for, financing opportunities with attractive companies in the industries in which we seek to invest. For additional information concerning the competitive risks we face, see "Risk Factors—Risks relating to our business and structure—We operate in a highly competitive market for investment opportunities."

 REGULATION

 The Small Business Investment Incentive Act of 1980 added the provisions of the 1940 Act applicable only to BDCs. BDCs are a special type of investment company. After a company files its election to be treated as a BDC, it may not withdraw its election without first obtaining the approval of holders of a majority of its outstanding voting securities. The following is a brief description of the 1940 Act provisions applicable to BDCs, qualified in its entirety by reference to the full text of the 1940 Act and the rules issued thereunder by the Securities and Exchange Commission ("SEC").

 Generally, to be eligible to elect BDC status, a company must primarily engage in the business of furnishing capital and making significant managerial assistance available to companies that do not have ready access to capital through conventional financial channels. Such companies that satisfy certain additional criteria described below are termed "eligible portfolio companies." In general, in order to qualify as a BDC, a company must: (i) be a domestic company; (ii) have registered a class of its securities pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"); (iii) operate for the purpose of investing in the securities of certain types of portfolio companies, including early-stage or emerging companies and businesses suffering or just recovering from financial distress (see following paragraph); (iv) make available significant managerial assistance to such portfolio companies; and (v) file a proper notice of election with the SEC.

 An eligible portfolio company generally is a domestic company that is not an investment company or a company excluded from investment company status pursuant to exclusions for certain types of financial companies (such as brokerage firms, banks, insurance companies, and investment banking firms) and that: (i) has a fully diluted market capitalization of less than $250 million and has a class of equity securities listed on a national securities exchange, (ii) does not have a class of securities listed on a national securities exchange, or (iii) is controlled by the BDC by itself or together with others (control under the 1940 Act is presumed to exist where a person owns at least 25 percent of the outstanding voting securities of the portfolio company) and the BDC has a representative on the Board of Directors of such company.

 We may be examined periodically by the SEC for compliance with the 1940 Act.

 As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. A majority of our directors must be persons who are not "interested persons", as that term is defined in the 1940 Act. Additionally, we are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect the BDC. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our shareholders arising from willful malfeasance, bad faith, gross negligence, or reckless disregard of the duties involved in the conduct of such person's office.

 The 1940 Act provides that we may not make an investment in non-qualifying assets unless at the time at least 70 percent of the value of our total assets (measured as of the date of our most recently filed financial statements) consists of qualifying assets. Qualifying assets include: (i) securities of eligible portfolio companies; (ii) securities of certain companies that were eligible portfolio companies at the time we initially acquired their securities and in which we retain a substantial interest; (iii) securities of certain controlled companies; (iv) securities of certain bankrupt, insolvent, or distressed companies; (v) securities received in exchange for or distributed in or with respect to any of the foregoing; and (vi) cash items, U.S. government securities, and high quality short-term debt. The SEC has adopted a rule permitting a BDC to invest its cash in certain money market funds. The 1940 Act also places restrictions on the nature of the transactions in which, and the persons from whom, securities can be purchased in some instances in order for the securities to be considered qualifying assets.

 We are permitted by the 1940 Act, under specified conditions, to issue multiple classes of debt and a single class of preferred stock if our asset coverage, as defined in the 1940 Act, is at least 200 percent after the issuance of the debt or the preferred stock (i.e., such senior securities may not be in excess of our net assets). Under specific conditions, we are also permitted by the 1940 Act to issue warrants.

 Except under certain conditions, we may sell our securities at a price that is below the prevailing net asset value per share only during the 12-month period after (i) a majority of our directors and our disinterested directors have determined that such sale would be in the best interest of us and our stockholders, and (ii) the holders of a majority of our outstanding voting securities and the holders of a majority of our voting securities held by persons who are not affiliated persons of ours approve our ability to make such issuances. A majority of the disinterested directors must determine in good faith that the price of the securities being sold is not less than a price that closely approximates the market value of the securities, less any distribution discount or commission.

 Certain transactions involving certain closely related persons of the Company, including its directors, officers, and employees, may require the prior approval of the SEC. However, the 1940 Act ordinarily does not restrict transactions between us and our portfolio companies.

 TAX STATUS

 We are subject to corporate income tax under state and federal law, including under Subchapter C of the Code. This is the same tax status as applies to ordinary operating corporations with publicly traded stock.

 INVESTMENT OPPORTUNITY

 SVVC invests primarily in equity securities of private technology companies in the United States. We believe that the growth potential exhibited by private technology companies, including cleantech companies, creates an attractive investment environment for SVVC.

 The last 20 years has been marked by dramatic changes in the initial public offering ("IPO") market. Since the dot-com bubble burst in 2000, emerging technology companies have often chosen to stay private longer. The combination of volatile equity markets, increased regulatory requirements (such as the Sarbanes-Oxley Act of 2002), and a lack of investment research coverage has made it less attractive for companies to access the public markets through an IPO. We believe the result is an environment with more opportunities to invest in relatively mature private companies, either directly via primary investments or by purchasing shares in the growing secondary market.

 At the same time we believe there are a number of powerful trends creating opportunities for innovative companies and investors alike. The dramatic growth of social networking, cloud computing, and powerful, connected mobile computing devices has enabled new ways of communicating, doing business, and accessing information anytime, anywhere. The Company was established to benefit from convergence of exciting technologies and the growth of private investment opportunities.

 COMPETITIVE ADVANTAGES

 We believe that we have the following competitive advantages over other capital providers in technology and cleantech companies:

 MANAGEMENT EXPERTISE

 Kevin Landis, our Chief Executive Officer and Chief Financial Officer, has principal management responsibility for Firsthand Capital Management, Inc. as its owner, President and Chief Investment Officer. Mr. Landis has more than 25 years of experience in technology sector investing, and he intends to dedicate a substantial portion of his time to managing the Company. Mr. Landis controls FCM and is a trustee of Firsthand Funds and a director of the Company.

 DISCIPLINED INVESTMENT APPROACH

 The Investment Adviser employs a disciplined approach in selecting investments. The Investment Adviser's investment philosophy focuses on ensuring that our investments have an appropriate return profile relative to risk. When market conditions make it difficult for us to invest according to our criteria, the Investment Adviser intends to be highly selective in deploying our capital. We believe this approach enables us to build an attractive investment portfolio that meets our return and value criteria over the long term.

 We believe it is critical to conduct extensive due diligence on investment targets. In evaluating new investments we, through the Investment Adviser, conduct a rigorous due diligence process that draws from the Investment Adviser's investment experience, industry expertise, and network of contacts.

 FOCUSING ON INVESTMENTS THAT CAN GENERATE POSITIVE RISK-ADJUSTED RETURNS

 The Investment Adviser seeks to maximize the potential for capital appreciation. In making investment decisions the Investment Adviser seeks to pursue and invest in companies that meet several of the following criteria:

 outstanding technology,

 barriers to entry (i.e., patents and other intellectual property rights),

 experienced management team,

 established financial sponsors that have a history of creating value with portfolio companies,

 strong and competitive industry position, and

 viable exit strategy.

 Assuming a potential investment meets most or all of our investment criteria, the Investment Adviser intends to be flexible in adopting transaction structures that address the needs of prospective portfolio companies and their owners. Our investment philosophy is focused on internal rates of return over the life of an investment. Given our investment criteria and due diligence process, we structure our investments so they correlate closely with the success of our portfolio companies.

 ABILITY TO SOURCE AND EVALUATE TRANSACTIONS THROUGH THE INVESTMENT ADVISER ' S RESEARCH CAPABILITY AND ESTABLISHED NETWORK

 FCM's investment management team has overseen investments in dozens of private companies across various industries while employed by FCM and its affiliates since 1994. We believe the expertise of the Investment Adviser's management team enables FCM to identify, assess, and structure investments successfully across all levels of a company's capital structure and to manage potential risk and return at all stages of the economic cycle.

 We seek to identify potential investments both through active origination and through dialogue with numerous management teams, members of the financial community, and corporate partners with whom Mr. Landis has long-standing relationships. We believe that the team's broad network of contacts within the investment, commercial banking, private equity and investment management communities in combination with their strong reputation in investment management, enables us to attract well-positioned prospective portfolio companies.

 LONGER INVESTMENT HORIZON WITH ATTRACTIVE PUBLICLY TRADED MODEL

 Unlike private equity and venture capital funds, we are not subject to standard periodic capital return requirements. Such requirements typically stipulate that funds raised by a private equity or venture capital fund, together with any capital gains on such invested funds, must be returned to investors after a pre-agreed time period. These provisions often force private equity and venture capital funds to seek returns on their investments through mergers, public equity offerings, or other liquidity events more quickly than they otherwise might, potentially resulting in both a lower overall return to investors and an adverse impact on their portfolio companies. While we are required to distribute substantially all realized gains, we believe that with our dividend reinvestment plan and our flexibility to make investments with a long-term view and without the capital return requirements of traditional private investment vehicles provide us with the opportunity to generate returns on invested capital and at the same time enable us to be a better long-term partner for our portfolio companies.

 INVESTMENTS

 FCM seeks to create a diversified portfolio of equity securities by making initial investments of approximately $1 million to $10 million of capital, on average, in the securities of micro-cap public and private companies.

 Our portfolio consists primarily of equity securities of private companies and cash and we expect that our portfolio will continue to consist primarily of, equity positions in private companies and cash. These investments include holdings in several private technology and cleantech companies. Moreover, we may acquire investments in the secondary market and, in analyzing such investments, we will employ the same analytical process as we use for our primary investments. For description of our current investments, see "Portfolio Investments."

 We generally seek to invest in companies from the broad variety of industries in which the Investment Adviser has expertise. The following is a representative list of the industries in which we may elect to invest.

 Advertising Technology

 Biofuels

 Cloud Computing

 Computer Hardware

 Computer Peripherals

 Computer Software

 Electronic Components

 Energy Efficiency

 Fuel Cells

 Mobile Computing

 Semiconductors

 Social Networking

 Solar Photovoltaics

 Solid-state Lighting

 Telecommunications

 Water Purification

 Wearable Technology

 Wind-Generated Electricity

 We may invest in other industries if we are presented with attractive opportunities.

 We may on a limited basis purchase or sell options on indexes or securities. We may engage in these transactions to manage risks or otherwise protect the value of the portfolio, and to use these strategies to a limited extent on an opportunistic basis.

 INVESTMENT SELECTION

 The Investment Adviser seeks to maximize the potential for capital appreciation.

 PROSPECTIVE PORTFOLIO COMPANY CHARACTERISTICS

 We have identified several criteria that we believe are important in identifying and investing in prospective portfolio companies. These criteria provide general guidelines for our investment decisions; however, we caution you that no single portfolio company (or prospective portfolio company) will meet all of these criteria. Generally, we use our experience and access to market information generated to identify investment candidates and to structure investments quickly and effectively.

 Outstanding Technology

 Our investment philosophy places a premium on identifying companies that have developed disruptive technologies, that is, technologies with the potential to dramatically alter the economics or performance of a particular type of product or service.

 Barriers to Entry

 We believe having defensible barriers to entry, in the form of patents or other intellectual property rights, is critically important in technology industries, in which change happens very rapidly. We seek out companies that have secured protection of key technologies through patents, trademarks, or other means.

 Experienced management and established financial sponsor relationship

 We generally require that our portfolio companies have an experienced management team. We also require the portfolio companies to have in place proper incentives to induce management to succeed and to act in concert with our interests as investors, including having significant equity interests. In addition, we focus our investments in companies backed by strong financial sponsors that have a history of creating value and with whom members of our investment adviser have an established relationship.

 Strong and defensible competitive market position in industry

 We seek to invest in target companies that have developed leading market positions within their respective markets and are well positioned to capitalize on growth opportunities. We seek companies that demonstrate significant competitive advantages versus their competitors, which should help to protect their market position and profitability.

 Viable exit strategy

 We seek to invest in companies that we believe will provide a steady stream of cash flow to reinvest in their respective businesses. In addition, we also seek to invest in companies whose business models and expected future cash flows offer attractive exit possibilities. These companies include candidates for strategic acquisition by other industry participants and companies that may repay our investments through an initial public offering of common stock or another capital market transaction. In today's market environment, we believe that a strategic sale is more likely than an IPO for many of our portfolio companies, although IPOs cannot be ruled out. We believe that an acquisition by a strategic buyer is possible at any time for any of our companies.

 DUE DILIGENCE

 We believe it is critical to conduct extensive due diligence on investment targets. In evaluating new investments, we, through the Investment Adviser, conduct a rigorous due diligence process that draws from the Investment Adviser's investment experience, industry expertise, and network of contacts. The Investment Adviser conducts extensive due diligence investigations in their investment activities. In conducting due diligence, the Investment Adviser uses publicly available information as well as information from its relationships with former and current management teams, consultants, competitors, and investment bankers.

 Our due diligence typically includes:

 review of historical and prospective financial information;

 review of technology, product, and business plan;

 on-site visits;

 interviews with management, employees, customers, and vendors of the potential portfolio company;

 background checks; and

 research relating to the company's management, industry, markets, products and services, and competitors.

 Upon the completion of due diligence, the Investment Adviser's investment committee determines whether to pursue the potential investment. Additional due diligence with respect to any investment may be conducted on our behalf by attorneys and accountants prior to the closing of the investment, as well as other outside consultants, experts, and/or advisers, as appropriate. To the extent unaffiliated, third-party consultants, experts, and/or advisers are used, we will be responsible for those expenses.

 INVESTMENT STRUCTURE

 Once we have determined that a prospective portfolio company is suitable for investment, we work with the management of that company and its other capital providers to structure an investment. We negotiate among these parties to agree on how our investment is expected to perform relative to the other capital in the portfolio company's capital structure.

 MANAGERIAL ASSISTANCE

 As a BDC, we offer, and must provide upon request, managerial assistance to certain of our portfolio companies. This assistance could involve, among other things, monitoring the operations of our portfolio companies, participating in board and management meetings, consulting with and advising officers of portfolio companies, and providing other organizational and financial guidance. We may receive fees for these services. FCM will provide such managerial assistance on our behalf to portfolio companies that request this assistance. For a description of relationships between us and our portfolio companies, please see "Portfolio Companies."

 ONGOING RELATIONSHIPS WITH PORTFOLIO COMPANIES

 Monitoring

 FCM monitors our portfolio companies on an ongoing basis. Specifically, FCM monitors the financial trends of each portfolio company to determine if they are meeting their respective business plans and to assess the appropriate course of action for each company.

 FCM has several methods of evaluating and monitoring the performance and fair value of our investments, which may include the following:

 Assessment of success in adhering to portfolio company's technology development, business plan and compliance with covenants;

 Periodic and regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements, and accomplishments;

 Comparisons to other portfolio companies in the industry, if any;

 Attendance at and participation in board meetings; and

 Review of monthly and quarterly financial statements and financial projections for portfolio companies.

 Valuation Process

 The following is a description of the steps we take each quarter to determine the value of our portfolio. Investments for which market quotations are readily available are recorded in our financial statements at such market quotations. With respect to investments for which market quotations are not readily available, our Board of Directors undertakes a multi-step valuation process each quarter, as described below under "Determination of Net Asset Value." Currently, our Board of Directors solicits valuation recommendations from a third-party valuation firm on a quarterly basis.

 We expect that all of our portfolio investments will be recorded at fair value as determined under the valuation process discussed above. As a result, there will be uncertainty with respect to the value of our portfolio investments.

 INVESTMENT MANAGEMENT AGREEMENT

 MANAGEMENT SERVICES

 FCM has entered into an Investment Management Agreement (the "Investment Management Agreement") with us whereby FCM provides investment management services. Subject to the overall supervision of our Board of Directors, the Investment Adviser manages the day-to-day operations of, provides investment management services to, and serves as portfolio manager for us. Mr. Landis, FCM's President and Chief Investment Officer, has been primarily responsible for our portfolio management since our inception. Under the terms of the Investment Management Agreement, FCM will:

 determine the composition of our portfolio, the nature and timing of the changes to our portfolio, and the manner of implementing such changes;

 identify, evaluate and negotiate the structure of the investments we make (including performing due diligence on our prospective portfolio companies); and

 close and monitor the investments we make.

 FCM's services under the Investment Management Agreement are not exclusive, and it is free to furnish similar services to other entities so long as its services to us are not impaired. FCM currently serves as investment manager to Firsthand Funds, a family of open-end mutual funds.

 INVESTMENT MANAGEMENT FEE

 Pursuant to the Investment Management Agreement, we pay FCM a fee for investment management services consisting of two components—a base management fee and an incentive fee.

 The base management fee will be calculated at an annual rate of 2.00% of our gross assets. For services rendered under the Investment Management Agreement, the base management fee will be payable quarterly in arrears. The base management fee will be calculated based on the average of (1) the value of our gross assets at the end of the current calendar quarter and (2) the value of our gross assets at the end of the preceding calendar quarter; and appropriately adjusted for any share issuances or repurchases during the current calendar quarter. Base management fees for any partial month or quarter will be pro-rated. The incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement, as of the termination date), and equals 20% of our realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fees.

 Mathematically, the formula for computing the annual incentive fee can be written as:

 For the purposes of calculating realized capital gains, the cost basis of each security acquired in the Reorganization shall be equal to the greater of the original purchase price of that security by Firsthand Funds or the fair market value of the security at the time of the Reorganization.

 EXAMPLE INCENTIVE FEE CALCULATION

 EXAMPLE: INCENTIVE FEE ON CAPITAL GAINS:

 Assumptions

 Year 1 = no net realized capital gains or losses
 Year 2 = $50,000 realized capital gains and $20,000 realized capital losses and unrealized capital depreciation. Capital gain incentive fee = 20% x (realized capital gains for year computed net of all realized capital losses and unrealized capital depreciation at year end)

 Calculation of Incentive Fee

 Year 1 incentive fee

 = 20% x (0)
 = 0 (no incentive fee)

 Year 2 incentive fee

 = 20% x ($50,000 - $20,000) - 0
 = 20% x $30,000
 = $6,000

 AVAILABLE INFORMATION

 Additional information about us, including quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, are available free of charge on our website at www.firsthandtvf.com. Information on our website is not part of this Annual Report on Form 10-K.

 EMPLOYEES

 We do not currently have any direct employees. Mr. Landis, our Chief Executive Officer, is the majority owner and Chief Investment Officer of the Investment Adviser. The Investment Adviser currently employs a staff of 6, including investment, legal, and administrative professionals.

 Item 1A.

 Risk Factors

 Investing in the Company involves a number of significant risks relating to our business and investment objective. As a result, there can be no assurance that we will achieve our investment objective.

 RISKS RELATING TO OUR BUSINESS AND STRUCTURE

 WE ARE DEPENDENT UPON FCM ' S KEY PERSONNEL FOR OUR FUTURE SUCCESS.

 If the Investment Adviser is unable to hire and retain qualified personnel, or if it loses any key member of its management team, our ability to achieve our investment objective could be significantly impaired.

 We depend on the diligence, skill, and access to the network of business contacts of the management of FCM, including Mr. Landis, the owner, President and Chief Executive Officer of FCM. We also depend, to a significant extent, on FCM's access to the investment information and deal flow generated by Mr. Landis and any other investment professionals of FCM. Mr. Landis and other management personnel of FCM evaluate, negotiate, structure, close, and monitor our investments. Our future success depends on the continued service of Mr. Landis and other management personnel of FCM. The resignation of FCM, or the departure of Mr. Landis or any other key managers hired by FCM could have a material adverse effect on our ability to achieve our investment objective. In addition, we can offer no assurance that FCM will remain the Investment Adviser.

 THE INVESTMENT ADVISER AND ITS MANAGEMENT MANAGE OTHER FUNDS.

 In addition to managing SVVC, FCM is also the investment adviser to two open-end mutual funds in the Firsthand Funds family: Firsthand Technology Opportunities Fund and Firsthand Alternative Energy Fund. Mr. Landis, who has primary responsibility for SVVC, also serves as portfolio manager of Firsthand Alternative Energy Fund and Firsthand Technology Opportunities Fund. This may reduce the time FCM and its investment management team have to devote to the affairs of SVVC. The other funds managed by FCM have stated investment objectives which differ from our own. Accordingly, there may be times when the interests of FCM's management team differ from our interests.

 THE INVESTMENT ADVISER MAY NOT BE ABLE TO ACHIEVE THE SAME OR SIMILAR RETURNS TO THOSE ACHIEVED BY ITS INVESTMENT PROFESSIONALS WHILE THEY WERE EMPLOYED AT PRIOR JOBS.

 Although Mr. Landis has been a portfolio manager of a number of open-end mutual funds in the Firsthand Funds family, Mr. Landis's track record and achievements are not necessarily indicative of future results that will be achieved by FCM on our behalf. FCM and its investment professionals' skills and expertise may not be as well suited to our objectives, strategies and requirements as they are for certain other funds. FCM and many of its investment professionals are relatively inexperienced in managing closed end funds and our investment objectives, policies and regulatory limitations differ substantially from the other funds FCM and its investment professionals have managed. Similarly, while the research and operational professionals that support Mr. Landis in his management of Firsthand Funds are substantially the same individuals that will be supporting us, there is no assurance that they will be able to provide the same level of services to us as they did (or currently do) for Firsthand Funds.

 OUR FINANCIAL CONDITION AND RESULTS OF OPERATION WILL DEPEND ON OUR ABILITY TO MANAGE FUTURE GROWTH EFFECTIVELY.

 Our ability to achieve our investment objective will depend on our ability to grow, which will depend, in turn, on FCM's ability to identify, invest in, and monitor companies that meet our investment criteria.

 Accomplishing this result on a cost-effective basis will be largely a function of FCM's structuring of the investment process, its ability to provide competent, attentive, and efficient services to us and our access to financing on acceptable terms. The management team of FCM will have substantial responsibilities under the Investment Management Agreement. In addition, the employees of FCM may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. Such demands on their time may distract them or slow our rate of investment. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition, and results of operations.

 WE OPERATE IN A HIGHLY COMPETITIVE MARKET FOR INVESTMENT OPPORTUNITIES.

 A number of entities will compete with us to make the types of investments that we plan to make. We will compete with other venture capital firms and venture capital funds, various public and private investment funds, including hedge funds, other BDCs, commercial and investment banks, commercial financing companies, and various technology and alternative energy companies' internal venture capital arms. Many of our potential competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a stronger network of contacts and better connections for deal flows or have access to funding sources that are not available to us. In addition, some of our competitors have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act will impose on us as a BDC. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective.

 REGULATIONS GOVERNING OUR OPERATION AS A BUSINESS DEVELOPMENT COMPANY WILL AFFECT OUR ABILITY TO, AND THE WAY IN WHICH WE, RAISE ADDITIONAL CAPITAL.

 We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock at a price below the current net asset value of the common stock, or sell warrants, options, or rights to acquire such common stock, at a price below the current net asset value of the common stock if our Board of Directors determines that such sale is in the best interests SVVC, and our stockholders approve SVVC's policy and practice of making such sales. Our stockholders have not approved a policy or practice of selling our common stock below our net asset value per share. However, our Board of Directors may ask our stockholders to vote on such a policy and practice at upcoming stockholders meetings. In any such case, the price at which our securities are to be issued and sold may not be less than a price which, in the determination of our Board of Directors, closely approximates the market value of such securities (less any distributing commission or discount).

 ANY FAILURE ON OUR PART TO MAINTAIN OUR STATUS AS A BUSINESS DEVELOPMENT COMPANY WOULD REDUCE OUR OPERATING FLEXIBILITY.

 If we do not remain a BDC, we might be regulated as a closed-end investment company under the 1940 Act, which would subject us to substantially more regulatory restrictions under the 1940 Act and correspondingly decrease our operating flexibility and increase our cost of doing business. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us or expose us to claims of private litigants.

 IF WE DO NOT INVEST A SUFFICIENT PORTION OF OUR ASSETS IN QUALIFYING ASSETS, WE COULD FAIL TO QUALIFY AS A BUSINESS DEVELOPMENT COMPANY OR BE PRECLUDED FROM INVESTING ACCORDING TO OUR CURRENT BUSINESS STRATEGY.

 As a BDC, we may not acquire any assets other than "qualifying assets" unless, at the time of and after giving effect to such acquisition, at least 70% of our total assets are qualifying assets. See "Regulation" above.

 We may be precluded from investing in what we believe are attractive investments if such investments are not qualifying assets for purposes of the 1940 Act. If we do not invest a sufficient portion of our assets in qualifying assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition, and results of operations. Similarly, these rules could prevent us from making follow-on investments in existing portfolio companies (which could result in the dilution of our position) or could require us to dispose of investments at inappropriate times in order to comply with the 1940 Act. If we need to dispose of such investments quickly, it would be difficult to dispose of such investments on favorable terms. For example, we may have difficulty in finding a buyer and, even if we do find a buyer, we may have to sell the investments at a substantial loss.

 WE ARE A NON-DIVERSIFIED INVESTMENT COMPANY WITHIN THE MEANING OF THE 1940 ACT, AND THEREFORE WE ARE NOT LIMITED WITH RESPECT TO THE PROPORTION OF OUR ASSETS THAT MAY BE INVESTED IN SECURITIES OF A SINGLE ISSUER.

 We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. To the extent that we assume large positions in the securities of a small number of issuers, our net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market's assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond our income tax diversification requirements, we do not have fixed guidelines for diversification, and our investments could be concentrated in relatively few portfolio companies.

 WE WILL NEED TO RAISE ADDITIONAL CAPITAL TO GROW.

 We will need additional capital to fund growth in our investments once we have fully invested the cash (and other liquid assets, if any) received, we may issue equity securities in order to obtain this additional capital. A reduction in the availability of new capital could limit our ability to grow or pursue business opportunities. During the years that we have elected and maintained our status as a RIC, we will be required to distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, to our stockholders to maintain our RIC status. As a result, if stockholders opt out of reinvesting those distributions back into SVVC, these earnings will not be available to fund new investments. If we fail to obtain additional capital to fund our investments, this could limit our ability to grow, which may have an adverse effect on the value of our securities.

 MANY OF OUR PORTFOLIO INVESTMENTS WILL BE RECORDED AT FAIR VALUE AS DETERMINED IN GOOD FAITH BY OUR BOARD OF DIRECTORS. AS A RESULT, THERE WILL BE UNCERTAINTY AS TO THE VALUE OF OUR PORTFOLIO INVESTMENTS.

 A large percentage of our portfolio investments will be in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We will value these securities quarterly at fair value according to our written valuation procedures and as determined in good faith by our Board of Directors. Our Board of Directors may use the services of a nationally recognized independent valuation firm to aid it in determining the fair value of these securities. The methods for valuing these securities may include: fundamental analysis (sales, income, or earnings multiples, etc.), discounts from market prices of similar securities, purchase price of securities, subsequent private transactions in the security or related securities, or discounts applied to the nature and duration of restrictions on the disposition of the securities, as well as a combination of these and other factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time, and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.

 THE LACK OF LIQUIDITY IN OUR INVESTMENTS MAY ADVERSELY AFFECT OUR BUSINESS.

 We primarily make investments in private companies. Substantially all of these securities will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we have material non-public information regarding such portfolio company.

 WE MAY EXPERIENCE FLUCTUATIONS IN OUR QUARTERLY RESULTS.

 We could experience fluctuations in our quarterly operating results due to a number of factors, including the performance of the portfolio securities we hold; the level of our expenses; variations in, and the timing of the recognition of, realized and unrealized gains or losses; the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods.

 THERE ARE SIGNIFICANT POTENTIAL CONFLICTS OF INTEREST THAT COULD IMPACT OUR INVESTMENT RETURNS.

 Our executive officers and directors may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do or of investment funds managed by affiliates of FCM that may be formed in the future. Accordingly, if this occurs, they may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of us or our stockholders.

 In the course of our investing activities, we will pay investment management and incentive fees to FCM, and will reimburse FCM for certain expenses it incurs. As a result, investors in our common stock will invest on a "gross" basis and receive distributions on a "net" basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of FCM has interests that differ from those of our stockholders, giving rise to a conflict.

 Several members of our Board of Directors are also trustees of the Board of Trustees of Firsthand Funds. Of the five directors of the Company, Messrs. Landis, Burglin, and Lee all serve as both directors for the Company and trustees for Firsthand Funds. Messrs. Petredis and Yee are the only directors of the Company who are not also trustees of Firsthand Funds. We believe such a commonality of the board brings continuity of oversight and allows our Board to maintain the institutional knowledge and experience of overseeing illiquid securities and their pricing methods.

 OUR INCENTIVE FEE MAY INDUCE FCM TO MAKE SPECULATIVE INVESTMENTS AND THESE FEES WILL, IN EFFECT, BE BORNE BY OUR COMMON STOCKHOLDERS.

 The incentive fee payable by us to FCM may create an incentive for FCM to make investments on our behalf that are risky or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to the Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage the Investment Adviser to invest in higher risk investments in the hope of securing higher returns.

 We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, as well as other special purpose vehicles set up by third parties for investment in a particular private company. To the extent we so invest, we will bear our ratable share of any such investment company's expenses, including management and incentive fees. We will also remain obligated to pay investment advisory fees, consisting of a base management fee and incentive fees, to FCM with respect to the assets invested in the securities and instruments of other investment companies under the Investment Management Agreement. With respect to any such investments, each of our stockholders will bear his or her share of the investment advisory fees of FCM as well as indirectly bearing the investment advisory fees and other expenses of any investment companies in which we invest.

 CHANGES IN LAWS OR REGULATIONS GOVERNING OUR OPERATIONS MAY ADVERSELY AFFECT OUR BUSINESS.

 We and our portfolio companies will be subject to regulation by laws at the local, state, and federal levels. These laws and regulations, as well as their interpretation, may be changed from time to time. Accordingly, any change in these laws or regulations could materially and adversely affect our business.

 PROVISIONS OF THE MARYLAND GENERAL CORPORATION LAW AND OF OUR CHARTER AND BYLAWS COULD DETER TAKEOVER ATTEMPTS AND HAVE AN ADVERSE IMPACT ON THE PRICE OF OUR COMMON STOCK.

 The Maryland General Corporation Law, our charter, and our bylaws contain provisions that may discourage, delay or make more difficult a change in control of the Company or the removal of the Company's directors. We are subject to the Maryland Business Combination Act, the application of which is subject to any requirements of the 1940 Act. Our Board of Directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our Board, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our Board does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. We are also subject to the Maryland Control Share Acquisition Act. With certain exceptions, the Maryland General Corporation Law provides that a holder of "control shares" of a Maryland corporation acquired in a "control share acquisition" has no voting rights with respect to those shares except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter, excluding shares owned by the acquiring person or by our officers or by our directors who are our employees. The Maryland Control Share Acquisition Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such an offer.

 We have also adopted other measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our Board of Directors in three classes serving staggered three-year terms and until their successors are duly elected and qualify, and provisions of our charter authorizing our Board of Directors (all without stockholder approval) to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock, and to amend our charter to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer, or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.

 OUR BOARD OF DIRECTORS MAY CHANGE OUR INVESTMENT OBJECTIVE, OPERATING POLICIES, AND STRATEGIES WITHOUT PRIOR NOTICE OR STOCKHOLDER APPROVAL.

 Our Board of Directors has the authority to modify or waive certain of our operating policies and strategies without prior notice and without stockholder approval (except as required by the 1940 Act). However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results, and value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.

 RISKS RELATED TO OUR INVESTMENTS

 OUR INVESTMENTS IN PROSPECTIVE PORTFOLIO COMPANIES MAY BE RISKY, AND YOU COULD LOSE ALL OR PART OF YOUR INVESTMENT.

 Equity Investments. We make equity investments primarily in equity securities and equity derivatives (such as options, warrants, rights, etc.) of privately placed venture capital stage technology and alternative energy companies as well as publicly traded micro-cap companies (those with market capitalizations of less than $250 million). Our goal is ultimately to dispose of these equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value or lose all value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.

 In addition, investing in privately placed technology and clean tech companies involves a number of significant risks, including that private companies generally have limited operating history and are not as well capitalized as public companies. In addition, private company valuations may fluctuate more dramatically than those of public companies and they frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.

 WE MAY INVEST IN MICRO-CAP PUBLIC COMPANIES AND COMPANIES WE MAY HOPE WILL HAVE SUCCESSFUL INITIAL PUBLIC OFFERINGS.

 Although micro-cap companies may have potential for rapid growth, they are subject to wider price fluctuations due to factors inherent in their size, such as lack of management experience and financial resources and limited trade volume and frequency. To make a large sale of securities of micro-cap companies that trade in limited volumes, SVVC may need to sell portfolio holdings at a discount or make a series of small sales over an extended period of time.

 We have invested in, and we expect to continue to invest in, companies that we believe are likely to issue securities in initial public offerings ("IPOs"). Although there is a potential the pre-IPO securities that we buy may increase in value if the company does issue securities in an IPO, IPOs are risky and volatile and may cause the value of our securities to fall dramatically. Also, because securities of pre-IPO companies are generally not freely or publicly tradeable, we may not have access to purchase securities in these companies in the amounts or at the prices we desire. Securities issued by these privately-held companies have no trading history, and information about such companies may be available for very limited periods. The companies that we anticipate holding successful IPOs may not ever issues shares in an IPO and a liquid market for their securities may never develop, which may negatively affect the price at which we can sell any such securities and make it more difficult to sell such securities, which could also adversely affect our liquidity.

 WE EXPECT TO PURCHASE SECURITIES IN IPOS, WHICH INVOLVE SIGNIFICANT RISKS FOR US, AND WE MAY NOT BE ABLE TO PARTICIPATE IN OFFERINGS TO THE EXTENT DESIRED OR AT ALL.

 Securities purchased in IPOs are often subject to the general risk associated with investments in companies with smaller market capitalizations, and typically to a heightened degree. Securities issued in IPOs have no trading history, and information about companies may be available for very limited periods. In addition, under certain market conditions, a relatively small number of companies may issue securities in IPOs. Our investment performance during periods when we are unable to invest significantly or at all in IPOs may be lower than during periods when we are able to do so.

 IPO securities may be volatile, and we cannot predict whether investments in IPOs will be successful. If the Company grows in size, the possible positive effects of IPO investments on the Company may decrease.

 WE HAVE NOT YET IDENTIFIED ALL OF THE PORTFOLIO COMPANY INVESTMENTS WE INTEND TO ACQUIRE.

 The Investment Adviser will select our investments, and our stockholders will have no input with respect to such investment decisions. These factors increase the uncertainty, and thus the risk, of investing in our shares.

 ECONOMIC RECESSIONS OR DOWNTURNS COULD IMPAIR OUR PORTFOLIO COMPANIES AND HARM OUR OPERATING RESULTS.

 Many of our portfolio companies are susceptible to economic slowdowns or recessions and may fail or require additional capital investments from us during those periods. Therefore, our non-performing assets are likely to increase and the value of our portfolio is likely to decrease during these periods. These events could harm our operating results.

 OUR FAILURE TO MAKE FOLLOW-ON INVESTMENTS IN OUR PORTFOLIO COMPANIES COULD IMPAIR THE VALUE OF OUR PORTFOLIO.

 Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as "follow-on" investments, in order to:

 increase or maintain in whole or in part our equity ownership percentage; or

 exercise warrants, options, or convertible securities that were acquired in the original or subsequent financing.

 We have the discretion to make any follow-on investments, subject to the availability of capital resources and the availability of securities in the applicable public company. We may elect not to make follow-on investments in a portfolio company and we may lack sufficient funds to make those investments. The failure to make follow-on investments may, in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make a desired follow-on investment, we may elect not to make a follow-on investment because we may not want to increase our concentration of risk, because we prefer other opportunities, or because we are inhibited by compliance with BDC requirements or the desire to maintain our tax status.

 WE SOMETIMES DO NOT HOLD CONTROLLING EQUITY INTERESTS IN OUR PORTFOLIO COMPANIES AND WE MAY NOT BE IN A POSITION TO EXERCISE CONTROL OVER OUR PORTFOLIO COMPANIES OR TO PREVENT DECISIONS BY MANAGEMENT OF OUR PORTFOLIO COMPANIES THAT COULD DECREASE THE VALUE OF OUR INVESTMENTS.

 Although we have held control and will continue to do so for some instruments, we do not anticipate always taking controlling equity positions in our portfolio companies. As a result, we will be subject to the risk that a portfolio company may make business decisions with which we disagree, and the stockholders and management of a portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity for the equity investments that we will typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company, and may therefore suffer a decrease in the value of our investments.

 AN INVESTMENT STRATEGY FOCUSED PRIMARILY ON PRIVATELY HELD COMPANIES PRESENTS CERTAIN CHALLENGES, INCLUDING THE LACK OF AVAILABLE INFORMATION ABOUT THESE COMPANIES, A DEPENDENCE ON THE TALENTS AND EFFORTS OF ONLY A FEW KEY PORTFOLIO COMPANY PERSONNEL, AND A GREATER VULNERABILITY TO ECONOMIC DOWNTURNS.

 We invest primarily in privately held companies. Generally, little public information exists about these companies, and we will be required to rely on the ability of FCM's investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, privately held companies frequently have less diverse product lines and a smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.

 OUR PORTFOLIO COMPANIES MAY ISSUE ADDITIONAL SECURITIES OR INCUR DEBT THAT RANKS EQUAL OR SENIOR TO OUR INVESTMENTS IN SUCH COMPANIES.

 We also invest primarily in equity securities issued by our portfolio companies. The portfolio companies may be permitted to issue additional securities or incur other debt that ranks equally with, or senior to, the equity securities in which we invest. By their terms, such other securities (especially if they are debt securities) may provide that the holders are entitled to receive payment of interest or principal before we are entitled to receive any distribution from the portfolio companies. Also, in the event of insolvency, liquidation, dissolution, reorganization, or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our equity investment in that portfolio company would typically be entitled to receive payment in full before equity investors like us may receive any distribution in respect of our investment. After repaying such senior creditors, the portfolio company may not have any remaining assets to distribute to us.

 WE MAY PURCHASE OR SELL OPTIONS ON SECURITIES AND INDEXES, WHICH MAY EXPOSE US, AND YOUR INVESTMENT IN OUR COMMON STOCK, TO CERTAIN RISKS.

 We may on a limited basis purchase or sell options on indexes or securities. The use of options has risks and our ability to successfully use these techniques depends on our ability to predict pertinent market movements, which cannot be assured. The use of options may result in losses greater than if they had not been used, may require us to sell or purchase portfolio securities at inopportune times or for prices other than current market values, may limit the amount of appreciation we can realize on an investment or may cause us to hold a security we might otherwise sell.

 OUR INVESTMENTS IN FOREIGN SECURITIES MAY INVOLVE SIGNIFICANT RISKS IN ADDITION TO THE RISKS INHERENT IN U.S. INVESTMENTS.

 Our investment strategy involves potential investments in equity securities of foreign companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations; political and social instability; expropriation; imposition of foreign taxes; less liquid markets and less available information than is generally the case in the United States; higher transaction costs; less government supervision of exchanges, brokers and issuers; less developed bankruptcy laws; difficulty in enforcing contractual obligations; lack of uniform accounting and auditing standards; and greater price volatility.

 Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or, if we do, that such strategies will be effective.

 Item 1B.

 Unresolved Staff Comments

 None.

 Item 1C.

 Cybersecurity

 Our Board of Directors (the "Board") is responsible for overseeing our risk management program, and cybersecurity is a critical element of this program. Management is responsible for the day-to-day administration of the Company's risk management program and its cybersecurity policies, processes, and practices. In general, the Adviser seeks to address material cybersecurity threats through a company-wide approach that addresses the confidentiality, integrity, and availability of the Adviser's information systems or the information that the Adviser collects and stores, by assessing, identifying and managing cybersecurity issues as they occur.

 Cybersecurity Risk Management and Strategy

 The Adviser's cybersecurity risk management strategy focuses on several areas:

 Identification and Reporting: The Adviser has implemented a comprehensive, cross-functional approach to assessing, identifying and managing material cybersecurity threats and incidents. The Adviser's program includes controls and procedures to properly identify, classify and escalate certain cybersecurity incidents to provide management visibility and obtain direction from management as to the public disclosure and reporting of material incidents in a timely manner.

 Technical Safeguards: The Adviser implements technical safeguards that are designed to protect the Adviser's information systems from cybersecurity threats, including firewalls, intrusion prevention and detection systems, anti-malware functionality, and access controls, which are evaluated and improved through vulnerability assessments and cybersecurity threat intelligence, as well as assistance from third party experts where necessary.

 Incident Response and Recovery Planning: The Adviser has established and maintains comprehensive incident response, business continuity, and disaster recovery plans designed to address the Adviser's response to a cybersecurity incident. The Adviser conducts occasional tabletop exercises to test these plans and ensure personnel are familiar with their roles in a response scenario.

 Third-Party Risk Management: The Adviser maintains a comprehensive, risk-based approach to identifying and overseeing material cybersecurity threats presented by third parties, including vendors and service providers

 Education and Awareness: The Adviser provides periodic training for all levels of personnel regarding cybersecurity threats as a means to equip the Adviser's personnel with effective tools to address cybersecurity threats, and to communicate the Adviser's evolving information security policies, standards, processes, and practices.

 The Adviser conducts periodic assessment and testing of its policies, standards, processes, and practices in a manner intended to address cybersecurity threats and events The results of such assessments and reviews are evaluated by management and reported to the Board, and the Adviser adjusts its cybersecurity policies, standards, processes, and practices as necessary based on the information provided by these assessments and reviews.

 Governance

 The Board, in coordination with the Adviser, oversees the Company's risk management program, including the management of cybersecurity threats. The Board receives regular updates and reports on developments in the cybersecurity space, including risk management practices, recent developments, vulnerability assessments, third-party and independent reviews, the threat environment, and information security issues encountered by the Company. The Board also receives prompt and timely information regarding any material cybersecurity risk, as well as ongoing updates regarding any such risk. On an annual basis, the Board and the Adviser discuss the Company's approach to overseeing cybersecurity threats.

 Material Effects of Cybersecurity Incidents

 Risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have not materially affected and are not reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition.

 Item 2.

 Properties

 Under the terms of the Investment Management Agreement, Firsthand Capital Management, Inc. is responsible for providing office space to the Company and for the costs associated with providing such space. Our offices are located at 150 Almaden Blvd., Suite 1250, San Jose, CA 95113.

 Item 3.

 Legal Proceedings

 We are not currently subject to any material pending legal proceedings.

 Item 4.

 Mine Safety Disclosures

 Not applicable.

 Item 5.

 Market for Registrant ' s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities

 MARKET INFORMATION

 Our common stock is traded on the Nasdaq Global Market under the symbol "SVVC." The following table sets forth the range of the high and low closing sales prices of the Company's shares during each quarter during the last fiscal year, as reported by Nasdaq Global Market. The quarterly stock prices quoted represent interdealer quotations and do not include markups, markdowns, or commissions.

 2023 Quarter Ending

 Low

 High

 March 31

 $

 0.92

 $

 1.15

 June 30

 $

 0.61

 $

 0.98

 September 30

 $

 0.42

 $

 0.69

 December 31

 $

 0.18

 $

 0.42

 SHAREHOLDERS

 As of February 29, 2024, there were approximately 950 shareholders of record and approximately 8,300 beneficial owners of the Company's common stock.

 DIVIDENDS

 There were no distributions in 2023.

 RECENT SALES OF UNREGISTERED SECURITIES

 The Company did not issue any unregistered securities during the year ended December 31, 2023.

 PERFORMANCE GRAPH

 The graph and table below compares the cumulative total return of holders of our common stock (market price) and of the Fund's NAV with the cumulative total returns of the S&P 500 Index and the NASDAQ Composite Index. There is a difference between the market price of our common stock and the Fund's NAV because the stock may trade at a discount or premium to the NAV in the secondary market. The comparison assumes that the value of the investment in our common stock (using both market price and NAV) and in the index (including reinvestment of dividends) was $10,000 on April 18, 2011 (our inception date), and tracks it through December 31, 2023.

 We, however, do not believe either the S&P 500 Index or the NASDAQ Composite Index to be appropriate comparable indices of the Company's benchmark results. The Company is a publicly traded venture capital fund that invests primarily in private and micro cap technology companies. The S&P 500 Index and the NASDAQ Composite Index are both indices of publicly traded large capitalization companies, with performance predominantly driven by the largest companies in the index. Nevertheless, we do not believe there is currently a widely accessible and generally accepted index that tracks publicly traded venture capital funds. When compared to the S&P 500 Index and the NASDAQ Composite Index, we have underperformed those broad market indices because equity securities of the private companies in our portfolio have not appreciated substantially during the recent bull market for publicly traded stocks.

 STOCK TRANSFER AGENT

 Computershare Investor Services, 462 South 4th Street, Suite 1600 Louisville, KY 40202 (1.800.331.1710) serves as our transfer agent.

 Item 6.

 Selected Financial Data

 The information below was derived from the audited Consolidated Financial Statements included in this report. This information should be read in conjunction with those Consolidated Financial Statements and Supplementary Data and the notes thereto. These historical results are not necessarily indicative of the results to be expected in the future.

 Consolidated Statements of Assets and Liabilities

 AS OF
 2023

 AS OF
 2022

 ASSETS

 Investment securities:

 Unaffiliated investments at acquisition cost

 $

 1,173,502

 *

 $

 1,772,422

 *

 Affiliated investments at acquisition cost

 Controlled investments at acquisition cost

 132,131,932

 140,355,353

 Total acquisition cost

 $

 133,967,669

 $

 142,790,010

 Unaffiliated investments at market value

 $

 173,502

 *

 $

 772,422

 *

 Affiliated investments at market value

 Controlled investments at market value

 8,260,345

 39,012,002

 Total Market value** (Note 6)

 8,733,779

 40,121,924

 Foreign currency at value (cost $2,629 and $3,235)

 2,765

 3,404

 Receivable from dividends and interest

 8,161

 14,463

 Other assets

 63,649

 64,066

 Total Assets

 8,808,354

 40,203,857

 LIABILITIES

 Payable to affiliates (Note 4)

 7,183,782

 9,188,187

 Trustees' fees payable

 13,891

 50,000

 Consulting fee payable

 43,000

 46,000

 Accrued expenses and other payables

 307,310

 310,079

 Total Liabilities

 7,547,983

 9,594,266

 NET ASSETS

 $

 $

 Net Assets consist of:

 Common Stock, par value $0.001 per share 100,000,000 shares authorized

 $

 6,893

 $

 6,893

 Paid-in-capital

 176,770,722

 176,770,722

 Total distributable earnings (loss)

 (175,517,244

)

 (146,168,024

)

 NET ASSETS

 $

 $

 Shares of Common Stock outstanding

 7,016,432

 7,016,432

 Shares of Treasury Stock outstanding

 (123,376

)

 (123,376

)

 Total Shares of Common Stock outstanding

 Net asset value per share (Note 2)

 $

 0.18

 $

 4.44

 *

 Includes Fidelity Investment Money Market Treasury Portfolio - Class I, which invests primarily in U.S. Treasury securities. The yields as of 12/31/23 and 12/31/22 were 5.23% and 4.13%, respectively. Please see  for additional information.

 **

 Includes warrants whose primary risk exposure is equity contracts.

 Consolidated Statements of Operations

 2023

 2022

 2021

 INVESTMENT INCOME

 Unaffiliated dividends

 —

 —

 $

 171,613

 Unaffiliated interest

 $

 37,275

 $

 3,318

 30,906

 Affiliated/controlled interest

 (10,015,197

)

 6,116,176

 Foreign tax withholding

 —

 3,457

 —

 TOTAL INVESTMENT INCOME

 122,631

 (10,008,422

)

 6,318,695

 EXPENSES

 Investment advisory fees (Note 4)

 455,559

 1,366,496

 2,220,811

 Administration fees

 116,785

 118,009

 122,177

 Custody fees

 8,743

 17,338

 24,661

 Transfer agent fees

 33,296

 38,054

 39,737

 Registration and filing fees

 35,300

 33,800

 32,700

 Professional fees

 398,882

 397,138

 367,471

 Printing fees

 299,958

 60,853

 80,307

 Trustees fees

 43,841

 Compliance fees

 110,336

 118,777

 120,487

 Miscellaneous fees

 81,068

 88,580

 46,907

 TOTAL GROSS EXPENSES

 1,583,768

 2,439,045

 3,255,258

 Less waiver and/or reimbursement (Note 4)

 (2,542,716

)

 —

 —

 TOTAL NET EXPENSES

 (958,948

)

 2,439,045

 3,255,258

 NET INVESTMENT INCOME/(LOSS), BEFORE TAXES

 1,081,579

 (12,447,467

)

 3,063,437

 Net Realized and Unrealized Gain (Loss) on Investments:

 Net realized gains (losses) from security transactions on:

 Affiliated/controlled

 (7,864,998

)

 (3,131,579

)

 11,753,038

 Foreign currency

 1,914

 Net realized gains (losses), net of deferred taxes

 (7,864,982

)

 (3,129,665

)

 11,753,065

 Net change in unrealized appreciation (depreciation) on:

 Non-affiliated investments

 —

 (280,160

)

 (551,274

)

 Affiliated/controlled investments and foreign currency

 (21,615,371

)

 (48,442,656

)

 (21,673,270

)

 Affiliated/controlled warrants investments (1)

 (950,446

)

 154,915

 20,298

 Net change in unrealized (depreciation), net of deferred taxes

 (22,565,817

)

 (48,567,901

)

 (22,204,246

)

 Net Realized and Unrealized (Loss) on Investments, Net of Deferred Taxes

 (30,430,799

)

 (51,697,566

)

 (10,451,181

)

 Net Decrease In Net Assets Resulting From Operations, Net of Deferred Taxes

 $

 (29,349,220

)

 $

 (64,145,033

)

 (7,387,744

)

 Net Decrease In Net Assets Per Share Resulting From Operations (2)

 $

 (4.26

)

 $

 (9.31

)

 $

 (1.07

)

 (1)

 Primary exposure is equity risk.

 (2)

 Per share results are calculated based on weighted average shares outstanding for each period.

 Item 7.

 Management ' s Discussion and Analysis of Financial Condition and Results of Operations

 The information contained in this section should be read in conjunction with our 2023 Consolidated Financial Statements and notes thereto.

 OVERVIEW

 We are an externally managed, closed-end, non-diversified management investment company organized as a Maryland corporation that has elected to be treated as a BDC under the 1940 Act. As such, we are required to comply with certain regulatory requirements. For instance, we generally have to invest at least 70% of our total assets in "qualifying assets," including securities of private or micro-cap public U.S. companies, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less. In addition, for tax purposes we have elected to be treated as a RIC under Subchapter M of the Code. FCM serves as our investment adviser and manages the investment process on a daily basis.

 Our investment objective is to seek long-term growth of capital, principally by seeking capital gains on our equity and equity-related investments. There can be no assurance that we will achieve our investment objective. Under normal circumstances, we invest at least 80% of our net assets for investment purposes in technology companies. We consider technology companies to be those companies that derive at least 50% of their revenues from products and/or services within the information technology sector or in the "cleantech" sector. Information technology companies include, but are not limited to, those focused on computer hardware, software, telecommunications, networking, Internet, and consumer electronics. While there is no standard definition of cleantech, it is generally regarded as including goods and services designed to harness renewable energy and materials, eliminate emissions and waste, and reduce the use of natural resources. In addition, under normal circumstances we invest at least 70% of our total assets in privately held companies and public companies with market capitalizations of less than $250 million. Our portfolio is primarily composed of equity and equity derivative securities of technology and cleantech companies (as defined above). These investments generally range between $1 million and $10 million each, although the investment size will vary proportionately with the size of our capital base. We acquire our investments through direct investments in private companies, negotiations with selling shareholders, and in organized secondary marketplaces for private securities.

 While our primary focus is to invest in illiquid private technology and cleantech companies, we also may invest in micro-cap publicly traded companies. In addition, we may invest up to 30 percent of the portfolio in opportunistic investments that do not constitute the private companies and micro-cap public companies described above. These other investments may include investments in securities of public companies that are actively traded or in actively traded derivative securities such as options on securities or security indices. These other investments may also include investments in high-yield bonds, distressed debt, or securities of public companies that are actively traded and securities of companies located outside of the United States. Our investment activities are managed by FCM.

 The following table summarizes the fair value of our investment portfolio by industry sector as of December 31, 2023 and December 31, 2022.

 December 31, 2023

 December 31, 2022

 7.0

 %

 55.9

 %

 0.0

 %

 29.0

 %

 333.2

 %

 25.8

 %

 306.6

 %

 11.5

 %

 8.8

 %

 2.9

 %

 0.0

 2.4

 %

 31.8

 %

 1.4

 %

 Exchange-Traded/Money Market Funds

 3.8

 %

 2.2

 %

 (Liabilities)/Other Assets

 (593.0

 %)

 (31.1

 %)

 Net Assets

 100.0

 %

 100.0

 %

 Certain trends in the technology industry may have an impact on the portfolio in coming quarters. In particular, the semiconductor industry, which has historically been a highly cyclical industry, has enjoyed a period of strong growth over the past several years. Given the substantial weighting of semiconductor investments in the current portfolio, the Fund will be sensitive to changes in this industry. Fund performance may also be impacted by the speed of adoption of certain new technologies, including, but not limited to: electron radiation for cancer treatment, X-ray inspection of electronic components, and small form factor satellites.

 MATURITY OF PRIVATE COMPANIES IN THE CURRENT PORTFOLIO

 The Fund invests in private companies at various stages of maturity. As our portfolio companies mature, they move from the "early (development) stage" to the "middle (revenue) stage" and then to the "late stage." We expect that this continuous progression may create a pipeline of potential exit opportunities through initial public offerings (IPOs) or acquisitions. Of course, some companies do not progress.

 The illustration below describes typical characteristics of companies at each stage of maturity and where we believe our current portfolio companies fit within these categories. We expect some of our portfolio companies to transition between stages of maturity over time. The transition may be forward if the company is maturing and is successfully executing its business plan or may be backward if the company is not successfully executing its business plan or decides to change its business plan substantially from its original plan.

 EARLY STAGE

 MIDDLE STAGE

 LATE STAGE

 Developing product or service for market, high level of research and development, little or no revenue.

 Established product, customers, business model; limited revenues.

 Appreciable revenue; may be break-even or profitable; IPO or acquisition candidate.

 RESULTS OF OPERATIONS

 The following information is a comparison for the year ended December 31, 2023, December 31, 2022, and December 31, 2021.

 INVESTMENT INCOME

 For the year ended December 31, 2023, we had investment income of $122,631 primarily attributable to an interest on convertible/term note investments with Hera.

 For the year ended December 31, 2022, we had investment income of $(10,008,422) primarily attributable to an interest adjustment on convertible/term note investments with IntraOp Medical Corp and Wrightspeed.

 For the year ended December 31, 2021, we had investment income of $6,318,695 primarily attributable to interest accrued on convertible/term note investments with IntraOp Medical Corp, Hera, and Wrightspeed.

 The higher level of investment income in the year ended December 31, 2023 compared to the year ended December 31, 2022 was due to an interest adjustment on notes issued by IntraOp and Wrightspeed in 2022.

 The lower level of investment income in the year ended December 31, 2022 compared to the year ended December 31, 2021 was due to an interest adjustment on notes issued by IntraOp and Wrightspeed.

 OPERATING EXPENSES

 Operating expenses totaled approximately $1,583,768 during the year ended December 31, 2023, $2,439,045 during the year ended December 31, 2022,, and $3,255,258 during the year ended December 31, 2021.

 Significant components of operating expenses for the year ended December 31, 2023, were a management fee expense of $455,559, and professional fees (audit, legal, accounting, and consulting) of $398,882.

 Significant components of operating expenses for the year ended December 31, 2022, were a management fee expense of $1,366,496 and professional fees (audit, legal, accounting, and consulting) of $397,138. Significant components of operating expenses for the year ended December 31, 2021, were a management fee expense of $2,220,811 and professional fees (audit, legal, accounting, and consulting) of $367,471.

 The lower level of operating expenses for the year ended December 31, 2023 compared to the year ended December 31, 2022 is primarily attributable to a decrease in our total net assets, on which the investment advisory fees are based.

 The lower level of operating expenses for the year ended December 31, 2022 compared to the year ended December 31, 2021 is primarily attributable to a decrease in total net assets, on which the investment advisory fees are based.

 NET INVESTMENT GAIN/(LOSS)

 The net investment gain/(loss) before taxes was $1,081,579 for the year ended December 31, 2023, $(12,447,467) for the year ended December 31, 2022, and $3,063,437 for the year ended December 31, 2021.

 The greater net investment gain before taxes in the year ended December 31, 2023 compared to the year ended December 31, 2022 is primarily attributable to a waiver of investment advisory fees (see Note 4).

 The greater net investment gain before taxes in the year ended December 31, 2022 compared to the year ended December 31, 2021 is primarily attributable to an interest adjustment in convertible notes with IntraOp Medical and Wrightspeed on which we accrue income.

 NET INVESTMENT REALIZED GAINS AND LOSSES AND UNREALIZED APPRECIATION AND DEPRECIATION

 A summary of the net realized and unrealized gains and losses on investments for the years ended December 31, 2023, December 31, 2022, and December 31, 2021, is shown below.

 Year Ended
 December 31, 2023

 Realized losses

 $

 (7,864,982

)

 Net change in unrealized depreciation on investments

 $

 (22,565,817

)

 Net realized and unrealized loss on investments

 $

 (30,430,799

)

 As of
 December 31, 2023

 Gross unrealized appreciation on portfolio investments

 $

 Gross unrealized depreciation on portfolio investments

 $

 (125,233,890

)

 Net unrealized depreciation on portfolio investments, warrants, and other assets

 $

 (125,233,890

)

 Year Ended
 December 31, 2022

 Realized losses

 $

 (3,129,665

)

 Net change in unrealized depreciation on investments

 $

 (48,567,901

)

 Net realized and unrealized loss on investments

 $

 (51,697,566

)

 As of
 December 31, 2022

 Gross unrealized appreciation on portfolio investments

 $

 957,122

 Gross unrealized depreciation on portfolio investments

 $

 (103,625,209

)

 Net unrealized depreciation on portfolio investments, warrants, and other assets

 $

 (102,668,087

)

 Year Ended
 December 31, 2021

 Realized gains

 $

 11,753,065

 Net change in unrealized depreciation on investments

 $

 (22,204,246

)

 Net realized and unrealized loss on investments

 $

 (10,451,181

)

 As of
 December 31, 2021

 Gross unrealized appreciation on portfolio investments

 $

 18,046,155

 Gross unrealized depreciation on portfolio investments

 $

 (72,146,172

)

 Net unrealized depreciation on portfolio investments, warrants, and other assets

 $

 (54,100,017

)

 During the year ended December 31, 2023, we recognized net realized losses of approximately $7,864,982 from the sale of investments. Realized losses were higher compared to the Fund's realized gains in 2022 due to the sale of investments, primarily SiGen in 2023.

 During the year ended December 31, 2023, net unrealized depreciation on total investments increased by $22,565,817. The change in net unrealized appreciation and depreciation of our private investments is based on portfolio asset valuations determined in good faith by our Board of Directors. The increase in unrealized depreciation on total investments during the year is due primarily to the decrease in value of our investments, most notably, IntraOp Medical, and Wrightspeed.

 During the year ended December 31, 2022, we recognized net realized losses of approximately $3,129,665 from the sale of investments. Realized losses were higher compared to the Fund's realized gains in 2021 due to the sale of investments, primarily Pivotal in 2022.

 During the year ended December 31, 2022, net unrealized depreciation on total investments increased by $48,567,901. The change in net unrealized appreciation and depreciation of our private investments is based on portfolio asset valuations determined in good faith by our Board of Directors. The increase in unrealized depreciation on total investments during the year is due primarily to the decrease in value of our investments, most notably, IntraOp Medical, Wrightspeed and Revasum.

 During the year ended December 31, 2021, we recognized net realized gains of approximately $11,753,065 from the sale of investments. Realized gains were higher compared to the Fund's realized losses in 2020 due to the sale of investments, primarily Pivotal in 2021.

 During the year ended December 31, 2021, net unrealized depreciation on total investments increased by $22,204,246. The change in net unrealized appreciation and depreciation of our private investments is based on portfolio asset valuations determined in good faith by our Board of Directors. The increase in unrealized depreciation on total investments during the year is due primarily to the decrease in value of our investments, most notably, IntraOp Medical, Wrightspeed and SVXR.

 INCOME AND EXCISE TAXES

 Beginning on June 30, 2018, we were no longer able to qualify as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). This change in tax status resulted from the increase in the value of a single holding, Pivotal Systems Corp., which meant that we were no longer able to satisfy the diversification requirements for qualification as a RIC. As a result of this change, we will be taxed as a corporation for our fiscal year ended December 31, 2018, and will continue to be taxed in that manner for future fiscal years, paying federal and applicable state corporate taxes on our taxable income, unless and until we are able to once again qualify as a RIC, based on changes in the composition of our portfolio. Consequently, at the close of each fiscal quarter beginning with the quarter ended June 30, 2018, we will record a deferred tax liability for any net realized gains and net ordinary income for the year-to-date period plus net unrealized gains as of the end of the quarter.

 NET INCREASE/(DECREASE) IN ASSETS RESULTING FROM OPERATIONS AND CHANGE IN NET ASSETS PER SHARE

 For the year ended December 31, 2023, the net decrease in net assets resulting from operations (net of deferred taxes) totaled $29,349,220 and the basic and fully diluted net change in net assets per share for the year ended December 31, 2023 was $(4.26).

 For the year ended December 31, 2022, the net decrease in net assets resulting from operations (net of deferred taxes) totaled $64,145,033 and the basic and fully diluted net change in net assets per share for the year ended December 31, 2022 was $(9.31).

 For the year ended December 31, 2021, the net decrease in net assets resulting from operations (net of deferred taxes) totaled $7,387,744 and the basic and fully diluted net change in net assets per share for the year ended December 31, 2020 was $(1.07).

 The greater decrease in net assets resulting from operations (net of deferred taxes) for the year ended December 31, 2023 as compared to the year ended December 31, 2022, is due primarily to a greater decrease in the asset valuations of our holdings, which are determined in good faith by our Board of Directors.

 The greater decrease in net assets resulting from operations (net of deferred taxes) for the year ended December 31, 2022 as compared to the year ended December 31, 2021, is due primarily to a greater decrease in the asset valuations of our holdings, which are determined in good faith by our Board of Directors.

 The lesser decrease in net assets resulting from operations (net of deferred taxes) for the year ended December 31, 2021 as compared to the year ended December 31, 2020, is due primarily to a greater increase in realized gains from investments, most notably Pivotal Systems.

 FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

 Our liquidity and capital resources are generated primarily from sales or liquidation proceeds of our investments. In management's view, we have sufficient liquidity and capital resources to pay our operating expenses and conduct investment activities over the next twelve months.

 Our primary uses of cash are to make investments, pay our operating expenses, and make distributions to our stockholders. For the years ended December 31, 2023, 2022, and 2021, our operating expenses were $1,583,768, $2,439,045, and $3,255,258, respectively.

 For the year ended December 31, 2023, our total cash reserves and liquid securities decreased approximately 88%, primarily due to the purchase of portfolio securities. We believe that our current liquid assets are sufficient to meet the Company's short-term financing needs.

 During the year ended December 31, 2022, cash and cash equivalents decreased to $73,502 at the end of the year, from $616,064 at the beginning of the year. The decrease in cash and cash equivalents primarily resulted from the sale of portfolio investments in 2023.

 At December 31, 2023, we had investments in public and private securities totaling approximately $8.7 million. Also, at December 31, 2023, we had approximately $0.1 million in cash. We primarily invest cash on hand in money market treasury portfolios. We expect the portion of our portfolio consisting of cash and cash equivalents to decrease as we become fully invested.

 As of December 31, 2023, net assets totaled approximately $1.3 million, with an NAV per share of $0.18. Our primary use of funds will be investments in portfolio companies and payments of fees and other operating expenses we incur. Additionally, we expect to raise additional capital to support our future growth through future equity offerings. To the extent we determine to raise additional equity through an offering of our common stock at a price below NAV, existing investors will experience dilution.

 PORTFOLIO INVESTMENTS

 PRIVATE INVESTMENTS

 We make investments in securities of both public and private companies. December 31, 2023, we had investments in the following private companies:

 EQX Capital, Inc.

 EQX Capital, Inc. ("EQX"), San Francisco, California, is an equipment leasing company.

 At December 31, 2023, our investment in EQX consisted of 1,950,000 shares of Series A preferred stock and 100,000 shares of common stock with an aggregate fair value of approximately $0.1 million.

 Hera Systems, Inc.

 Hera Systems, Inc. ("Hera"), San Jose, CA, is currently developing a constellation of micro satellites to launch into low Earth orbit with imaging and communications capabilities.

 At December 31, 2023, our investment in Hera consisted of 3,642,324 shares of Series A preferred stock, 7,039,203 shares of Series B preferred stock, 2,650,000 shares of Series C preferred stock, $1,200,000 par value convertible note, $5,359,791 par value convertible note, and 24,414,922 shares of Series B warrants with an aggregate fair value of approximately $4.2 million.

 IntraOp Medical Corp.

 IntraOp Medical Corporation ("IntraOp"), Sunnyvale, California, manufactures and markets the Mobetron, a medical device for delivering Intra Operative Electron Radiation Therapy to cancer patients.

 At December 31, 2023, our investment in IntraOp consisted of 26,856,187 shares of Series C preferred stock, $3,000,000 par value term note, $2,000,000 par value term note, $1,300,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $1,000,000 par value convertible note, $400,000 par value convertible note, $750,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $500,000 par value convertible note, $200,000 par value convertible note, $150,000 par value convertible note, $350,000 par value convertible note, $700,000 par value convertible note, a $10,961,129 par value convertible note, with a combined aggregate fair value of approximately $88 thousand.

 Kyma, Inc.

 Kyma, Inc. ("Kyma"), Raleigh, NC, is a supplier of high-quality gallium nitride-based wafers to semiconductor device manufacturers in the electronics and optical markets.

 At December 31, 2023, our investment in Kyma consisted of a $100,000 par value convertible note with a combined fair value of approximately $100 thousand.

 Lyncean Technologies, Inc.

 Lyncean Technologies, Inc. ("Lyncean"), Fremont, CA, is a developer X-ray and extreme ultraviolet (EUV) light sources for laboratory and commercial use.

 At December 31, 2023, our investment in Lyncean consisted of 869,792 shares of Series B preferred stock with a combined fair value of approximately $0.

 UCT Coatings, Inc.

 UCT Coatings, Inc. ("UCT"), Stuart, Florida, is a leader in the development of metal coatings that reduce friction and improve efficiency in mechanical systems.

 At December 31, 2023, our investments in UCT consisted of 1,500,000 shares of common stock with a combined fair value of approximately $300 thousand.

 Wrightspeed, Inc.

 Wrightspeed, Inc. ("Wrightspeed"), San Jose, California, is a supplier of electric drivetrains for heavy-duty commercial vehicles.

 At December 31, 2023, our investments in Wrightspeed consisted of 69,102 shares of common stock, 60,733,693 shares of Series AA preferred stock, warrants to purchase 609,756 shares of Series AA preferred stock, $750,000 par value convertible note, $400,000 par value convertible note, $900,000 par value convertible note, $1,050,000 par value convertible note, $400,000 par value convertible note, $375,000 par value convertible note, $2,000,000 par value convertible note, $1,400,000 par value convertible note, $1,200,000 par value convertible note, $700,000 par value convertible note, $300,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $1,000,000 par value convertible note, $200,000 par value convertible note, $185,000 par value convertible note, $65,000 par value convertible note, $250,000 par value convertible note, $250,000 par value convertible note, $250,000 par value convertible note, $250,000 par value convertible note, $250,000 par value convertible note, $250,000 par value convertible note, $250,000 par value convertible note, $135,000 par value convertible note, $165,000 par value convertible note, $125,000 par value convertible note, a $4,929,015 par value convertible note, and a a $100,000 par value convertible note and a $40,000 par value convertible note with a combined fair value of approximately $0.

 PUBLIC INVESTMENTS

 At December 31, 2023, we had investments in the following public securities:

 Revasum, Inc.

 Revasum, ("Revasum"), San Luis Obispo, California, designs CMP and grinding technology for the semiconductor equipment industry.

 At December 31, 2023, our investment in Revasum consisted of 39,774,889 shares of CDIs with an aggregate fair value of approximately $3.9 million

 Fidelity Investments Money Market Treasury Portfolio - Class I

 Fidelity Investments Money Market Treasury Portfolio - Class I ("Money Market") is a money market portfolio that invests primarily in U.S. treasury securities.

 At December 31, 2023, our investment in Money Market consisted of 73,502 shares of the money market fund with a market value of approximately $74 thousand.

 DISTRIBUTION POLICY

 Our board of directors will determine the timing and amount, if any, of our distributions. For each year in which the Fund has qualified as a RIC, we intend to pay distributions on an annual basis out of assets legally available therefore. In order to qualify as a RIC and to avoid corporate-level tax on our income, we must distribute to our stockholders at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, on an annual basis. In addition, we also intend to distribute any realized net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) at least annually.

 CONTRACTUAL OBLIGATIONS

 The Fund does not have any Contractual Obligations that meet the requirements for disclosure under Item 303 of Regulation S-K.

 OFF-BALANCE SHEET ARRANGEMENTS

 The Fund does not have any Off-Balance Sheet Arrangements.

 CRITICAL ACCOUNTING POLICIES

 This discussion of our financial condition and results of operations is based upon our financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP. The preparation of these financial statements will require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses. Changes in the economic environment, financial markets, and any other parameters used in determining such estimates could cause actual results to differ. In addition to the discussion below, we will describe our critical accounting policies in the notes to our future financial statements.

 Valuation of Portfolio Investments

 As a business development company, we generally invest in illiquid equity and equity derivatives of securities of venture capital stage technology companies. Under written procedures established by our board of directors, securities traded on stock exchanges, or quoted by NASDAQ, are valued according to the NASDAQ Stock Market, Inc. ("NASDAQ") official closing price, if applicable, or at their last reported sale price as of the close of trading on the New York Stock Exchange ("NYSE") (normally 4:00 P.M. Eastern Time). If a security is not traded that day, the security will be valued at its most recent bid price. Securities traded in the over-the-counter market, but not quoted by NASDAQ, are valued at the last sale price (or, if the last sale price is not readily available, at the most recent closing bid price as quoted by brokers that make markets in the securities) at the close of trading on the NYSE. Securities traded both in the over-the-counter market and on a stock exchange are valued according to the broadest and most representative market. We obtain these market values from an independent pricing service or at the mean between the bid and ask prices obtained from at least two brokers or dealers (if available, otherwise by a principal market maker or a primary market dealer). In addition, a large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities quarterly at fair value as determined in good faith by our board of directors. Our board of directors may use the services of a nationally recognized independent valuation firm to aid it in determining the fair value of these securities. The methods for valuing these securities may include: fundamental analysis (sales, income, or earnings multiples, etc.), discounts from market prices of similar securities, purchase price of securities, subsequent private transactions in the security or related securities, or discounts applied to the nature and duration of restrictions on the disposition of the securities, as well as a combination of these and other factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time, and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.

 Revenue Recognition

 We record interest income on an accrual basis and dividend income on the ex-dividend date to the extent that we expect to collect such amounts. We do not accrue as a receivable interest on loans and debt securities if we have reason to doubt our ability to collect such interest. Loan origination fees, original issue discount, and market discount are capitalized, and we amortize any such amounts as interest income. Upon the prepayment of a loan or debt security, any unamortized loan origination is recorded as interest income. We will record prepayment premiums on loans and debt securities as interest income when we receive such amounts.

 Net Realized Gains or Losses and Net Change in Unrealized Appreciation or Depreciation

 We measure realized gains or losses by the difference between the net proceeds from the repayment or sale and the cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized. Net change in unrealized appreciation or depreciation reflects the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation, when gains or losses are realized.

 Recently Issued Accounting Standards

 From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that are adopted by us as of the specified effective date. We believe that the impact of recently issued standards that are not yet effective will not have a material impact on our financial statements upon effectiveness.

 Inflation

 Inflation has not had a significant effect on our results of operations in any of the reporting periods presented herein. However, our portfolio companies have experienced, and may in the future experience, the impacts of inflation on their operating results.

 SUBSEQUENT EVENTS

 Subsequent to the close of the year on December 31, 2023, and through the date of the issuance of the financial statements included herein, a number of material events related to our portfolio of investments occurred, consisting primarily of purchased and sold securities. Since that date, we have not purchased any additional private securities.

 Item 7A.

 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 The Fund's business activities contain elements of risk. We consider the principal types of market risk to be valuation risk and small company investment risk.

 VALUATION RISK

 Value, as defined in Section 2(a)(41) of the 1940 Act, is (i) the market price for those securities for which market quotations are readily available and (ii) fair value as determined in good faith by, or under the direction of, the Board of Directors for all other assets.

 Because there is typically no public market for our interests in the small privately-held companies in which we invest, the valuation of the securities in that portion of our portfolio is determined in good faith by our Board of Directors with the assistance of our Valuation Committee, comprised of the independent members of our Board of Directors, in accordance with our Valuation Procedures. In addition, the Board of Directors may use the services of a nationally recognized independent valuation firm to aid it in determining the fair value of some of these securities. In the absence of a readily ascertainable market value, the determined value of our portfolio of securities may differ significantly from the values that would be placed on the portfolio if a ready market for such securities existed. Determining fair value requires that judgment be applied to the specific facts and circumstances of each portfolio investment, although our valuation policy is intended to provide a consistent basis for determining fair value of the portfolio investments. The methods for valuing these securities may include: fundamental analysis (sales, income, or earnings multiples, etc.), discounts from market prices of similar securities, purchase price of securities, subsequent private transactions in the security or related securities, or discounts applied to the nature and duration of restrictions on the disposition of the securities, as well as a combination of these and other factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time, and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed.

 Furthermore, changes in valuation of any of our investments in privately-held companies from one period to another may be volatile.

 Investments in privately held, immature companies are inherently more volatile than investments in more mature businesses. Such immature businesses are inherently fragile and easily affected by both internal and external forces.

 Our portfolio companies can lose much or all of their value suddenly in response to an internal or external adverse event. Conversely, these immature businesses can gain suddenly in value in response to an internal or external positive development.

 The values assigned to our assets are based on available information and do not necessarily represent amounts that might ultimately be realized, as these amounts depend on future circumstances and cannot be reasonably determined until the individual investments are actually liquidated or become readily marketable. Upon sale of investments, the values that are ultimately realized may be different from what is presently estimated. This difference could be material.

 PRIVATELY PLACED SMALL COMPANIES RISK

 The Fund invests in small companies, and its investments in these companies are considered speculative in nature. The Fund's investments often include securities that are subject to legal or contractual restrictions on resale that adversely affect the liquidity and marketability of such securities. As a result, the Fund is subject to risk of loss which may prevent our shareholders from achieving price appreciation, dividend distributions and return of capital.

 WE MAY HOLD A PORTION OF OUR ASSETS IN CASH

 As of December 31, 2023, we do not have a significant portion of the Fund's assets invested in cash and/or cash equivalents. We may, however, from time to time hold a substantial portion of our assets in cash and/or cash equivalents, which are expected to earn low yields. Given the current low interest rate environment, to the extent the management fee and other operating expenses exceed interest income on the cash holdings of the Fund, the Fund may experience losses. Furthermore, the investment advisory fee payable by us will not be reduced while our assets are invested in cash-equivalent securities.

 In some cases, particularly for primary transactions, it is to our advantage to hold sufficient cash reserve so that we can make additional subsequent investments in these companies in order to (a) avoid having our earlier investments become diluted in future dilutive financings, (b) invest additional capital into existing portfolio companies in case additional investments are necessary, and/or (c) exercise warrants, options, or convertible securities that were acquired as part of the earlier transactions. For this reason, in the case of primary transactions (as opposed to secondary transactions where we do not buy the securities from the issuing companies but instead from existing stockholders), we typically reserve cash in an amount at least equal to our initial investment for such follow-on opportunities. Cash reserves held with respect to a particular investment should, therefore, decline as it is held longer, and will typically not be needed once that portfolio company becomes public or we determine it is no longer in our best interest to make investments in such portfolio company.

 We may from time to time liquidate various investments. We are required to distribute substantially all of our net realized gains to stockholders on an annual basis and, therefore, will generally hold the proceeds of liquidated investments in cash pending its distribution.

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To the Board of Directors and Shareholders

 of Firsthand Technology Value Fund, Inc.

 Opinion on the Financial Statements

 We have audited the accompanying consolidated statements of assets and liabilities of Firsthand Technology Value Fund, Inc. (the "Company"), including the consolidated schedules of investments, as of December 31, 2023 and 2022, and the related consolidated statements of operations, changes in net assets, and cash flows for each of the years in the three-year period ended December 31, 2023, and the consolidated financial highlights for each of the years in the five-year period ended December 31, 2023, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, the results of its operations, the changes in its net assets, and its cash flows for each of the years in the three-year period ended December 31, 2023, and the financial highlights for each of the years in the five-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 Basis for Opinion

 These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We have served as the Company's auditor since 1997.

 We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our procedures included confirmation of securities owned as of December 31, 2023 by correspondence with the custodian and portfolio companies. We believe that our audits provide a reasonable basis for our opinion.

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To the Board of Directors and Shareholders

 of Firsthand Technology Value Fund, Inc.

 Page Two

 Critical Audit Matter

 The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgements. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.

 As discussed in Note 6, level 3 investments were valued at $4,797,872 which represented 381% of the Company's net assets as of December 31, 2023. As part of the valuation process, the Board of Directors and the Audit Committee of the Board of Directors review the valuation models and assumptions prepared by an independent third-party valuation firm. The Company's level 3 investments are valued using acceptable industry methods including a market approach, an income approach, a cost approach, or a combination of such approaches. The market approach uses prices and other relevant information generated by market transactions. The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) discounted to a single present value amount. The cost approach uses the Company's cost basis of the investment. In following these approaches, the types of factors that management may take into account in fair value pricing investments include observable market inputs together with significant unobservable inputs, including relevant comparable company multiples, discount rates, volatility and recent transactions.

 The principal consideration for our determination that performing procedures relating to the valuation of level 3 investments is a critical audit matter as there was significant judgement by management to determine the fair value of these level 3 investments, which included significant unobservable inputs as described above. This in turn led to a high degree of auditor judgement, subjectivity, and effort in performing audit procedures and evaluating the audit evidence obtained related to the unobservable inputs.

 Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of level 3 investments and testing the completeness, accuracy, reliability, and relevance of key data used in the valuation models and testing the computation of these level 3 investments based on the inputs used.

 Emphasis of Matter

 As discussed in Note 1, the Company issued a press release announcing approval to withdraw its BDC election and pursue liquidation.

 Additionally, As discussed in Note 10 to the financial statements, the Company has two unconsolidated significant subsidiaries, as defined under S-X Rule 3-09 for which audited financial statements as of December 31, 2023 were not available as of the date the consolidated financial statements were issued. Because the audited financial statements were not available, the Company has presented summarized financial information for one subsidiary as of December 31, 2023 and 2022 and for the three years ending December 31, 2023 and audited financial statements for the fiscal period ending January 1, 2023 for the second subsidiary.

 Our opinion is not modified with respect to these matters.

 /S/ TAIT, WELLER & BAKER LLP
 PCAOB ID 445

 Philadelphia, Pennsylvania
 March 28, 2024

 Item 8.

 FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 Consolidated Statements of Assets and Liabilities

 AS OF
 2023

 AS OF
 2022

 ASSETS

 Investment securities:

 Unaffiliated investments at acquisition cost

 $
 1,173,502
 *

 $
 1,772,422
 *

 Affiliated investments at acquisition cost

 Controlled investments at acquisition cost

 132,131,932

 140,355,353

 Total acquisition cost

 $
 133,967,669

 $
 142,790,010

 Unaffiliated investments at market value

 $
 173,502
 *

 $
 772,422
 *

 Affiliated investments at market value

 Controlled investments at market value

 8,260,345

 39,012,002

 Total Market value** (Note 6)

 8,733,779

 40,121,924

 Foreign currency at value (cost $ 2,629 and $ 3,235)

 2,765

 3,404

 Receivable from dividends and interest

 8,161

 14,463

 Other assets

 63,649

 64,066

 Total Assets

 8,808,354

 40,203,857

 LIABILITIES

 Payable to affiliates (Note 4)

 7,183,782

 9,188,187

 Trustees' fees payable

 13,891

 50,000

 Consulting fee payable

 43,000

 46,000

 Accrued expenses and other payables

 307,310

 310,079

 Total Liabilities

 7,547,983

 9,594,266

 NET ASSETS

 $

 $

 Net Assets consist of:

 Common Stock, par value $ 0.001 per share 100,000,000 shares authorized

 $
 6,893

 $
 6,893

 Paid-in-capital

 176,770,722

 176,770,722

 Total distributable earnings (loss)

 ( 175,517,244
)

 ( 146,168,024
)

 NET ASSETS

 $

 $

 Shares of Common Stock outstanding

 7,016,432

 7,016,432

 Shares of Treasury Stock outstanding

 ( 123,376
)

 ( 123,376
)

 Total Shares of Common Stock outstanding

 Net asset value per share (Note 2)

 $
 0.18

 $
 4.44

 *

 Includes Fidelity Investment Money Market Treasury Portfolio - Class I, which invests primarily in U.S. Treasury securities. The yields as of 12/31/23 and 12/31/22 were 5.23% and 4.13%, respectively. Please see  for additional information.

 **

 Includes warrants whose primary risk exposure is equity contracts.

 Consolidated Schedule of Investments

 VALUE

 EQX CAPITAL, INC.( 8.8 %)

 Common Stock *(1)(2)(4)

 6/10/2016

 $
 20,000

 $

 Preferred Stock - Series A *(1)(2)(4)

 6/10/16-11/7/16

 110,227

 HERA SYSTEMS, INC. ( 333.2 %) Aerospace

 Note Matures December 2024 Interest Rate 10% (1)(2)(4)(6)

 12/29/2022

 3,431,683

 Convertible Note Matures December 2024 Interest Rate 10% (1)(2)(4)

 12/29/2022

 768,317

 Preferred Stock - Series A *(1)(2)(4)

 9/18/2015

 3,642,324

 Preferred Stock - Series B *(1)(2)(4)

 8/7/17 - 2/1/19

 7,039,203

 6,587,102

 Preferred Stock - Series C *(1)(2)(4)

 8/7/19-2/12/20

 7/9/18 - 9/4/18

 12,250,000

 2/1/2019

 5,250,000

 8/7/2017

 6,214,922

 9/28/2017

 INTRAOP MEDICAL CORP. ( 7.0 %) Medical Devices

 10/11/2019

 1,577

 10/22/2021

 3,154

 10/29/2019

 1,577

 10/6/2021

 1,577

 PORTFOLIO
 COMPANY (% OF NET ASSETS) AND INDUSTRY

 ACQUISITION
 DATE

 VALUE

 INTRAOP MEDICAL CORP. (continued)

 11/12/2021

 $

 $
 1,577

 11/29/2021

 1,577

 12/31/2018

 34,570

 2/27/2020

 3,154

 2/28/2022

 3/25/2020

 1,577

 3/30/2022

 4/20/2021

 3,154

 4/6/2022

 1,104

 5/8/2020

 1,261

 6/10/2021

 1,577

 6/10/2022

 2,208

 7/12/2019

 4,100

 7/16/2021

 1,577

 PORTFOLIO
 COMPANY (% OF NET ASSETS) AND INDUSTRY

 ACQUISITION
 DATE

 VALUE

 INTRAOP MEDICAL CORP. (continued)

 7/31/2020

 $

 $
 1,577

 8/28/2020

 2,365

 9/22/2021

 1,577

 Preferred Stock - Series C *(1)(2)(4)

 7/12/2013

 26,856,187

 26,299,939

 Term Note Matures December 2024 Interest Rate 8% (1)(2)(4)(6)

 2/10/2017

 6,308

 Term Note Matures December 2024 Interest Rate 8% (1)(2)(4)(6)

 2/28/2014

 9,461

 KYMA, INC. ( 7.9 %) Advanced Materials

 Convertible Note Matures March 2024 Interest Rate 10% (1)(4)

 3/11/2019

 LYNCEAN TECHNOLOGIES, INC. ( 0.0 %)

 Preferred Stock - Series B *(1)(4)

 7/3/2018

 869,792

 REVASUM, INC. ( 306.5 %)

 CDIs *(2)

 11/14/16 - 10/3/22

 39,774,889

 9,268,218

 UCT COATINGS, INC. ( 23.8 %)
 Common Stock *(1)(3)(4)

 1,500,000

 ACQUISITION
 DATE

 VALUE

 WRIGHTSPEED, INC. ( 0.0 %)

 Common Stock *(1)(2)

 6/7/2019

 69,102

 $
 7,460,851

 $

 1/10/2023

 10/13/2020

 10/20/2021

 10/21/2022

 10/5/2021

 11/11/2020

 11/14/2022

 11/23/2021

 11/24/2020

 12/11/2020

 12/23/2020

 12/28/2021

 12/9/2022

 2/23/2021

 2/23/2022

 3/11/2022

 4/12/2021

 4/14/2022

 5/10/2022

 5/18/2021

 Consolidated Schedule of Investments -continued

 ACQUISITION
 DATE

 VALUE

 WRIGHTSPEED, INC. (CONTINUED)

 5/26/2022

 $

 $

 6/10/2022

 6/22/2021

 6/28/2022

 6/7/2019

 7/13/2022

 7/26/2021

 7/28/2022

 8/12/2020

 8/12/2022

 8/19/2021

 9/10/2022

 9/22/2021

 Convertible Note Matures December 2024 Interest Rate 18% (1)(2)(4)(6)
 8/25/2023

 Preferred Stock - Series AA *(1)(2)(4)
 6/7/19 - 7/20/20

 60,733,693

 17,355,887

 Consolidated Schedule of Investments -continued

 VALUE

 INVESTMENT COMPANY ( 5.8 %)

 Fidelity Investments Money Market Treasury Portfolio - Class 1 (5)

 Various

 $
 $

 TOTAL INVESTMENTS (Cost $ 133,967,669) — 693.0 %

 8,733,779

 LIABILITIES IN EXCESS OF OTHER ASSETS — ( 593.0)%

 ( 7,473,408
)

 NET ASSETS — 100.0 %

 $

 All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

 CDI:CHESS Depositary Interests

 *

 Non-income producing security.

 ( 1)

 Restricted security. Fair Value is determined by or under the direction of the Company ' s Board of Directors (see Note 3). At December 31, 2023, we held $ 4,797,872 (or 380.7 % of net assets) in restricted securities (see Note 2).

 ( 2)

 Controlled investments.

 ( 3)

 Affiliated issuer.

 ( 4)

 Fair Value Level 3 security. ( 380.7 % of net assets).

 ( 5)

 The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

 ( 6)

 Security whose interest accrues until maturity however, based on December 31, 2023 valuation no such interest accrued during year ended December 31, 2023.

 Consolidated Schedule of Investments

 VALUE

 EQX CAPITAL, INC.
 ( 2.9 %)

 Common Stock *(1)(2)(4)

 6/10/2016

 $

 20,000

 $

 Preferred Stock - Series A *(1)(2)(4)

 6/10/16-11/7/16

 877,125

 HERA SYSTEMS, INC.
 ( 25.8 %)

 Convertible Note Matures December 2024 Interest Rate 5% (1)(2)(4)

 12/29/2022

 Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4)

 12/29/2022

 Preferred Stock - Series A *(1)(2)(4)

 9/18/2015

 3,642,324

 4,735

 Preferred Stock - Series B *(1)(2)(4)

 8/7/17 - 2/1/19

 7,039,203

 6,587,102

 275,585

 Preferred Stock - Series C *(1)(2)(4)

 8/7/19-2/12/20

 103,748

 7/9/18 - 9/4/18

 12,250,000

 478,608

 2/1/2019

 5,250,000

 205,117

 8/7/2017

 6,214,922

 242,817

 9/28/2017

 27,349

 7,897,750

 INTRAOP MEDICAL CORP.
 ( 55.9 %)

 12/31/2018

 6,746,169

 7/12/2019

 800,102

 10/11/2019

 VALUE

 INTRAOP MEDICAL CORP.

 10/29/2019

 $

 $

 2/27/2020

 3/25/2020

 5/8/2020

 246,185

 7/31/2020

 8/28/2020

 461,597

 4/20/2021

 6/10/2021

 7/16/2021

 9/22/2021

 10/6/2021

 10/22/2021

 VALUE

 INTRAOP MEDICAL CORP.

 11/12/2021

 $

 $

 11/29/2021

 2/28/2022

 123,093

 3/30/2022

 92,319

 4/6/2022

 215,412

 6/10/2022

 430,824

 Preferred Stock - Series C *(1)(2)(4)

 7/12/2013

 26,856,187

 26,299,938

 Term Note Matures December 2022 Interest Rate 8% (1)(2)(4)(6)

 2/28/2014

 1,846,389

 Term Note Matures December 2022 Interest Rate 8% (1)(2)(4)(6)

 2/10/2017

 1,230,926

 KYMA, INC.
 ( 0.3 %)

 Convertible Note Matures March 2023 Interest Rate 10% (1)(4)

 3/11/2019

 LYNCEAN TECHNOLOGIES, INC.
 ( 0.0 %)

 Preferred Stock - Series B *(1)(4)

 7/3/2018

 869,792

 VALUE

 REVASUM, INC.
 ( 11.5 %)

 CDIs *(2)

 11/14/16 - 10/3/22

 39,774,889

 $

 9,268,219

 $

 SILICON GENESIS CORP.
 ( 2.4 %)

 Preferred Stock - Series 1-E *(1)(2)(4)

 5,704,480

 2,372,403

 320,592

 Preferred Stock - Series 1-C *(1)(2)(4)

 82,914

 109,518

 Preferred Stock - Series 1-D *(1)(2)(4)

 850,830

 431,901

 2,552

 Common Stock *(1)(2)(4)

 921,892

 169,045

 Common Stock Warrants *(1)(2)(4)

 37,982

 6,678

 Preferred Stock - Series 1-F *(1)(2)(4)

 912,453

 456,389

 70,806

 Preferred Stock - Series 1-G *(1)(2)(4)

 3/10/2016

 48,370,793

 3,880,592

 306,671

 Preferred Stock - Series 1-H *(1)(2)(4)

 3/10/2016

 837,942

 936,895

 35,529

 737,224

 UCT COATINGS, INC.
 ( 1.1 %)

 Common Stock *(1)(3)(4)

 1,500,000

 WRIGHTSPEED, INC.
 ( 29.0 %)

 Common Stock *(1)(2)(4)

 4/11/2013 - 5/6/2019

 69,102

 7,460,851

 6/7/2019

 1,601,930

 8/12/2020

 243,750

 9/10/2020

 292,500

 VALUE

 WRIGHTSPEED, INC.

 10/13/2020

 $

 $

 341,250

 11/11/2020

 11/24/2020

 121,875

 12/11/2020

 12/23/2020

 650,000

 2/23/2021

 455,000

 4/12/2021

 390,000

 5/18/2021

 6/22/2021

 7/26/2021

 8/19/2021

 9/22/2021

 97,500

 VALUE

 WRIGHTSPEED, INC.

 10/5/2021

 $

 $

 227,500

 10/20/2021

 11/23/2021

 12/28/2021

 2/23/2022

 3/11/2022

 60,125

 4/14/2022

 21,125

 5/10/2022

 5/26/2022

 6/10/2022

 6/28/2022

 7/13/2022

 VALUE

 WRIGHTSPEED, INC.

 7/28/2022

 $

 $

 8/12/2022

 10/21/2022

 43,875

 11/14/2022

 53,625

 12/9/2022

 40,625

 Preferred Stock - Series AA *(1)(2)(4)

 6/7/19 - 7/20/20

 60,733,693

 17,355,887

 Preferred Stock Warrants - Series AA *(1)(2)(4)

 6/7/2019

 609,756

 3,232

 8,862,686

 VALUE

 INVESTMENT COMPANY
 ( 2.2 %)

 Fidelity Investments Money Market Treasury Portfolio - Class I (5)

 Various

 672,422

 $

 672,422

 $

 672,422

 TOTAL INVESTMENTS (Cost $ 142,790,010) — 131.1 %

 $

 40,121,924

 LIABILITIES IN EXCESS OF OTHER ASSETS — ( 31.1)%

 ( 9,512,333

)

 NET ASSETS — 100.0 %

 $

 All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

 CDI CHESS Depositary Interests

 *

 Non-income producing security.

 ( 1)

 Restricted security. Fair Value is determined by or under the direction of the Company ' s Board of Directors (See note 3). At December 31, 2022, we held $ 35,929,005 (or 117.4 % of net assets) in restricted securities (see Note 2).

 ( 2)

 Controlled investments.

 ( 3)

 Affiliated issuer.

 ( 4)

 Fair Value Level 3 security. ( 117 % of net assets).

 ( 5)

 The Fidelity Investments Money Market Portfolio invests primarily in U.S. Treasury securities.

 ( 6)

 Security whose interest accrues over the life of the Note and is not payable until maturity. An interest adjustment was made in 2022. See Note 2 to the financial statements.

 Consolidated Statements of Operations

 2023

 2022

 2021

 INVESTMENT INCOME

 Unaffiliated dividends

 —

 —

 $
 171,613

 Unaffiliated interest

 $
 37,275

 $
 3,318

 30,906

 Affiliated/controlled interest

 ( 10,015,197
)

 6,116,176

 Foreign tax withholding

 —

 3,457

 —

 TOTAL INVESTMENT INCOME

 122,631

 ( 10,008,422
)

 6,318,695

 EXPENSES

 Investment advisory fees (Note 4)

 455,559

 1,366,496

 2,220,811

 Administration fees

 116,785

 118,009

 122,177

 Custody fees

 8,743

 17,338

 24,661

 Transfer agent fees

 33,296

 38,054

 39,737

 Registration and filing fees

 35,300

 33,800

 32,700

 Professional fees

 398,882

 397,138

 367,471

 Printing fees

 299,958

 60,853

 80,307

 Trustees fees

 43,841

 Compliance fees

 110,336

 118,777

 120,487

 Miscellaneous fees

 81,068

 88,580

 46,907

 TOTAL GROSS EXPENSES

 1,583,768

 2,439,045

 3,255,258

 Less waiver and/or reimbursement (Note 4)

 ( 2,542,716
)

 —

 —

 TOTAL NET EXPENSES

 ( 958,948
)

 2,439,045

 3,255,258

 NET INVESTMENT INCOME/(LOSS), BEFORE TAXES

 1,081,579

 ( 12,447,467
)

 3,063,437

 Net Realized and Unrealized Gain (Loss) on Investments:

 Net realized gains (losses) from security transactions on:

 Affiliated/controlled

)

 ( 3,131,579
)

 11,753,038

 Foreign currency

 1,914

 Net realized gains (losses), net of deferred taxes

 ( 7,864,982
)

 ( 3,129,665
)

 11,753,065

 Net change in unrealized appreciation (depreciation) on:

 Non-affiliated investments

 —

 ( 280,160
)

 ( 551,274
)

 Affiliated/controlled investments and foreign currency

 ( 21,615,371
)

 ( 48,442,656
)

 ( 21,673,270
)

 Affiliated/controlled warrants investments (1)

 ( 950,446
)

 154,915

 20,298

 Net change in unrealized (depreciation), net of deferred taxes

 ( 22,565,817
)

 ( 48,567,901
)

 ( 22,204,246
)

 Net Realized and Unrealized (Loss) on Investments, Net of Deferred Taxes

 ( 30,430,799
)

 ( 51,697,566
)

 ( 10,451,181
)

 Net Decrease In Net Assets Resulting From Operations, Net of Deferred Taxes

 $
 ( 29,349,220
)

 $
 ( 64,145,033
)

 ( 7,387,744
)

 Net Decrease In Net Assets Per Share Resulting From Operations (2)

 $
 ( 4.26
)

 $
 ( 9.31
)

 $
 ( 1.07
)

 (1)

 Primary exposure is equity risk.

 (2)

 Per share results are calculated based on weighted average shares outstanding for each period.

 Consolidated Statements of Cash Flows

 2023

 2022

 2021

 CASH FLOWS FROM OPERATING ACTIVITIES

 Net increase (decrease) in Net Assets resulting from operations

 $
 ( 29,349,220
)

 $
 ( 64,145,033
)

 $
 ( 7,387,744
)

 Adjustments to reconcile net increase (decrease) in Net Assets derived from operations to net cash provided by (used in) operating activities

 Purchases of investments

 ( 140,000
)

 ( 9,412,526
)

 ( 17,350,000
)

 Proceeds from disposition of investments

 498,425

 9,937,261

 16,104,357

 Net purchases/sales from short-term investments

 598,921

 ( 1,217,769
)

 1,738,739

 Increase (decrease) in dividends, interest, and reclaims receivable

 6,302

 11,471,179

 ( 5,757,044
)

 Increase (decrease) in due to Custodian

 —

 ( 13,589
)

 13,589

 Increase (decrease) in payable to affiliates

 ( 2,004,405
)

 1,485,273

 2,252,215

 Increase (decrease) in other assets

 —

 ( 38,351
)

 Increase (decrease) in accrued expenses and other payables

 ( 41,878
)

 198,958

 ( 27,671
)

 Net realized gain (loss) from investments

 7,864,982

 3,131,579

 ( 11,753,065
)

 Net unrealized appreciation (depreciation) from investments, other assets, and warrants transactions

 22,565,817

 48,568,071

 22,204,246

 Net cash provided by (used in) operating activities

 ( 639
)

 3,404

 ( 729
)

 CASH FLOWS FROM FINANCING ACTIVITIES

 Net cash provided by (used in) financing activities

 —

 —

 —

 Net increase (decrease) in cash

 ( 639
)

 3,404

 ( 729
)

 Cash and foreign currency - beginning of year

 3,404

 —

 Cash and foreign currency - end of year

 $
 2,765

 $
 3,404

 $
 —

 Consolidated Statements of Changes in Net Assets

 2023

 2022

 2021

 FROM OPERATIONS:

 Net investment income (loss), net of deferred taxes

 $
 1,081,579

 $
 ( 12,447,467
)

 $
 3,063,437

 Net realized gain (loss) from security transactions, foreign currency and warrants transactions, net of deferred taxes

 ( 7,864,982
)

 ( 3,129,665
)

 11,753,065

 Net change in unrealized (depreciation) on investments and warrants transactions, net of deferred taxes

 ( 22,565,817
)

 ( 48,567,901
)

 ( 22,204,246
)

 Net decrease in net assets from operations

 ( 29,349,220
)

 ( 64,145,033
)

 ( 7,387,744
)

 FROM CAPITAL SHARE TRANSACTIONS:

 Value for shares repurchased

 —

 —

 —

 TOTAL DECREASE IN NET ASSETS

 ( 29,349,220
)

 ( 64,145,033
)

 ( 7,387,744
)

 NET ASSETS:

 Beginning of year

 94,754,624

 102,142,368

 End of year

 $

 $

 $
 94,754,624

 COMMON STOCK ACTIVITY:

 Shares repurchased

 —

 —

 —

 Net increase (decrease) in shares outstanding

 —

 —

 —

 Shares outstanding, beginning of year

 Shares outstanding, end of year

 Consolidated Financial Highlights Selected per share data and ratios for a share outstanding throughout each year

 2023

 2022

 2021

 2020

 2019

 Net asset value at beginning of year

 $
 4.44

 $
 13.75

 $
 14.82

 $
 17.70

 $
 26.69

 Income from investment operations:

 Net investment income (loss), before deferred taxes

 0.16

 ( 1.81
)

 0.44
 (1)

 0.09
 (1)

 0.90
 (1)

 Deferred tax benefit

 —

 —

 —

 —

 0.08

 Net investment gain (losses)

 0.16

 ( 1.81
)

 0.44

 0.09

 0.82

 Net realized and unrealized gains (losses) on investments, before deferred taxes

 ( 4.42
)

 ( 7.50
)

 ( 1.51
)

 ( 2.30
)

 ( 12.15
)

 Deferred tax expense

 —

 —

 —

 ( 1.13
)

 2.34

 Net realized and unrealized gains (losses) on investments, after deferred taxes

 ( 4.42
)

 ( 7.50
)

 ( 1.51
)

 ( 3.43
)

 ( 9.81
)

 Total from investment operations

 ( 4.26
)

 ( 9.31
)

 ( 1.07
)

 ( 3.34
)

 ( 8.99
)

 Distributions from:

 Realized capital gains

 —

 —

 —

 —

 —

 Anti-dilutive effect from capital share transactions

 —

 —

 —

 0.46

 —

 Net asset value at end of year

 $
 0.18

 $
 4.44

 $
 13.75

 $
 14.82

 $
 17.70

 Market value at end of year

 $
 0.30

 $
 0.95

 $
 4.01

 $
 4.47

 $
 6.43

 Total Return

 Based on Net Asset Value

 ( 95.95
)%

 ( 67.71
)%

 ( 7.22
)%

 ( 16.27
)%

 ( 33.68
)%

 Based on Market Value

 ( 68.42
)%

 ( 76.31
)%

 ( 10.29
)%

 ( 30.48
)%

 ( 42.59
)%

 Consolidated Financial Highlights - continued Selected per share data and ratios for a share outstanding throughout each year

 Net assets at end of year (millions)

 $
 1.3

 $
 30.6

 $
 94.8

 $
 102.1

 $
 127.1

 Ratio of total expenses to average net assets:

 Before tax (benefit)/expense

 (7.21
)%

 4.11
 %

 3.12
 %

 3.10
 %

 (2.84
)%(2)

 Deferred tax (benefit)/expense (3)(4)

 —

 —

 —

 8.02%
 (5)

 (9.91
)%

 Total expenses

 (7.21
)%

 4.11
 %

 3.12
 %

 11.12
 %

 (12.75
)%(2)

 Total expenses, excluding incentive fees and deferred tax expense

 (7.21
)%

 4.11
 %

 3.12
 %

 3.10
 %

 2.80
 %

 Total expenses, excluding incentive fees and deferred tax expenses and fee waiver

 11.91
 %

 4.11
 %

 3.12
 %

 3.10
 %

 2.80
 %

 Ratio of net investment income (loss) to average net assets:

 Before tax benefit

 8.13
 %

 (20.96
)%

 2.94
 %

 0.64
 %

 3.93%
 (2)

 Deferred tax benefit (4)(6)

 —

 —

 —

 —

 (0.33
)%

 Net investment income (loss)

 8.13
 %

 (20.96
)%

 2.94
 %

 0.64
 %

 3.60
 %

 Net investment income before fee waiver

 ( 10.99
)%

 ( 20.96
)%

 2.94
 %

 0.64
 %

 3.60
 %

 Portfolio turnover rate

 %

 %

 %

 %

 %

 ( 1)

 Calculated using average shares outstanding.

 ( 2)

 Amount includes the incentive fee. For the year ended December 31, 2019, the ratio of the incentive fee to average net assets was ( 5.64)%.

 ( 3)

 Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses).

 ( 4)

 The deferred tax expense and tax benefit are based on average net assets.

 ( 5)

 As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense.

 ( 6)

 Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only.

 Notes to Consolidated Financial Statements

 NOTE 1. THE COMPANY

 Firsthand Technology Value Fund, Inc. (the "Company," the "Fund," "us," "our," and "we"), is a Maryland corporation and an externally managed, non-diversified, closed-end management investment company that has elected to be treated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). The Company acquired its initial portfolio of securities through the reorganization of Firsthand Technology Value Fund, a series of Firsthand Funds, into the Company. The reorganization was completed on April 15, 2011. The Company commenced operations on April 18th, 2011. Under normal circumstances, the Company will invest at least 80 % of its assets for investment purposes in technology companies, which are considered to be those companies that derive at least 50 % of their revenues from products and/ or services within the information technology sector or the "cleantech" sector. Information technology companies include, but are not limited to, those focused on computer hardware, software, telecommunications, networking, Internet, and consumer electronics. While there is no standard definition of cleantech, it is generally regarded as including goods and services designed to harness renewable energy and materials, eliminate emissions and waste, and reduce the use of natural resources. In addition, under normal circumstances we will invest at least 70 % of our assets in privately held companies and in public companies with market capitalizations less than $250 million. Our portfolio is primarily composed of equity and equity derivative securities of technology and cleantech companies (as defined above). These investments generally range between $ 1 million and $ 10 million each, although the investment size will vary proportionately with the size of the Company's capital base. The Company's shares as of September 30. 2023 were listed on the NASDAQ Global Market under the symbol "SVVC." Subsequent to September 30, on October 6, 2023, the Company notified NASDAQ of the fund's intention to voluntarily delist. As of the date these financial statements were issued the Company's shares are quoted on the OTCQB market under the symbol "SVVC." Firsthand Capital Management, Inc., which was previously known as SiVest Group, Inc. ("FCM" or the "Advisor"), serves as the investment adviser to the Company.

 On October 13, 2023, the Fund issued a press release announcing a plan to seek shareholder approval to withdraw its BDC election and pursue liquidation.

 The Company is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board ("FASB") Accounting Standards Codification Topic 946.

 CONSOLIDATION OF SUBSIDIARIES. On May 8, 2015, the Board of Directors of the Company approved the formation of a fully owned and controlled subsidiary (as defined by the 1940 Act) of the Company named Firsthand Venture Investors ("FVI"), a California general partnership formed on March 30, 2015. After the close of business on June 30, 2015, the Company contributed substantially all of its assets to FVI in return for a controlling general partner ownership interest in FVI. The transaction was completed on July 1, 2015. Under this structure, we have all or substantially all of our investment activities conducted through our fully owned subsidiary, FVI.

 During the fiscal years ended December 31, 2016 and 2017, with the approval of its Board of Directors, the Company organized three separate fully owned and controlled subsidiaries (as defined by the 1940 Act). Each subsidiary was a Cayman Islands corporation and the financial statements of each subsidiary were reported on a consolidated basis with the Company. Each subsidiary was formed for the purpose of holding one or more investments made by the Company, and was treated as a controlled foreign corporation under the Internal Revenue Code not separately subject to U.S. federal income tax. FVI was treated as the sole U.S. shareholder of each subsidiary.

 The Board of Directors of the Company approved the liquidation of those three Cayman subsidiaries on November 2, 2018. That liquidation was completed on December 27, 2018.

 NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 The following is a summary of significant accounting policies followed in the preparation of the Company's financial statements included in this report:

 BASIS OF PRESENTATION. The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") pursuant to the requirements on Form 10 -K. ASC 946, Financial Services — Investment Companies ("ASC 946"), and Articles 6, 10 and 12 of Regulation S- X. In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of the financial statements for the periods presented, have been included.

 Under the 1940 Act, ASC 946, and the regulations pursuant to Article 6 of Regulation S- X, we are precluded from consolidating any entity other than another investment company or an operating company which provides substantially all of its services to benefit us. Consequentially, as of December 31, 2018, the Company consolidated some special purpose entities. These special purpose entities only hold investments of the Company and have no other significant asset and liabilities. All significant intercompany transactions and balances have been eliminated in consolidation.

 USE OF ESTIMATES. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

 PORTFOLIO INVESTMENT VALUATIONS. Investments are stated at "value" as defined in the 1940 Act and in the applicable regulations of the Securities and Exchange Commission and in accordance with GAAP. Value, as defined in Section 2 (a)( 41) of the 1940 Act, is (i) the market value of those securities for which a market quotation is readily available and (ii) the fair value as determined in good faith by the Advisor as the valuation designee appointed by the Board of Directors, and subject to oversight by the Board of Directors. On December 31, 2023, our financial statements include venture capital investments valued at approximately $ 4.7 million. The fair values of our venture capital investments were also determined by the Advisor as the valuation designee. Upon sale of these investments, the values that are ultimately realized may be different from what is presently estimated. The difference could be material. Also see note 6 regarding the fair value of the company's investments.

 CASH AND CASH EQUIVALENTS. The Company considers liquid assets deposited with a bank, investments in money market funds, and certain short-term debt instruments with maturities of three months or less to be cash equivalents. These investments represent amounts held with financial institutions that are readily accessible to pay our expenses or purchase investments. Cash and cash equivalents are valued at cost plus accrued interest, which approximates market value.

 RESTRICTED SECURITIES. At December 31, 2023, we held $ 4,797,872 in restricted securities. At December 31, 2022, we held $ 35,929,006 in restricted securities.

 INCOME RECOGNITION. Dividend income is recorded on the ex-dividend date. Interest income is accrued as earned. Discounts and premiums on securities purchased are amortized over the lives of the respective securities. Other non-cash dividends are recognized as investment income at the fair value of the property received. When debt securities are determined to be non-income producing, the Company ceases accruing interest and writes off any previously accrued interest. These write-offs are recorded as an adjustment to interest income.

 SHARE VALUATION. The net asset value ("NAV") per share of the Fund is calculated by dividing the sum of the value of the securities held by the Fund, plus cash or other assets, minus all liabilities (including estimated accrued expenses) by the total number of shares outstanding of the Fund, rounded to the nearest cent.

 REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS. A realized gain or loss is recognized when an investment is disposed of and is computed as the difference between the Company's cost basis in the investment at the disposition date and the net proceeds received from such disposition. Realized gains and losses are calculated on a specific identification basis. Unrealized appreciation or depreciation is computed as the difference between the fair value of the investment and the cost basis of such investment.

 INCOME TAXES. The Company provides for state and federal corporate income tax, as appropriate, because it is regarded as a corporation under Subchapter C of the Code. The Company recognizes interest and penalties in income tax expense.

 FOREIGN CURRENCY TRANSLATION. The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the foreign exchange rate on the date of valuation. The Company does not isolate that portion of the results of operation resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company's investments in foreign securities may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social, or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.

 SECURITIES TRANSACTIONS. Securities transactions are accounted for on the date the transaction for the purchase or sale of the securities is entered into by the Company (i.e., trade date).

 CONCENTRATION OF CREDIT RISK. The Company places its cash and cash equivalents with financial institutions and, at times, cash held in checking accounts may exceed the Federal Deposit Insurance Corporation insured limit.

 OPTIONS. The Company is subject to equity price risk in the normal course of pursuing its investment objectives and may enter into options written to hedge against changes in the value of equities. The Company may purchase put and call options to attempt to provide protection against adverse price effects from anticipated changes in prevailing prices of securities or stock indices. The Company may also write put and call options. When the Company writes an option, an amount equal to the premium received by the Company is recorded as a liability and is subsequently adjusted to the current fair value of the option written.

 Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option.

 DERFERRED COMPENSATION. On December 26, 2022, the Company adopted a deferred compensation plan (the "Plan") for its eligible directors which allows such directors to defer some or all of their fees for services as Directors to the Fund. Under the terms of the Plan, deferred compensation withheld is notionally invested in the Fund's common stock using the net asset value per share on the date such compensation would have otherwise been payable. The payment due to eligible participants is valued using the net asset value of the fund at the time the payment is due. As of September 30, 2023, each of the Fund's eligible directors has deferred 50 % of their compensation at the earlier of January 1, 2025 or their separation of service from the Fund.

 The average quarterly volume of the Company's derivatives during the year ended December 31, 2023 is as follows:

 PURCHASED OPTIONS
 (CONTRACTS)

 WARRANTS
 (NOTIONAL VALUE)

 WRITTEN OPTIONS
 (CONTRACTS)

 —

 791,176

 —

 NOTE 3. BUSINESS RISKS AND UNCERTAINTIES

 We invest a substantial portion of our assets in privately-held companies, the securities of which are inherently illiquid. We also seek to invest in small publicly-traded companies that we believe have exceptional growth potential and to make opportunistic investments in publicly-traded companies, both large and small. In the case of investments in small publicly-traded companies, although these companies are publicly traded, their stock may not trade at high volumes, and prices can be volatile, which may restrict our ability to sell our positions. We may also be subject to contractual restrictions or securities law limits on our ability to sell portfolio holdings because of, for example, our affiliation with a portfolio company or the relative size of our holding in a company. These privately held and publicly traded businesses tend to lack management depth, have limited or no history of operations and typically have not attained profitability. Because of the speculative nature of our investments and the lack of public markets for privately held investments, there is greater risk of loss than is the case with traditional investment securities.

 We do not choose investments based on a strategy of diversification. We also do not rebalance the portfolio should one of our portfolio companies increase in value substantially relative to the rest of the portfolio. Therefore, the value of our portfolio may be more vulnerable to events affecting a single sector, industry or portfolio company and, therefore, may be subject to greater volatility than a company that follows a diversification strategy.

 Because there is typically no public or readily-ascertainable market for our interests in the small privately-held companies in which we invest, the valuation of those securities is determined in good faith by the Valuation Committee, comprised of all members of the Board who are not "interested persons" of the Company, as such term is defined in Section 2 (a)( 19) of the 1940 Act, in accordance with our Valuation Procedures and is subject to significant estimates and judgments. The determined value of the securities in our portfolio may differ significantly from the values that would be placed on these securities if a ready market for the securities existed. Any changes in valuation are recorded in our Statement of Operations as "Net increase (decrease) in unrealized appreciation on investments." Changes in valuation of any of our investments in privately-held companies from one period to another may be volatile.

 The Board has engaged an independent valuation firm to provide it with valuation assistance with respect to certain of our portfolio investments. The Company intends to continue to engage an independent valuation firm to provide us with assistance regarding our determination of the fair value of select portfolio investments each quarter unless directed by the Board to cancel such valuation services. The scope of the services rendered by an independent valuation firm is at the discretion of the Board. The Board is ultimately and solely responsible for determining the fair value of the Company's investments in good faith.

 With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process to be followed each quarter, as described below:

 ( 1)

 each quarter the valuation process begins with each portfolio company or investment being initially valued by the Advisor's Valuation Committee or the independent valuation firm;

 ( 2)

 the Valuation Committee of the Board on a quarterly basis reviews the preliminary valuation of the Advisor's Valuation Committee and that of the independent valuation firms and makes the fair value determination, in good faith, based on the valuation recommendations of the Advisor's Valuation Committee and the independent valuation firms; and

 ( 3)

 at each quarterly Board meeting, the Board considers the valuations recommended by the Advisor's Valuation Committee and the independent valuation firms that were previously submitted to the Valuation Committee of the Board and ratifies the fair value determinations made by the Valuation Committee of the Board.

 NOTE 4. INVESTMENT MANAGEMENT FEE

 The Company has entered into an investment management agreement (the "Investment Management Agreement") with FCM pursuant to which the Company will pay FCM a fee for providing investment management services consisting of two components—a base management fee and an incentive fee.

 The base management fee will be calculated at an annual rate of 2.00 % of our gross assets. For services rendered under the Investment Management Agreement, the base management fee will be payable quarterly in arrears. The base management fee will be calculated based on the average of ( 1) the value of our gross assets at the end of the current calendar quarter and ( 2) the value of the Company's gross assets at the end of the preceding calendar quarter; and will be appropriately adjusted for any share issuances or repurchases during the current calendar quarter. Base management fees for any partial month or quarter will be pro-rated.

 The incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement, as of the termination date), commencing on April 15, 2011, and equals 20 % of the Company's realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fees, provided that the incentive fee determined as of December 31, 2023, will be calculated for a period of shorter than twelve calendar months to take into account any realized gains computed net of all realized capital losses and unrealized capital depreciation from inception. For the year ended December 31, 2023, there were no Incentive fee adjustments. For the year ended December 31, 2022, there were no incentive fee adjustments. For the year ended December 31, 2021, there were no incentive fee adjustments.

 Effective September 30, 2023, the Company has entered into a fee waiver agreement with FCM (the "Fee Waiver Agreement"). Pursuant to the terms of the Fee Waiver Agreement, FCM agrees to ( 1) waive future accruals of the base management fee starting October 1, 2023, through December 31, 2024, with future recoupment to the extent permitted by the Investment Management Agreement, and ( 2) waive $ 2.5 million of base management fee that has been accrued but unpaid prior to but unpaid as of September 30, 2023. Any accrued base management fee waived under section ( 2) may be recouped by FCM within ten years.

 NOTE 5. DEBT

 The Company currently has no plan to use leverage and does not have any significant outstanding debt obligations (other than normal operating expense accruals).

 NOTE 6. FAIR VALUE

 Securities traded on stock exchanges, or quoted by NASDAQ, are valued according to the NASDAQ Stock Market, Inc. ("NASDAQ") official closing price, if applicable, or at their last reported sale price as of the close of trading on the New York Stock Exchange ("NYSE") (normally 4:00 P.M. Eastern Time). If a security is not traded that day, the security will be valued at its most recent bid price.

 Securities traded in the over-the-counter market, but not quoted by NASDAQ, are valued at the last sale price (or, if the last sale price is not readily available, at the most recent closing bid price as quoted by brokers that make markets in the securities) at the close of trading on the NYSE.

 Securities traded both in the over-the-counter market and on a stock exchange are valued according to the broadest and most representative market.

 Securities and other assets that do not have market quotations readily available are valued at their fair value as determined by FCM, as the Board's valuation designee under SEC rule 2a - 5. Those valuations are determined in accordance with the Valuation Procedures used by FCM, subject to oversight by the Board.

 In pricing illiquid, privately placed securities, FCM, as the valuation designee, is responsible for ( 1) determining overall valuation guidelines and ( 2) ensuring that the investments of the Company are valued within the prescribed guidelines.

 FCM and the Board receive information and recommendations from an independent valuation firm.

 The values assigned to these investments are based on available information and do not necessarily represent amounts that might ultimately be realized when that investment is sold, as such amounts depend on future circumstances and cannot reasonably be determined until the individual investments are actually liquidated or become readily marketable.

 APPROACHES TO DETERMINING FAIR VALUE. GAAP. defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). In effect, GAAP applies fair value terminology to all valuations whereas the 1940 Act applies market value terminology to readily marketable assets and fair value terminology to other assets.

 The main approaches to measuring fair value utilized are the market approach, the income approach, and the asset-based approach. The choice of which approach to use in a particular situation depends on the specific facts and circumstances associated with the company, as well as the purpose for which the valuation analysis is being conducted. Firsthand and the independent valuation firm rely primarily on the market approach. We also considered the income and asset-based approaches in our analysis because certain of the portfolio companies do not have substantial operating earnings relative to the value of their underlying assets.

 -

 Market Approach (M): The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. For example, the market approach often uses market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range each appropriate multiple falls requires the use of judgment in considering factors specific to the measurement (qualitative and quantitative).

 -

 Income Approach (I): The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) to a single present value amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. Those valuation techniques include present value techniques; option-pricing models, such as the Black-Scholes-Merton formula (a closed-form model) and a binomial model (a lattice model), which incorporate present value techniques; and the multi-period excess earnings method, which is used to measure the fair value of certain assets.

 -

 Asset-Based Approach (A): The asset-based approach examines the value of a company's assets net of its liabilities to derive a value for the equity holders.

 FAIR VALUE MEASUREMENT. In accordance with the guidance from the Financial Accounting Standards Board on fair value measurements and disclosures under GAAP, the Company discloses the fair value of its investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure the fair value. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements).

 The guidance establishes three levels of the fair value hierarchy as follows:

 Level 1 -

 Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the date of measurement.

 Level 2 -

 Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument in an inactive market, prices for similar instruments in an active or inactive market, interest rates, prepayment speeds, credit risks, yield curves, default rates, and similar data.

 Level 3 -

 Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Company's own assumptions about the assumptions a market participant would use in valuing the asset or liability based on the best information available.

 The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.

 The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

 The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the inputs used to value the Company's net assets as of December 31, 2023:

 ASSETS

 LEVEL 1
 QUOTED PRICES

 LEVEL 2 OTHER
 OBSERVABLE

 UNOBSERVABLE

 Common Stocks

 $
 —

 $
 —

 $

 —

 —

 —

 —

 Total Common Stocks

 —

 299,987

 ASSETS (continued)

 LEVEL 1
 QUOTED PRICES

 LEVEL 2 OTHER
 OBSERVABLE

 UNOBSERVABLE

 Preferred Stocks

 —

 —

 Total Preferred Stocks

 —

 —

 Asset Derivatives *

 Equity Contracts

 —

 —

 —

 Total Asset Derivatives

 —

 —

 —

 Convertible Notes

 —

 —

 —

 —

 —

 —

 Total Convertible Notes

 —

 —

 4,387,713

 Mutual Funds

 —

 —

 Total

 $
 3,935,907

 $
 —

 $
 4,797,872

 *

 Asset derivatives include warrants.

 At the end of each calendar quarter, management evaluates the Level 2 and Level 3 assets and liabilities for changes in liquidity, including but not limited to: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and Level 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges.

 The following is a summary of the inputs used to value the Company's net assets as of December 31, 2022.

 ASSETS

 LEVEL 1
 QUOTED PRICES

 LEVEL 2 OTHER
 OBSERVABLE INPUTS

 LEVEL 3 SIGNIFICANT
 UNOBSERVABLE INPUTS

 Common Stocks

 $
 —

 $
 —

 $

 —

 —

 —

 —

 —

 —

 —

 —

 Total Common Stocks

 —

 349,287

 ASSETS (continued)

 LEVEL 1
 QUOTED PRICES

 LEVEL 2 OTHER
 OBSERVABLE

 UNOBSERVABLE

 Preferred Stocks

 $
 —

 $
 —

 $
 384,067

 —

 —

 —

 —

 —

 —

 737,112

 Total Preferred Stocks

 —

 —

 3,036,652

 Asset Derivatives *

 Equity Contracts

 —

 —

 Total Asset Derivatives

 —

 —

 Convertible Notes

 —

 —

 —

 —

 6,559,791

 —

 —

 7,809,430

 —

 —

 Total Convertible Notes

 —

 —

 31,585,942

 Mutual Funds

 672,422

 —

 —

 Total

 $
 4,192,918

 $
 —

 $
 35,929,006

 *

 Asset derivatives include warrants.

 Following is a reconciliation of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value.

 INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)

 BALANCE
 AS OF

 NET
 PURCHASES/
 CONVERSIONS

 NET SALES/
 CONVERSIONS

 NET
 GAINS/
 (LOSSES)

 NET
 UNREALIZED
 APPRECIATION
 (DEPRECIATION)
 (1)

 TRANSFERS
 IN (OUT) OF

 BALANCE
 AS OF

 Common Stocks

 $

 $
 —

 $
 —

 $
 —

 $
 ( 37,568
)

 $
 —

 $

 —

 —

 —

 ( 546
)

 —

 —

 —

 —

 ( 11,075
)

 —

 —

 —

 ( 7,966
)

 ( 161,079
)

 168,934

 —

 —

 Total Common Stocks

 349,287

 —

 ( 7,966
)

 ( 161,079
)

 119,745

 —

 299,987

 Preferred Stocks

 384,067

 —

 —

 —

 ( 384,067
)

 —

 —

 —

 —

 —

 ( 1,049,478
)

 —

 —

 —

 —

 —

 ( 755,823
)

 —

 737,112

 —

 ( 490,456
)

 ( 7,697,241
)

 7,450,585

 —

 —

 Total Preferred Stocks

 3,036,652

 —

 ( 490,456
)

 ( 7,697,239
)

 5,261,217

 —

 Asset Derivatives

 Equity Contracts

 —

 —

 ( 6,678
)

 ( 950,447
)

 —

 —

 Total Asset Derivatives

 —

 —

 ( 6,678
)

 ( 950,447
)

 —

 —

 Convertible and Non-Convertible Notes

 —

 —

 —

 —

 —

 6,559,791

 —

 —

 —

 ( 2,359,791
)

 —

 7,809,430

 140,000

 —

 —

 ( 7,949,430
)

 —

 —

 —

 —

 —

 ( 17,029,008
)

 —

 Total Convertible Notes

 31,585,942

 140,000

 —

 —

 ( 27,338,229
)

 —

 4,387,713

 Total

 $
 35,929,006

 $
 140,000

 $
 ( 498,422
)

 $
)

 $
 ( 22,907,714
)

 $
 —

 $
 4,797,872

 ( 1)

 The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of December 31, 2023 was $( 30,530,677).

 Following is a reconciliation of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value.

 INVESTMENTS AT FAIR VALUE USING SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3)

 BALANCE
 AS OF

 NET
 PURCHASES/
 CONVERSIONS

 NET SALES/
 CONVERSIONS

 NET
 GAINS/
 (LOSSES)

 NET
 UNREALIZED
 APPRECIATION
 (DEPRECIATION)
 (1)

 TRANSFERS
 IN (OUT) OF

 BALANCE
 AS OF
 12/31/2022

 Common Stocks

 $
 613,650

 $
 —

 $
 —

 $
 —

 $
 ( 276,150
)

 $
 —

 $

 1,126

 —

 —

 —

 ( 580
)

 —

 31,490

 —

 —

 —

 ( 20,360
)

 —

 —

 —

 —

 ( 166
)

 —

 Total Common Stocks

 646,543

 —

 —

 —

 ( 297,256
)

 —

 349,287

 Preferred Stocks

 324,245

 —

 —

 —

 59,822

 —

 384,067

 1,777,068

 —

 —

 —

 ( 727,590
)

 —

 1,898,420

 —

 ( 350,000
)

 —

 ( 682,425
)

 —

 1,050,442

 —

 —

 —

 ( 313,330
)

 —

 737,112

 670,062

 —

 —

 —

 ( 670,062
)

 —

 —

 280,160

 —

 —

)

 3,802,032

 —

 —

 Total Preferred Stocks

 6,000,397

 —

 ( 350,000
)

)

 1,468,447

 —

 3,036,652

 Asset Derivatives

 Equity Contracts

 802,210

 —

 —

 —

 154,915

 —

 Total Asset Derivatives

 802,210

 —

 —

 —

 154,915

 —

 Convertible Notes

 —

 —

 —

 —

 —

 4,380,000

 7,414,791

 ( 5,235,000
)

 —

 —

 —

 6,559,791

 21,404,015

 2,625,000

 —

 —

 ( 16,219,585
)

 —

 7,809,430

 26,411,129

 2,400,000

 —

 —

 ( 11,694,408
)

 Total Convertible Notes

 52,295,144

 12,439,791

 ( 5,235,000
)

 —

 ( 27,913,993
)

 —

 31,585,942

 Total

 $
 59,744,294

 $
 12,439,791

 $
 ( 5,585,000
)

 $
)

 $
 ( 26,587,887
)

 $
 —

 $
 35,929,006

 ( 1)

 The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of December 31, 2022 was $( 30,670,079).

 The table below represents quantitative disclosure about significant unobservable inputs for Level 3 fair value measurements at December 31, 2023:

 FAIR VALUE AT 12/31/23

 VALUATION TECHNIQUES (1)

 UNOBSERVABLE INPUTS

 RANGE (WEIGHTED AVG.)(2)

 Direct venture capital investments: Advanced Materials
 $0.4M

 Volatility (2)
 Discount for Lack of Marketability (4)

 8x – 1.0x (0.9x)
 50.0%(50%)
 3.84%(3.84%)
 22.7% (22.7%)

 Direct venture capital investments: Aerospace

 $4.2M

 2.1x – (2.1x)

 Direct venture capital investments: Automotive

 $0.0M

 Liquidation Value
 Market Value of Invested Capital

 $0 - ($0)

 Direct venture capital investments: Equipment Leasing

 $0.1M

 Liquidation Value

 Risk-Free Rate
 (3)

 50.0% (50.0%)
 3.84% (3.84%)

 Direct venture capital investments: Medical Devices

 $0.1M

 Revenue Multiple (3)
 Risk Free Rate

 1.2x – 1.5x (1.4x)
 4.01%(4.01%)

 ( 1)

 As of December 31, 2022, the Fund used Prior Transaction Analysis and Market Comparable Companies approaches to value certain investments. As of December 31, 2023, the Fund discontinued use of these approaches in certain cases in which more reliable indications of value were developed..

 ( 2)

 Weighted average is calculated by weighing the significant unobservable input by the relative fair value of each investment in the category.

 ( 3)

 An increase in the input would result in an increase in the security ' s valuation; a decrease in the input would result in a decrease in the security ' s valuation.

 ( 4)

 An increase in the input would result in a decrease in the security ' s valuation; a decrease in the input would result in an increase in the security ' s valuation.

 Changes in any of our unobservable inputs, individually, may change the fair value of certain of the Company's investments.

 Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company's investments may fluctuate from period to period. Additionally, the fair value of the Company's investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that the Company may ultimately realize. Further, such investments are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a portfolio investment in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it.

 In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected in the valuations currently assigned. The below chart represents quantitative disclosure about significant unobservable inputs for Level 3 fair value measurements at December 31, 2022:

 FAIR VALUE AT 12/31/22

 VALUATION TECHNIQUES (1)

 UNOBSERVABLE INPUTS

 RANGE (WEIGHTED AVG.) (2)

 Direct venture capital investments: Advanced Materials

 $0.2M

 Revenue Multiple (3)
 Discount for Lack of Marketability (3)

 5.7x - 7.6x (6.7x)
 0.7x – 1.0x (0.9x)
 50.0% (50.0%)
 22.7% (22.7%)

 Direct venture capital investments: Aerospace

 $7.9M

 5.2x – (5.2x)
 60.0% (60.0%)

 Direct venture capital investments: Automotive

 $8.9M

 Prior Transaction Analysis
 Probability-Weighted Expected Return Method

 Discount for Lack of Marketability (4)
 Going Concern Probability (3)

 50.0% (50.0%)
 0.0% – 22.7% (0%)
 10% (10%)

 Direct venture capital investments: Equipment Leasing

 $0.9M

 Liquidation Value

 2.6x - 3.5x 3.2x)
 50.0% (50.0%)

 continued

 FAIR VALUE AT 12/31/22

 VALUATION TECHNIQUES (1)

 UNOBSERVABLE INPUTS

 RANGE (WEIGHTED AVG.) (2)

 Direct venture capital investments: Intellectual Property

 $0.2M

 Discounted Cash Flow

 Weighted Average Cost of Capital (4)
 Discount for Lack of Marketability (4)

 12.5% (12.5%)
 55.0% (55.0%)
 0.0% - 24.3% (0.0%)

 Direct venture capital investments: Medical Devices

 $17.1M

 Revenue Multiple (3)

 2.2x – 2.5x (2.3x)

 ( 1)

 As of December 31, 2022, the Fund used various methods to develop fair market estimates.

 ( 2)

 Weighted average is calculated by weighing the significant unobservable input by the relative fair value of each investment in the category.

 ( 3)

 An increase in the input would result in an increase in the security ' s valuation; a decrease in the input would result in a decrease in the security ' s valuation.

 ( 4)

 An increase in the input would result in an decrease in the security ' s valuation; a decrease in the input would result in a increase in the security ' s valuation.

 NOTE 7. FEDERAL INCOME TAXES

 Beginning in 2018, we were no longer able to qualify as a RIC under Subchapter M of the Code. The increase in value that resulted from the initial public offerings (IPOs) of Pivotal Systems and Revasum meant that we were no longer able to satisfy the diversification requirements for qualification as a RIC. As a result of this change, we were taxed as a corporation for our fiscal year ended December 31, 2018, and will continue to be taxed in that manner for future fiscal years, paying federal and applicable state corporate taxes on our taxable income, unless and until we are able to once again qualify as a RIC, based on changes in the composition of our portfolio. Consequently, at the close of each fiscal quarter beginning with the quarter ended June 30, 2018, we will record a deferred tax liability for any net realized gains and net ordinary income for the year-to-date period plus net unrealized gains as of the end of the quarter.

 The reorganization described in Note 1 (the formation of FVI as a fully owned subsidiary for investment activities) was structured to avoid any adverse tax consequences for the Company and its shareholders. For the fiscal years which the Company operates as a RIC, we believe Company's engaging in investment activities through FVI did not, in our view, jeopardize the Company's ability to continue to qualify as a RIC under the Code at that time when the Company was eligible to be treated as a RIC.

 The following information is based upon the U.S. federal income tax cost of portfolio investments as of December 31, 2023.

 FEDERAL INCOME
 TAX COST:

 Gross unrealized appreciation

 $
 —

 Gross unrealized depreciation

 ( 125,233,890
)

 Net unrealized (depreciation)

 $
 ( 125,233,890
)

 Federal income tax cost, Investments

 $
 133,967,669

 The Company did not qualify as a regulated investment company pursuant to Subchapter M of the Internal Revenue Code, therefore it is taxed as a corporation. As a corporation, the Company is obligated to pay federal and state income tax on taxable income. The Company's net deferred tax asset balance has a full valuation allowance based on management's estimate of future realization of such assets. The Company is currently using an estimated tax rate of 21 % for Federal and 6.98 % for state taxes.

 The Company's income tax provision consists of the following as of December 31:

 2023

 2022

 Deferred tax (expense)/benefit

 Federal

 $
 —

 $
 —

 State

 —

 —

 Total deferred tax (expense)/benefit

 $
 —

 $
 —

 Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Such temporary differences are principally: (i) taxes on unrealized gains/(losses), which are attributable to the temporary difference between fair market value and tax basis, and (ii) the net tax benefit of accumulated net operating losses and capital loss carryforwards. Deferred tax assets and liabilities are measured using effective tax rates expected to apply to taxable income in the years such temporary differences are realized or otherwise settled.

 Components of the Company's deferred tax assets and liabilities as of December 31, 2023 and 2022 are as follows:

 2023

 2022

 Deferred tax assets:

 Net operating loss carryforward

 $
 3,465,923

 $
 4,616,720

 Capital loss carryforward

 9,161,034

 6,960,412

 Net unrealized losses (gains) on investment securities

 35,040,442

 28,726,530

 Total deferred tax assets, net

 47,667,399

 40,303,662

 Valuation allowance

 ( 47,667,399
)

 ( 40,303,662
)

 Net

 $
 —

 $
 —

 For the year ended December 31, 2023, the Company had an effective tax rate of 0 % and a statutory tax rate of 21 % ( 27.98 % with state income tax) with the difference being attributable to changes in the components of the deferred tax assets and the valuation allowance account.

 For the year ended December 31, 2022, the Company had an effective tax rate of 0 % and a statutory tax rate of 21 % ( 27.98 % with state income tax) with the difference being attributable to changes in the components of the deferred tax assets and the valuation allowance account.

 To the extent the Company has a deferred tax asset or if a portion of the deferred tax liability is offset by a tax asset resulting from net operating losses, consideration is given to whether or not a valuation allowance is required against the deferred tax asset amount. A valuation allowance is required if, based on the evaluation criterion provided by Accounting Standard Codification ("ASC") 740, Income Taxes (ASC 740), it is more-likely-than- not that some portion or all of the deferred tax asset will not be realized. Among the factors considered in assessing the Company's valuation allowance are: the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of the statutory carryforward periods, and the associated risks that operating and capital loss carryforwards may expire unused. Based on the Company's assessment, it has determined that in the future it is more likely than not that the Company will not generate the necessary appropriate character of income within the carryforward periods to realize its deferred tax assets, and as such, has placed a full allowance on the deferred tax assets.

 From time to time, and as new information becomes available, the Company will modify its forecasts, estimates or assumptions regarding its deferred tax liability or asset.

 Modifications of the Company's estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance, changes in generally accepted accounting principles or related guidance or interpretations thereof, limitations imposed on net operating losses (if any), and changes in applicable tax law could result in increases or decreases in the Company's NAV, which could be material. Such changes could have a material impact on the Company's NAV and results of operations with respect to the Company's shareholders in the period it is recorded, even though the shareholders at such time might not have held shares in the Company at the time the deferred tax asset or liability had been established.

 The Company's policy is to classify interest and penalties associated with underpayment of federal and state income taxes, if any, as income tax expense on its Statement of Operations. As of December 31, 2022, the Company did not have any interest or penalties associated with the underpayment of any income taxes.

 The Company files income tax returns in the U.S. federal jurisdiction and California. The Company has reviewed all major jurisdictions and concluded that there is no significant impact on the Company's net assets and no tax liability resulting from unrecognized tax benefits relating to uncertain tax positions expected to be taken on its tax returns. Furthermore, management of the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months.

 As of December 31, 2023, the Company had net operating loss carryforwards for federal and state of income tax purposes of $ 12,387,144 which may be carried forward indefinitely.

 As of December 31, 2023, the Company had net capital loss carryforwards for federal and state income tax purposes, which may be carried forward for 5 years, as follows:

 EXPIRATION DATE

 AMOUNT

 12/31/24

 $
 14,230,073

 12/31/25

 7,516,642

 12/31/27

 3,129,665

 12/31/28

 7,864,982

 Total

 $
 32,741,364

 NOTE 8. INVESTMENT TRANSACTIONS

 Investment transactions (excluding short-term investments) were as follows for the year ended December 31, 2023.

 PURCHASES AND SALES

 Purchases of investment securities

 $
 140,000

 Proceeds from sales and maturities of investment securities

 $
 ( 498,425
)

 The Fund may purchase securities from, or sell securities to, an affiliated Fund under specific conditions outlined in procedures adopted by the Board. The procedures have been designed to ensure that any purchase or sale of securities by the Funds from or to another Fund or portfolio that is or could be considered an affiliate by virtue of having a common investment advisor (or affiliated investment advisors), common Trustees, and/or common officers complies with Rule 17a - 7 of the 1940 Act. Further, as defined under the procedures, each transaction is effected at the current market price. Pursuant to these procedures, for the year ended December 31, 2023, the Firsthand Technology Value Fund did not purchase or sell securities to an affiliated fund.

 NOTE 9. SHARE BUYBACKS

 SHARE BUYBACKS. On April 26, 2016, the Board of Directors of the Fund approved a discretionary share repurchase plan (the "Plan"). Pursuant to the Plan, the Fund was authorized to purchase in the open market up to $ 2 million worth of its common stock. The Plan allowed the Fund to acquire its own shares at certain thresholds below its NAV per share, in accordance with the guidelines specified in Rule 10b - 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The intent of the Plan was to increase NAV per share and thereby enhance shareholder value. The Fund completed the repurchase plan in September 2016, having repurchased and retired a total of 272,008 shares of stock, at a total cost of approximately $ 2 million.

 On November 10, 2017, the Board of Directors of the Fund approved a discretionary share purchase plan (the "Plan"). Pursuant to the Plan, the Fund was authorized to purchase in the open market up to $ 2 million worth of its common stock. The Plan allowed the Fund to acquire its own shares in accordance with the guidelines specified in Rule 10b - 18 of the Exchange Act. The intent of the Plan was to increase NAV per share and thereby enhance shareholder value. As of December 31, 2017, the Fund had repurchased and retired 128,551 shares of stock at a total cost of approximately $ 1.1 million. The Fund had 7,302,146 shares outstanding as of December 31, 2017.

 On August 31, 2018, the Fund announced a plan to repurchase up to $ 2 million worth of SVVC stock in the open market by March 31, 2019. The Fund completed this open market repurchase plan on October 24, 2018. Through that date, the Fund repurchased 123,376 shares at an average price of $ 16.21 per share, for total consideration of $ 2.0 million. As of December 31, 2018, the Fund had 7,178,770 shares outstanding.

 TENDER OFFERS. On December 22, 2014, pursuant to our agreement with a shareholder, the Fund commenced a tender offer to purchase up to $ 20 million of its issued and outstanding common shares for cash at a price per share equal to 95 % of the Company's NAV per share determined as of the close of ordinary trading on the NASDAQ Global Market on December 31, 2014 ($23.2702 per share). The tender offer, which expired on January 22, 2015 at 12:00 midnight,

 New York City time, was oversubscribed. Because the number of shares tendered exceeded the maximum amount of its offer, the Fund purchased shares from tendering shareholders on a pro-rata basis based on the number of shares properly tendered. Of the 5,044,728 shares properly tendered, the Fund purchased 859,468 shares of common stock pursuant to the tender offer.

 On December 16, 2019, the Fund announced the commencement of a "modified Dutch auction" tender offer to purchase up to $ 2 million of its common stock at a price per share not less than $ 6.00 and not greater than $ 8.00, in $ 0.10 increments. The tender offer expired on February 14, 2020, and resulted in the purchase by the Fund of 285,714 shares of common stock at a price of $ 7.00 per share. As of March 31, 2020, the Fund had 6,893,056 shares outstanding.

 NOTE 10. INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS

 Under the 1940 Act, the Company is required to identify investments where it owns greater than 5% (but less than 25%) of the portfolio company's outstanding voting shares as an affiliate of the Company. Also, under the 1940 Act, the Company is required to identify investments where it owns greater than 25% of the portfolio company's outstanding voting shares as a controlled investment of the Company. A summary of the Company's investments in affiliates and controlled investments for the period from December 31, 2022, through December 31, 2023, is noted below:

 VALUE

 SHARES
 HELD

 EQX Capital, Inc. Common Stock*

 $

 $
 —

 $
 —

 $
 —

 $
 —

 $
 ( 11,075
)

 $

 EQX Capital, Inc. Series A Preferred Stock*

 —

 —

 —

 —

 ( 755,823
)

 Total Equipment Leasing

 $
 877,125

 $
 —

 $
 —

 $
 ( 766,898
)

 $
 110,227

 —

 (4,467
)

 —

 —

 ( 1,928,108
)

 3,431,683

 —

 89,823

 —

 —

 ( 431,683
)

 768,317

 Hera Systems, Inc. Series A Preferred*

 4,735

 —

 —

 —

 —

 ( 4,735
)

 —

 3,642,324

 Hera Systems, Inc. Series B Preferred*

 275,585

 —

 —

 —

 —

 ( 275,585
)

 —

 7,039,203

 Hera Systems, Inc. Series B*

 478,608

 —

 —

 —

 —

 ( 478,608
)

 —

 12,250,000

 Hera Systems, Inc. Series B*

 242,817

 —

 —

 —

 —

 ( 242,817
)

 —

 6,214,922

 Hera Systems, Inc. Series B*

 205,118

 —

 —

 —

 —

 ( 205,118
)

 —

 5,250,000

 Hera Systems, Inc. Series B*

 27,349

 —

 —

 —

 —

 ( 27,349
)

 —

 VALUE

 Hera Systems, Inc. Series C Preferred*

 $
 103,747

 $
 —

 $
 —

 $
 —

 $
 —

 $
 ( 103,747
)

 $
 —

 Total Aerospace

 $
 7,897,750

 $

 $
 —

 $
 ( 3,697,750
)

 $

 6,746,169

 —

 —

 —

 —

 ( 6,711,599
)

 34,570

 800,102

 —

 —

 —

 —

 ( 796,002
)

 4,100

 —

 —

 —

 —

 ( 306,154
)

 1,577

 —

 —

 —

 —

 ( 306,154
)

 1,577

 1,846,389

 —

 —

 —

 —

 ( 1,836,928
)

 9,461

 —

 —

 —

 —

 ( 612,309
)

 3,154

 246,185

 —

 —

 —

 —

 ( 244,924
)

 1,261

 —

 —

 —

 —

 ( 306,154
)

 1,577

 461,597

 —

 —

 —

 —

 ( 459,232
)

 2.365

 —

 —

 —

 —

 ( 306,154
)

 1,577

 —

 —

 —

 —

)

 1,577

 —

 —

 —

 —

)

 1,577

 —

 —

 —

 —

 ( 612,309
)

 3,154

 —

 —

 —

 —

)

 1,577

 —

 —

 —

 —

 ( 612,309
)

 3,154

 —

 —

 —

 —

)

 1,577

 —

 —

 —

 —

)

 1,577

 VALUE
 12/31/2

 $

 $
 —

 $
 —

 $
 —

 $
 —

 $
)

 $
 1,577

 123,093

 —

 —

 —

 —

 ( 122,462
)

 430,824

 —

 —

 —

 —

 ( 428,616
)

 2,208

 92,319

 —

 —

 —

 —

 ( 91,846
)

 215,412

 —

 —

 —

 —

 ( 214,308
)

 1,104

 IntraOp Medical Corp. Series C Preferred*

 —

 —

 —

 —

 —

 —

 —

 26,856,187

 IntraOp Medical Corp. Term Note*

 1,230,926

 —

 —

 —

 —

 ( 1,224,618
)

 6,308

 Total Medical Devices

 $

 $
 —

 $
 —

 $
 ( 17,029,008
)

 $

 Semiconductor Equipment*

 Revasum, Inc. CDI*(1)

 —

 —

 —

 —

 341,909

 39,774,889

 Total Semiconductor Equipment

 $

 $
 —

 $
 —

 $
 341,909

 $

 Silicon Genesis Corp. Common Stock*

 —

 —

 ( 7,966
)

 ( 161,080
)

 168,935

 —

 —

 Silicon Genesis Corp. Common Warrants*

 —

 —

 ( 1
)

 ( 6,677
)

 6,677

 —

 —

 Silicon Genesis Corp. Series 1-E Preferred*

 320,592

 —

 —

 ( 49,292
)

 ( 2,323,111
)

 2,051,811

 —

 —

 Silicon Genesis Corp. Series 1-D Preferred*

 2,552

 —

 —

 ( 7,351
)

 ( 424,549
)

 429,348

 —

 —

 Silicon Genesis Corp. Series 1-G Preferred*

 306,671

 —

 ( 417,972
)

 ( 3,462,620
)

 3,573,908

 —

 —

 Silicon Genesis Corp. Series 1-H Preferred*

 35,529

 —

 —

 ( 7,241
)

 ( 929,654
)

 901,366

 —

 —

 Silicon Genesis Corp. Series 1-F Preferred*

 70,806

 —

 —

 ( 7,884
)

 ( 448,505
)

 385,583

 —

 —

 Silicon Genesis Corp. Series 1-C Preferred*

 —

 —

 ( 716
)

 ( 108,802
)

 108,556

 —

 —

 Total Intellectual Property

 $
 737,224

 $
 —

 $
)

 $
 7,626,184

 $
 —

 VALUE

 SHARES
 HELD

 UCT Coatings, Inc. Common Stock

 $

 $
 —
 $
 —

 $
 —
 $
 —
 $
 ( 37,568
)

 $

 1,500,000

 Total Advanced Materials

 $

 $
 —

 $
 —
 $
 ( 37,568
)

 $

 Wrightspeed, Inc. Common Stock*

 —

 —

 —

 —

 ( 546
)

 —

 69,102

 —

 —

 —

 —

 ( 65,000
)

 —

 —

 —

 —

 ( 40,000
)

 —

 —

 ( 740
)

 —

 —

 ( 100,000
)

 —

 40,625

 —

 —

 —

 —

 ( 40,625
)

 —

 53,625

 —

 —

 —

 —

 ( 53,625
)

 —

 43,875

 —

 —

 —

 —

 ( 43,875
)

 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

)

 —

 97,500

 —

 —

 —

 —

 ( 97,500
)

 —

 —

 —

 —

 —

)

 —

 VALUE

 $

 $
 —

 $
 —

 $
 —

 $
 —

 $
)

 $
 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

)

 —

 21,125

 —

 —

 —

 —

 ( 21,125
)

 —

 60,125

 —

 —

 —

 —

 ( 60,125
)

 —

 227,500

 —

 —

 —

 —

 ( 227,500
)

 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

 ( 130,000
)

 —

 650,000

 —

 —

 —

 —

 ( 650,000
)

 —

 455,000

 —

 —

 —

 —

 ( 455,000
)

 —

 390,000

 —

 —

 —

 —

 ( 390,000
)

 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

)

 —

 —

 —

 —

 —

)

 —

 VALUE

 $
 $
 —
 $
 —
 $
 —
 $
 —

 $
 ( 130,000
)

 $
 —

 121,875

 —

 —

 —

 —

 ( 121,875
)

 —

 292,500

 —

 —

 —

 —

 ( 292,500
)

 —

 243,750

 —

 —

 —

 —

 ( 243,750
)

 —

 1,601,930

 —

 —

 —

 —

 ( 1,601,930
)

 —

 —

 —

 —

 —

)

 —

 341,250

 —

 —

 —

 —

 ( 341,250
)

 —

 —

 —

 —

 —

)

 —

 Wrightspeed, Inc. Series AA Preferred*

 —

 —

 —

 —

 ( 1,049,478
)

 —

 60,733,693

 Wrightspeed, Inc. Series AA Warrants*

 3,232

 —

 —

 —

 —

 ( 3,232
)

 —

 —

 Total Automotive

 $
 8,862,686

 $
 —

 $
 —

 $
 ( 9,002,686
)

 $
 —

 Total Affiliates and Controlled Investments

 $
 39,349,502

 $

 $
)

 $
 ( 22,565,817
)

 $
 8,560,277

 Total Affiliates

 —

 —

 ( 37,568
)

 Total Controlled Investments

 $
 39,012,002

 $

 $
)
 $
 ( 22,528,249
)

 $
 8,260,345

 *

 Controlled Investments.

 ( 1)

 CDI:CHESS Depositary Interests

 A summary of the Company's investments in affiliates and controlled investments for the period from December 31, 2021, through December 31, 2022, is noted below:

 VALUE

 SHARES
 HELD

 EQX Capital, Inc. Common Stock*

 $
 31,490

 $
 —

 $
 —

 $
 —

 $
 —

 $
 ( 20,360
)

 $

 EQX Capital, Inc. Series A Preferred Stock*

 1,898,420

 —

 —

 ( 350,000
)

 —

 ( 682,425
)

 Total Equipment Leasing

 $
 1,929,910

 $
 —

 $
 —

 $
 ( 702,785
)

 $
 877,125

 —

 15,417

)

 —

 —

 —

 —

 —

 15,788

)

 —

 —

 —

 —

 —

 15,657

)

 —

 —

 —

 —

 —

 15,488

)

 —

 —

 —

 —

 —

 29,951

 ( 250,000
)

 —

 —

 —

 —

 —

 15,256

)

 —

 —

 —

 —

 —

 15,133

)

 —

 —

 —

 —

 —

 75,000

 6,125

 ( 75,000
)

 —

 —

 —

 —

 VALUE

 $

 $
 —

 $
 17,175

 $
)

 $
 —

 $
 —

 $
 —

 —

 —

 90,000

 6,900

 ( 90,000
)

 —

 —

 —

 —

 —

 70,000

 5,075

 ( 70,000
)

 —

 —

 —

 —

 —

 75,000

 5,167

 ( 75,000
)

 —

 —

 —

 —

 —

 55,000

 3,575

 ( 55,000
)

 —

 —

 —

 —

 —

 75,000

 4,542

 ( 75,000
)

 —

 —

 —

 —

 —

 75,000

 4,229

 ( 75,000
)

 —

 —

 —

 —

 —

 21,203

 ( 200,000
)

 —

 —

 —

 —

 —

 16,054

)

 —

 —

 —

 —

 —

 16,168

)

 —

 —

 —

 —

 —

 16,308

)

 —

 —

 —

 —

 —

 16,464

)

 —

 —

 —

 —

 50,000

 —

 5,518

 ( 50,000
)

 —

 —

 —

 —

 —

 27,756

 ( 250,000
)

 —

 —

 —

 —

 —

 28,098

 ( 250,000
)

 —

 —

 —

 —

 —

 28,408

 ( 250,000
)

 —

 —

 —

 —

 —

 13,458

)

 —

 —

 —

 —

 220,000

 —

 25,429

 ( 220,000
)

 —

 —

 —

 —

 —

 23,371

 ( 200,000
)

 —

 —

 —

 —

 20,000

 —

 2,355

 ( 20,000
)

 —

 —

 —

 —

 —

 4,746

 ( 40,000
)

 —

 —

 —

 —

 —

 71,384

 ( 500,000
)

 —

 —

 —

 —

 VALUE

 $

 $
 —

 $
 73,869

 $
 ( 500,000
)

 $
 —

 $
 —

 $
 —

 —

 —

 —

 —

 —

 —

 —

 —

 —

 90,000

 4,625

 ( 90,000
)

 —

 —

 —

 —

 —

 4,722

 ( 100,000
)

 —

 —

 —

 —

 —

 4,466

 —

 —

 —

 —

 —

 —

 —

 Hera Systems, Inc. Series A Preferred*

 8,377

 —

 —

 —

 —

 ( 3,642
)

 4,735

 3,642,324

 Hera Systems, Inc. Series B Preferred*

 229,479

 —

 —

 —

 —

 46,106

 275,585

 7,039,203

 Hera Systems, Inc. Series B Warrants*

 398,738

 —

 —

 —

 —

 79,870

 478,608

 12,250,000

 Hera Systems, Inc. Series B Warrants*

 202,296

 —

 —

 —

 —

 40,521

 242,817

 6,214,922

 Hera Systems, Inc. Series B Warrants*

 170,888

 —

 —

 —

 —

 34,230

 205,118

 5,250,000

 Hera Systems, Inc. Series B Warrants*

 22,785

 —

 —

 —

 —

 4,564

 27,349

 Hera Systems, Inc. Series C Preferred*

 86,390

 —

 —

 —

 —

 17,357

 103,747

 Total Aerospace

 $
 5,498,953

 $
 580,691

 $
 —

 $
 219,006

 $
 7,897,750

 —

 ( 5,721,295
)

 —

 —

 ( 4,214,960
)

 6,746,169

 —

 ( 542,140
)

 —

 —

 ( 499,898
)

 800,102

 —

 ( 178,884
)

 —

 —

 ( 192,269
)

 —

 ( 183,777
)

 —

 —

 ( 192,269
)

 —

 58,522

 —

 —

 ( 1,153,611
)

 1,846,389

 VALUE

 $

 $
 —

 $
 ( 296,025
)

 $
 —

 $
 —

 $
 ( 384,537
)

 $
 615463

 —

 ( 104,983
)

 —

 —

 ( 153,815
)

 246,185

 —

 ( 141,630
)

 —

 —

 ( 192,269
)

 —

 ( 157,311
)

 —

 —

 ( 288,403
)

 461,597

 —

 ( 111,390
)

 —

 —

 ( 192,269
)

 —

 ( 6,781
)

 —

 —

)

 —

 ( 10,274
)

 —

 —

)

 —

 ( 29,178
)

 —

 —

 ( 384,537
)

 —

 ( 17,877
)

 —

 —

)

 —

 ( 105,249
)

 —

 —

 ( 384,537
)

 615,462

 —

 ( 20,753
)

 —

 —

)

 —

 ( 421
)

 —

 —

)

 —

 ( 34,726
)

 —

)

 —

 —

 ( 76,907
)

 $
 123,093

 —

 —

 ( 269,176
)

 430,824

 VALUE

 $
 —
 $
 $
 —

 $
 —

 $
 —

 $
 ( 57,681
)

 $
 92,319

 —

 —

 —

 —

 ( 134,588
)

 215,412

 IntraOp Medical Corp. Series C Preferred*

 670,062

 —

 —

 —

 —

 ( 670,062
)

 —

 26,856,187

 IntraOp Medical Corp. Term Note*

 —

 39,452

 —

 —

 ( 769,074
)

 1,230,926

 Total Medical Devices

 $
 27,081,191

 $
 ( 7,564,540
)

 $
 —

 $
 ( 11,364,470
)

 $

 Pivotal Systems Corp. CDI*(1)

 9,287,771

 —

 —

 ( 2,107,064
)

 2,097,192

 ( 9,277,899
)

 —

 —

 SVXR, Inc. Series A Preferred Stock

 —

 —

 —

 —

)

 4,082,192

 —

 —

 Revasum, Inc. CDI*(1)

 21,466,824

 2,734

 —

 ( 3,100,396
)

 ( 1,146,382
)

 ( 13,702,284
)

 39,774,889

 Total Semiconductor Equipment

 $
 30,754,595

 $
 —

 $
 ( 3,131,382
)

 $
 ( 18,897,991
)

 $

 Silicon Genesis Corp. Common Stock*

 —

 —

 —

 —

 ( 166
)

 921,892

 Silicon Genesis Corp. Common Warrants*

 —

 —

 —

 —

 ( 2
)

 37,982

 Silicon Genesis Corp. Series 1-C Preferred Stock*

 1,990

 —

 —

 —

 —

 ( 1,028
)

 82,914

 Silicon Genesis Corp. Series 1-D Preferred*

 5,275

 —

 —

 —

 —

 ( 2,723
)

 2,552

 850,830

 Silicon Genesis Corp. Series 1-E Preferred*

 453,506

 —

 —

 —

 —

 ( 132,914
)

 320,592

 5,704,480

 Silicon Genesis Corp. Series 1-F Preferred*

 100,187

 —

 —

 —

 —

 ( 29,381
)

 70,806

 912,453

 VALUE

 Silicon Genesis Corp. Series 1-G Preferred*

 $
 439,206
 $
 —
 $
 —

 $
 —
 $
 —
 $
 ( 132,535
)

 $
 306,671

 $
 40,370,793

 Silicon Genesis Corp. Series 1-H Preferred*

 50,277

 —

 —

 —

 —

 ( 14,748
)

 35,529

 837,942

 Total Intellectual Property

 $
 1,050,721

 $
 —

 $
 —
 $
 ( 313,497
)

 $
 737,224

 UCT Coatings, Inc. Common Stock

 613,650

 —

 —

 —

 —

 ( 276,150
)

 1,500,000

 Total Advanced Materials

 $
 613,650

 $
 —

 $
 —
 $
 ( 276,150
)

 $

 Wrightspeed, Inc. Common Stock*

 1,126

 —

 —

 —

 —

 ( 580
)

 69,102

 —

 —

 —

 —

 ( 84,375
)

 40,625

 125.000

 —

 —

 —

 —

 ( 111,375
)

 53,625

 —

 —

 —

 —

 ( 91,125
)

 43,875

 —

 —

 —

 —

)

 —

 —

 —

 —

)

 —

 —

 —

 —

)

 —

 —

 —

 —

)

 —

 —

 —

 —

)

 —

 —

 —

 —

)

 —

 —

 —

 —

)

 —

 —

 —

 —

 ( 43,875
)

 21,125

 —

 —

 —

 —

 ( 124,875
)

 60,125

 —

 —

 —

 —

 ( 135,000
)

 —

 ( 20,533
)

 —

 —

 ( 472,500
)

 227,500

 VALUE

 $

 $
 —
 $
 ( 1,333
)

 $
 —
 $
 —

 $
)

 $

 —

 ( 13,000
)

 —

 —

)

 —

 ( 64,355
)

 —

 —

)

 —

 ( 45,000
)

 —

 —

)

 —

 ( 10,100
)

 —

 —

 ( 202,500
)

 97,500

 ( 51,807
)

 ( 270,000
)

 —

 ( 250,063
)

 —

 —

 ( 1,350,000
)

 650,000

 —

 ( 145,600
)

 —

 —

 ( 945,000
)

 455,000

 —

 ( 105,600
)

 —

 —

 ( 810,000
)

 390,000

 —

 ( 76,000
)

 —

 —

)

 —

 ( 24,333
)

 —

 —

)

 —

 ( 53,000
)

 —

 —

)

 —

 ( 159,157
)

 —

 —

 ( 708,750
)

 341,250

 —

 ( 56,294
)

 —

 —

 ( 270,000
)

 —

 ( 50,813
)

 —

 —

 ( 253,125
)

 121,875

 —

 ( 147,524
)

 —

 —

 607,500
)

 292,500

 —

 ( 131,069
)

 —

 —

 ( 506,250
)

 243,750

 —

 ( 1,625,767
)

 —

 —

 ( 3,327,085
)

 1,601,930

 Wrightspeed, Inc. Series AA Preferred*

 1,777,068

 —

 —

 —

 —

 ( 727,590
)

 60,733,693

 Wrightspeed, Inc. Series AA Warrants*

 7,500

 —

 —

 —

 —

 ( 4,268
)

 3,232

 609,756

 Total Automotive
 $
 23,189,709

 $
 ( 3,031,348
)

 $
 —

 $
 ( 16,952,023
)
 $
 8,862,686

 Total Affiliates and Controlled Investments
 $
 90,118,729

 $
 ( 10,015,197
)

 $
 ( 3,131,382
)
 $
 ( 48,287,910
)
 $
 39,349,502

 Total Affiliates

 613,650

 —

 $
)

 3,806,042

 Total Controlled Investments

 $
 89,505,079

 $
 ( 10,015,197
)

 $
 950,810

 $
 ( 52,093,952
)

 $
 39,012,002

 *

 Controlled investments.

 ( 1)

 CDI:CHESS Depositary Interests

 As of December 31, 2023, Kevin Landis, the Company's Chairman, President and Chief Executive Officer, represented the Company and sat on the boards of directors of Hera Systems, Inc.; IntraOp Medical Corp.; Revasum, Inc.; and Wrightspeed, Inc. As of December 31, 2023, Mr. Landis served as interim CEO at IntraOp Medical Corp. and Wrightspeed, Inc. Serving on boards of directors of portfolio companies may cause conflicts of interest. The Advisor has adopted various procedures to ensure that the Company will not be unfavorably affected by these potential conflicts.

 Unconsolidated Significant Subsidiaries

 Our investments are generally in small companies in a variety of industries. In accordance with Rules 3 - 09 and 4 - 08 (g) of Regulation S- X ("Rule 3 - 09" and "Rule 4 - 08 (g)," respectively), we must determine which of our unconsolidated controlled portfolio companies are considered "significant subsidiaries," if any as defined by S- X Rule 1 - 02 (w)( 2). In evaluating these investments, there are two tests utilized to determine if any of our controlled investments are considered significant subsidiaries: the investment test, and the income test. Rule 3 - 09 requires separate audited financial statements of an unconsolidated majority-owned subsidiary in an annual report if any of the three tests exceeds 20%. Rule 4 - 08 (g) requires summarized financial information in an annual report if any of the three tests exceeds 10% and summarized financial information in a quarterly report if any of the three tests exceeds 20%.

 As of December 31, 2023, our investments in Hera Systems, Inc. ("Hera") and Revasum, Inc. ("Revasum") exceeded the 20 % significance threshold in at least one of the tests under Rule 3 - 09 (the "Rule"). The Rule requires audited financial statements be attached as exhibits to the Form 10 -K. However, because Hera's audited financial statements are not yet available, summarized financial statement information will be provided as noted below which is a requirement of Rule 4 - 08 (g) for investments that exceed 10% of one of the significance tests. Further, because Revasum's audited financials for 2023 are not yet available, its audited financials for 2022 are attached as an exhibit and will be supplemented with 2023 financials when they become available.

 HERA SYSTEMS, INC.

 BALANCE SHEET DATA AS OF:

 12/31/2023

 12/31/2022

 Total Current Assets

 $
 9,056,463

 $
 6,108,143

 Total Non-Current Assets

 $
 102,851

 $
 140,285

 Total Current Liabilities

 $
 16,076,101

 $
 11,571,082

 Total Non-Current Liabilities

 $
 —

 $
 1,203,300

 Non-controlling interest

 $
 —

 $
 —

 INCOME STATEMENT DATA FOR THE YEARS ENDED:

 12/31/2023

 12/31/2022

 12/31/2021

 Revenue

 $
 14,834,683

 $
 4,541,826

 $
 —

 Gross Profits

 $
 1,248,611

 $
 339,482

 $
 —

 Income/(loss) from operations

 $
 250,937

 $
 ( 1,180,839
)

 $
 ( 1,537,472
)

 Total net income/(loss) including net income/(loss) attributable to non-controlling interest

 $
 ( 390,832
)

 $
 ( 3,581,348
)

 $
 ( 2,455,401
)

 Net Income/(loss) attributable to non-controlling interest

 $
 —

 $
 —

 $
 —

 NOTE 11. MARKET DISRUPTION AND GEOPOLITICAL RISKS

 Certain local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, or other events could have a significant impact on a security or instrument. Since 2020, the novel strain of coronavirus (COVID- 19) has negatively affected the worldwide economy, as well as the economies of individual countries, the financial health of individual companies and the market in general in significant and unforeseen ways. Following Russia's large-scale invasion of Ukraine, the President of the United States signed an Executive Order in February 2022 prohibiting U.S. persons from entering transactions with the Central Bank of Russia and Executive Orders in March 2022 prohibiting U.S. persons from importing oil and gas from Russia as well as other popular Russian exports, such as diamonds, seafood and vodka. The duration of the coronavirus outbreak and the Russian-Ukraine conflict could adversely affect the Company's performance. The ultimate impact of COVID- 19 and Russia invasion on the financial performance of the Company's investments is not reasonably estimable at this time.

 NOTE 12. SUBSEQUENT EVENTS

 Management has evaluated the impact of all subsequent events on the Company through the date the financial statements were issued. Subsequent to year end, on February 5, 2024, the securities of Revasum (the "Company") were suspended from quotation under Listing Rule 17.2 of the ASX (Australian Securities Exchange). The suspension was extended for an additional two weeks on March 4, 2024, as the Company continues to pursue its strategic process which includes acquisition offers from third -parties.

 On March 18, 2024, the ASX suspended Revasum securities from quotation indefinitely under Listing Rule 17.5 for the Company's failure to file its annual financial report in a timely manner.

 Item 9.

 CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 None

 Item 9A.

 CONTROLS AND PROCEDURES

 DISCLOSURE CONTROLS AND PROCEDURES

 Our Chief Executive Officer and Chief Financial Officer performed an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of December 31, 2022, and, based on that evaluation, have concluded that the disclosure controls and procedures are effective.

 REPORT OF MANAGEMENT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of, our principal executive and financial officer, or persons performing similar functions, and effected by our Board of Directors, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and our directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.

 Our management evaluated as of December 31, 2023, the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework. Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2023.

 INHERENT LIMITATIONS OF EFFECTIVENESS OF CONTROLS

 Our management, including our Chief Executive Officer and Chief Financial Officer, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the control. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

 CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 There have been no changes in our internal control over financial reporting that occurred during our fourth quarter ended December 31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 Item 9B.

 OTHER INFORMATION

 None

 Item 10.

 DIRECTORS, EXECUTIVES OFFICERS AND CORPORATE GOVERNANCE

 Information required by this item will be contained in the Company's proxy statement to be filed with the SEC, in connection with the Company's annual meeting of shareholders to be held in 2024 (the "2024 Proxy Statement"), which information is incorporated herein by reference.

 The Company has adopted a code of ethics that applies to the Company's chief executive officer, a copy of which is posted on our website

 Our CEO certifies the accuracy of the financial statements contained in our periodic reports, and so certified in this Form 10-K through the filing of Section 302 certifications as exhibits to this Form 10-K.

 Section 16(a) Beneficial Ownership Reporting Compliance

 Section 16(a) of the Securities Exchange Act of 1934 requires the Company's officers and directors, and persons who own more than ten percent of a registered class of the Company's equity securities, to file with the Securities and Exchange Commission and the Nasdaq Stock Market reports of ownership of the Company's securities and changes in reported ownership. Officers, directors and greater than ten percent shareholders are required by SEC rules to furnish the Company with copies of all Section 16(a) reports they file.

 Based solely on a review of the reports furnished to the Company, or written representations from reporting persons that all reportable transaction were reported, the Company believes that during the fiscal year ended December 31, 2022, the Company's officers, directors and greater than ten percent owners timely filed all reports they were required to file under Section 16(a).

 Item 11.

 EXECUTIVE COMPENSATION

 Information required by this item will be contained in the 2023 Proxy Statement, which information is incorporated herein by reference.

 Item 12.

 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 Information required by this item will be contained in the 2024 Proxy Statement, which information is incorporated herein by reference.

 Item 13.

 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 Information required by this item will be contained in the 2024 Proxy Statement, which information is incorporated herein by reference.

 Item 14.

 PRINCIPAL ACCOUNTANT FEES AND SERVICES

 Information required by this item will be contained in the 2023 Proxy Statement, which information is incorporated herein by reference.

 Item 15.

 EXHIBITS, FINANCIAL STATEMENTS SCHEDULES

 1. Financial Statements

 The following financial statements of the Company are filed as part of this report:

 AUDITED FINANCIAL STATEMENTS

 Report of Independent Registered Public Accounting Firm

 Statement of Assets and Liabilities as of December 31, 202 3

 Schedule of Investments as of December 31, 202 3

 Statement of Operations as of December 31, 202 3

 Statement of Cash Flows as of December 31, 202 3

 Statement of Changes in Net Assets as of December 31, 202 3

 Financial Highlights

 Notes to Financial Statements

 EXHIBIT INDEX

 Exhibit Number

 Descriptions

 3.1

 Registrant's Articles of Amendment and Restatement are incorporated by reference to Exhibit (a)(2) of Pre-Effective Amendment No. 1 to the Registrant's Registration Statement on Form N-2 (File No. 333-168195) as filed with the Securities and Exchange Commission on September 24, 2010.

 3.2

 Certificate of Correction to Registrant's Articles of Amendment and Restatement is incorporated by reference to Exhibit (a)(2) of the Registrant's Registration Statement on Form N-2 (File No. 333-179606) as filed with the Securities and Exchange Commission on February 21, 2012.

 3.3

 Registrant's Amended and Restated Bylaws – is incorporated by reference to Exhibit 3.1 to the Registrant's Form 8-K as filed with the Securities and Exchange Commission on October 29, 2021.

 10.1

 Registrant's Dividend Reinvestment Plan is incorporated by reference to Exhibit (e) of Pre-Effective Amendment to the Registrant's Registration Statement on Form N-2 (File No. 333-168195) as filed with the Securities and Exchange Commission on September 24, 2010.

 10.2

 Form of Investment Management Agreement between Registrant and SiVest Group, Inc. (now known as Firsthand Capital Management, Inc.) is incorporated by reference to Exhibit (g) of Pre-Effective Amendment to the Registrant's Registration Statement on Form N-2 (File No. 333-168195) as filed with the Securities and Exchange Commission on September 24, 2010.

 10.3

 Form of Custodian Services Agreement between Registrant and PFPC Trust Company is incorporated by reference to Exhibit (j) of Pre-Effective Amendment to the Registrant's Registration Statement on Form N-2 (File No. 333-168195) as filed with the Securities and Exchange Commission on September 24, 2010.

 10.4

 Form of Administration and Accounting Agreement between Registrant and BNY Mellon Investment Servicing (US), Inc. is incorporated by reference to Exhibit (k)(1) of Pre-Effective Amendment to the Registrant's Registration Statement on Form N-2 (File No. 333-168195) as filed with the Securities and Exchange Commission on September 24, 2010.

 10.4.1

 Form of Amendment to Administration and Accounting Agreement between Registrant and BNY Mellon Investment Servicing (US), Inc. as filed with the Securities and Exchange Commission on March 18, 2019.

 10.5

 Notice of Assignment dated February 9, 2011 by PFPC Trust Company assigning Custodian Services Agreement is incorporated by reference to Exhibit (j)(2) of the Registrant's Registration Statement on Form N-2 (File No. 333-179606) as filed with the Securities and Exchange Commission on February 21, 2012.

 10.6

 Form of Transfer Agency Services Agreement between Registrant and BNY Mellon Investment Servicing (US), Inc. is incorporated by reference to Exhibit (k)(2) of Pre-Effective Amendment to the Registrant's Registration Statement on Form N-2 (File No. 333-168195) as filed with the Securities and Exchange Commission on September 24, 2010.

 14.1

 Registrant's Code of Ethics for Principal Executive and Senior Financial Officers is incorporated by reference to Exhibit 14 to the Registrant's Form 10-K as filed with the Securities and Exchange Commission on March 21, 2012.

 24.1

 Power of Attorney is incorporated by reference to Exhibit 24 to the Registrant's Form 10-K as filed with the Securities and Exchange Commission on March 21, 2012.

 31.1

 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. – filed herewith

 32.1

 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. – filed herewith.

 99.1

 Separate Financial Statements of Revasum, Inc. filed pursuant to Rule 3-09 and 4-08(g) of regulation S-X-filed herewith.

 101.INS

 101.SCH

 101.CAL

 101.DEF

 101.LAB

 101.PRE

 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 FIRSTHAND TECHNOLOGY VALUE FUND, INC.

 Date: April 5, 2023

 By:

 Kevin Landis
 President

 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated.

 Signatures

 Title

 Date

 /s/ Kevin Landis

 Chairman of the Board, Chief Executive Officer, and Chief Financial Officer

 March [ ], 2024

 Kevin Landis

 *

 Director

 March [ ], 2024

 Greg Burglin

 *

 Director

 March [ ], 2024

 Kimun Lee

 * Signed by Kevin Landis pursuant to powers of attorney.

 Privacy Notice

 FIRSTHAND TECHNOLOGY VALUE FUND, INC.

 FACTS

 WHAT DOES FIRSTHAND TECHNOLOGY VALUE FUND, INC. DO WITH YOUR PERSONAL INFORMATION?

 Why?

 Financial companies choose how they share your personal information. Federal law gives consumers the right to limit some but not all sharing. Federal law also requires us to tell you how we collect, share, and protect your personal information. Please read this notice carefully to understand what we do.

 What?

 The types of personal information we collect and share depend on the product or service you have with us. This information can include:
 Social Security number
 Banking information
 Account transactions
 Retirement assets

 How?

 All financial companies need to share customers' personal information to run their everyday business. In the section below, we list the reasons financial companies can share their customers' personal information; the reasons Firsthand Capital management, Inc. chooses to share; and whether you can limit this sharing.

 Reasons we can share your personal information

 Does Firsthand Technology
 Value Fund, Inc. share?

 Can you limit this sharing?

 For our everyday business purposes —such as to process your transactions, maintain your account(s), respond to court orders and legal investigations

 Yes

 No

 For our marketing purposes —to offer our products and services to you

 No

 N/A

 For joint marketing with other financial companies

 No

 N/A

 For our affiliates ' everyday business purposes —information about your transactions and experiences

 No

 N/A

 For our affiliates ' everyday business purposes —information about your creditworthiness

 No

 N/A

 For our affiliates to market to you

 No

 N/A

 For nonaffiliates to market to you

 No

 N/A

 Who we are

 Who is providing this notice?

 Firsthand Technology Value Fund, Inc. is a publicly traded venture capital fund, listed on NASDAQ, that is a business development company under the Investment Company Act of 1940

 What we do

 How does Firsthand Technology Value Fund, Inc. protect my personal information?

 To protect your personal information from unauthorized access and use, we use security measures that comply with federal law. These measures include computer safeguards and secured files and buildings.

 How does Firsthand Technology Value Fund, Inc. collect my personal information?

 We collect your personal information, for example, when you
 open an account or deposit money

 Why can't I limit all sharing?

 Federal law gives you the right to limit only
 sharing for affiliates' everyday business purposes—information about your creditworthiness
 affiliates from using your information to market to you
 sharing for nonaffiliates to market to you
 State laws and individual companies may give you additional rights to limit sharing.

 Definitions

 Affiliates

 Companies related by common ownership or control. They can be financial and nonfinancial companies.
 Firsthand Capital Management, Inc. and Firsthand Funds

 Nonaffiliates

 Companies not related by common ownership or control. They can be financial and nonfinancial companies.
 BNY Mellon Investment Servicing (U.S.) Inc. (Transfer Agent for Firsthand Technology Value Fund, Inc. and Firsthand Funds)

 Joint marketing

 A formal agreement between nonaffiliated financial companies that together market financial products or services to you.

 Other important information

 This notice applies to individual consumers who are customers or former customers. This notice replaces all previous notices of our consumer privacy policy, and may be amended at any time. We will keep you informed of changes or amendments as required by law.

 Additional Information for California Residents

 This section supplements the information contained in the other sections of this Privacy Notice and applies solely to clients, visitors, users, and others who reside in the state of California ("consumers" or "you") and for whom we have data that is subject to the California Consumer Privacy Act of 2018 as may be amended or supplemented from time to time ("CCPA"). This Privacy Notice, including this additional information, is provided to comply with the CCPA and other California privacy laws. Any terms defined in the CCPA have the same meaning when used in this section.

 Depending upon how you interact with us, you may have various rights in connection with our processing of your personal information, each of which is explained below.

 Access. You may have the right to confirm with us whether your personal information is processed, and if it is, to request access to that personal information including the categories of personal information processed, the purpose of the processing and the recipients or categories of recipients. We do have to consider the interests of others though, so this is not an absolute right and there are additional exceptions under the CCPA. Also, we are not obligated to respond to more than two access requests for the same individual's personal information within a 12-month period.
 Deletion. You may have the right to ask us to erase personal information concerning you, except we are not obligated to do so if we need to retain such data in order to comply with a legal obligation or to establish, exercise, or defend legal claims or under other exceptions under the CCPA.

 You have a right to receive non-discriminatory treatment for the exercise of the privacy rights conferred by the CCPA.

 To exercise one or more of these rights, please contact us as explained below. Please note that we may need to verify your identity before we can fulfill your request.

 You can submit your request by calling us at (800) 331-1710.

 When we tell you that we need additional information to verify your identity, you must get us the information within ten (10) calendar days or we may deny your request. We will endeavor to respond to a verified request within 45 days, unless there are grounds for extending our response timeframe by up to an additional 45 days. In the event of an extension, we will explain to you why the extension is necessary. In some cases, your ability to access or delete your personal information will be limited, as required or permitted by applicable law, even when the CCPA applies to the personal information we have for you.

 [THIS PAGE INTENTIONALLY LEFT BLANK]